| Title | Author | Year | SCOPUS | PUBMED | ISI | TCI | |
|---|---|---|---|---|---|---|---|
| 1. | Expression and Function of Candidate Genes Involved in Cholangiocarcinama | Watcharin Loilome Puangrat Yongvanit |
2005 | ||||
| 2. | Altered gene expression in Opisthorchis viverrini-associated cholangiocarcinoma in hamster model. | Loilome, W. Yongvanit, P. Wongkham, C. Tepsiri, N.N. Sripa, B. Sithithaworn, P. Miwa, M. |
2006 | ||||
| 3. | Altered gene expression levels associating with 5-fluorouracil resistance in cholangiocarcinoma cell lines | Nisana N. Tepsiri Watcharin Loilome Piyawan Amimanan Patcharee Jearanaikoon Wichittra Tassaneeyakul |
2006 | ||||
| 4. | Plasma 8-isoprostane: a new biomarker in opisthorchiasis-associated cholangiocarcinoma | Puangrat Yongvanit Somkid Dechakhamphu Somchai Pinlaor Nisana N. Tepsiri Watcharin Loilome Narong Khantekaew Paiboon Sithithaworn |
2006 | ||||
| 5. | Prkar1a gene overexpression in liver tissue with cholangiocarcinoma | Watcharin Loilome Anucha Puapairoj Nisana N. Tepsiri Paiboon Sithithaworn Masanao Miwa Puangrat Yongvanit |
2006 | ||||
| 6. | Comparison of Italic cytoxicity of generic paclitaxel and irinotecan formulations with their reference formulations on seven human intrahepatic cholangiocarcinoma cell lines | Nisana Namwat Banchob Sripa Watcharin Loilome Vajarabhongsa Bhudisawadi Wichittra Tassaneeyakul |
2007 | ||||
| 7. | Characterization of 5-fluorouracil-resistant cholangiocarcinoma cell lines | Namwat, N. Amimanan, P. Loilome, W. Jearanaikoon, P. Sripa, B. Bhudhisawasdi, V. Tassaneeyakul, W. |
2008 | ||||
| 8. | Over-expression of PRKAR1A in hepatic progenitor cells during cholangiocarcinogenesis induced by liver fluke (Opisthorchis, viverrini) | P. Yonavanit N. Namwat W. Loilome R. Thanan E. Phanomsri C. Pairojkul |
2008 | ||||
| 9. | Glioblastoma cell growth is suppressed by disruption of fibroblast growth factor pathway signaling | Loilome, W. | 2009 | ||||
| 10. | Apoptotic activity of caged xanthones from Garcinia hanburyi in cholangiocarcinoma cell lines | Chariya Hahnvajanawong Wongwarut Boonyanugomol Tapanawan Nasomyon Watcharin Loilome Nisana Namwat Natthinee Anantachoke Wichittra Tassaneeyakul Banchob Sripa Wises Namwat Vichai Reutrakul |
2010 | ||||
| 11. | Determination of Growth Inhibitory Effect of Gemcitabine on Human Intrahepatic Cholangiocarcinoma Cell lines and Comparison of its Inhibition Between the Generic and Reference Formulation | Hasaya Dokduang Nisana Namwat Apinya Jusakul Vajarabhongsa Bhudisawadi Watcharin Loilome Puangrat Yongvanit Banchob Sripa Wichittra Tassaneeyakul |
2010 | ||||
| 12. | Erratum: Glioblastoma cell growth is suppressed by disruption of fibroblast growth factor pathway signaling (Journal of Neuro-Oncology DOI:10.1007/s11060- 009-9885-5) | Loilome, W. | 2010 | ||||
| 13. | Glioblastoma cell growth is suppressed by disruption of fibroblast growth factor pathway signaling (vol 94, pg 359, 2009) | Watcharin Loilome Avadhut D. Joshi Colette M. J. ap Rhys Sara Piccirillo Angelo L. Vescovi Gary L. Gallia Gregory J. Riggins |
2010 | ||||
| 14. | Myristoylated alanine-rich C kinase substrate phosphorylation promotes cholangiocarcinoma cell migration and metastasis via the protein kinase C-dependent pathway | Techasen, A Loilome, W Namwat, N Takahashi, E Sugihara, E Puapairoj, A Miwa, M Saya, H Yongvanit, P |
2010 | ||||
| 15. | Adverse Effects Caused by Adaptive Imbalance to Genotoxic Stress after Infection and Inflammation | Sasithorn Kadsanit Chadamas Pinitsoontorn Watcharin Loilome Puangrat Yongvanit |
2011 | ||||
| 16. | Downregulation of reversion-inducing-cysteine-rich protein with Kazal motifs (RECK) is associated with enhanced expression of matrix metalloproteinases and cholangiocarcinoma metastases | Namwat, N. Puetkasichonpasutha, J. Loilome, W. Yongvanit, P. Techasen, A. Puapairoj, A. Sripa, B. Tassaneeyakul, W. Khuntikeo, N. Wongkham, S. |
2011 | ||||
| 17. | Mechanisms of oxysterol-induced carcinogenesis | Jusakul, A Yongvanit, P Loilome, W Namwat, N Kuver, R |
2011 | ||||
| 18. | PRKAR1A is overexpressed and represents a possible therapeutic target in human cholangiocarcinoma. | Watcharin Loilome Sirinun Juntana Nisana Namwat Vajarabhongsa Bhudhisawasdi Anucha Puapairoj Banchob Sripa Masanao Miwa Hideyuki Saya Gregory J. Riggins Puangrat Yongvanit |
2011 | ||||
| 19. | Anti-inflammatory agents suppress the prostaglandin E2 production and migration ability of cholangiocarcinoma cell lines. | Jurairat Jongthawin Anchalee Techasen Watcharin Loilome Puangrat Yongvanit Nisana Namwat |
2012 | ||||
| 20. | Anti-inflammatory, antioxidant and hepatoprotective effects of Thunbergia laurifolia Linn. on experimental opisthorchiasis | Wonkchalee, O Boonmars, T Aromdee, C Laummaunwai, P Khunkitti, W Vaeteewoottacharn, K Sriraj, P Aukkanimart, R Loilome, W Chamgramol, Y Pairojkul, C Wu, Z Juasook, A Sudsarn, P |
2012 | ||||
| 21. | Anti-inflammatory effect of prednisolone on the growth of human liver fluke in experimental opisthorchiasis | Amornrat Juasook Thidarut Boonmars Sasithorn Kaewkes Watcharin Loilome Kulathida Veteewuthacharn Zhiliang Wu Puangrat Yongvanit |
2012 | ||||
| 22. | Cytokines released from activated human macrophages induce epithelial mesenchymal transition markers of cholangiocarcinoma cells. | Techasen, A. Loilome, W. Namwat, N. Dokduang, H. Jongthawin, J. Yongvanit, P. |
2012 | ||||
| 23. | Down-Regulated Expression of HSP70 in Correlation with Clinicopathology of Cholangiocarcinoma | Boonjaraspinyo, S Boonmars, T Kaewkes, S Laummaunwai, P Pinlaor, S Loilome, W Yongvanit, P Wu, Z Puapairoj, A Bhudhisawasdi, V |
2012 | ||||
| 24. | Evaluation of Tyrosine Kinase Inhibitor Combinations for Glioblastoma Therapy | Joshi, AD Loilome, W Siu, IM Tyler, B Gallia, GL Riggins, GJ |
2012 | ||||
| 25. | Expression of oxysterol binding protein isoforms in opisthorchiasis-associated cholangiocarcinoma: A potential molecular marker for tumor metastasis | Loilome, W Wechagama, P Namwat, N Jusakul, A Sripa, B Miwa, M Kuver, R Yongvanit, P |
2012 | ||||
| 26. | Expression profiles of oncomir miR-21 and tumor suppressor let-7a in the progression of Opisthorchiasis-associated cholangiocarcinoma | N. Namwat P. Chusorn W. Loilome A. Techasen J. Puetkasichonpasutha C. Pairojkul N. Khuntikeo P. Yongvanit |
2012 | ||||
| 27. | Hepatic cytochrome P450 2A6 and 2E1 status in peri-tumor tissues of patients with Opisthorchis viverrini-associated cholangiocarcinoma. | Puangrat Yongvanit Emorn Phanomsri Nisana Namwat Jureeporn Kampan Wichittra Tassaneeyakul Watcharin Loilome Anucha Puapairoj Narong Khuntikeo |
2012 | ||||
| 28. | Identification of biliary bile acids in patients with benign biliary diseases, hepatocellular carcinoma and cholangiocarcinoma. | Jusakul, A. Khuntikeo, N. Ioannou, G.N. Loilome, W. Namwat, N. Bhudhisawasdi, V. Pugkhem, A. Pairojkul, C. Yongvanit, P. |
2012 | ||||
| 29. | Identification of pathogenic cholesterol oxidation products in hepatic tissue and bile of cholangiocarcinoma patients | A. Jusakul W. G. Haigh C. Savard W. Loilome N. Namwat N. Khuntikeo C. Pairojkul S. Pinlaor R. Kuver P. Yongvanit |
2012 | ||||
| 30. | Impaired antioxidant enzyme activity and increased DNA repair enzyme expression in hamster liver tissues related to cholangiocarcinoma development. | Watcharin Loilome Sasithorn Kadsanit Nisana Namwat Anchalee Techasen Anucha Puapairoj Ananya Dechakhamphu Chadamas Pinitsoontorn Puangrat Yongvanit |
2012 | ||||
| 31. | Increased expression of TLR-2, COX-2, and SOD-2 genes in the peripheral blood leukocytes of opisthorchiasis patients induced by Opisthorchis viverrini antigen | Yongvanit, P Thanan, R Pinlaor, S Sithithaworn, P Loilome, W Namwat, N Techasen, A Dechakhamphu, S |
2012 | ||||
| 32. | Liver fluke-induced hepatic oxysterols stimulate DNA damage and apoptosis in cultured human cholangiocytes. | Apinya Jusakul Watcharin Loilome Nisana Namwat W. Geoffrey Haigh Rahul Kuver Somkid Dechakhamphu Pradit Sukontawarin Somchai Pinlaor Sum P. Lee Puangrat Yongvanit |
2012 | ||||
| 33. | Molecular Carcinogenesis of Cholangiocarcinoma II: Associated Genes in the Genesis of Cholangiocarcinoma | Nisana Namwat Watcharin Loilome Puangrat Yongvanit Thailand Khon Kaen University |
2012 | ||||
| 34. | Opisthorchis viverrini-antigen induces expression of MARCKS during inflammation-associated cholangiocarcinogenesis | Anchalee Techasen Watcharin Loilome Nisana Namwat Kunyarat Duenngai Ubon Cha'on Raynoo Thanan Paiboon Sithithaworn Masanao Miwa Puangrat Yongvanit |
2012 | ||||
| 35. | Overexpression of PDGFA and its receptor during carcinogenesis of Opisthorchis viverrini-associated cholangiocarcinoma. | Boonjaraspinyo, S. Boonmars, T. Kaewkes, S. Loilome, W. Sithithaworn, P. Yongvanit, P. Bhudhisawasdi, V. |
2012 | ||||
| 36. | PI3K/Akt Signaling Pathway in Normal and Malignant Cells | Supak Yothaisong Watcharin Loilome |
2012 | ||||
| 37. | Platelet-derived growth factor may be a potential diagnostic and prognostic marker for cholangiocarcinoma. | Boonjaraspinyo, S. Boonmars, T. Loilome, W. Sithithaworn, P. Pinlaor, S. Yongvanit, P. Nielsen, P.S. Pairojkul, C. Khuntikeo, N. |
2012 | ||||
| 38. | PRKAR1A overexpression is associated with increased ECPKA autoantibody in liver fluke-associated cholangiocarcinoma: application for assessment of the risk group. | Loilome, W Yooyuen, S Namwat, N Sithithaworn, P Puapairoj, A Kano, J Noguchi, M Miwa, M Yongvanit, P |
2012 | ||||
| 39. | Suppression of PRKAR1A expression enhances anti-proliferative and apoptotic effects of protein kinase inhibitors and chemotherapeutic drugs on cholangiocarcinoma cells. | Loilome, W. Juntana, S. Pinitsoontorn, C. Namwat, N. Tassaneeyakul, W. Yongvanit, P. |
2012 | ||||
| 40. | Tumor Microenvironment and its Functions | Malinee Thanee Puangrat Yongvanit Watcharin Loilome |
2012 | ||||
| 41. | Tumor necrosis factor-α (TNF-α) stimulates the epithelial-mesenchymal transition regulator Snail in cholangiocarcinoma | Techasen, A Namwat, N Loilome, W Bungkanjana, P Khuntikeo, N Puapairoj, A Jearanaikoon, P Saya, H Yongvanit, P |
2012 | ||||
| 42. | Anti-apoptotic phenotypes of cholestan-3β,5α,6β-triol- resistant human cholangiocytes: Characteristics contributing to the genesis of cholangiocarcinoma | Apinya Jusakul Watcharin Loilome Nisana Namwat Anchalee Techasen Rahul Kuver George N. Ioannou Christopher Savard W. Geoffrey Haigh Puangrat Yongvanit |
2013 | ||||
| 43. | Immunosuppressive prednisolone enhances early cholangiocarcinoma in Syrian hamsters with liver fluke infection and administration of N-nitrosodimethylamine | Juasook, A Boonmars, T Wu, Z Loilome, W Veteewuthacharn, K Namwat, N Sudsarn, P Wonkchalee, O Sriraj, P Aukkanimart, R |
2013 | ||||
| 44. | Increased activation of PI3K/AKT signaling pathway is associated with cholangiocarcinoma metastasis and PI3K/mTOR inhibition presents a possible therapeutic strategy | Yothaisong, S Dokduang, H Techasen, A Namwat, N Yongvanit, P Bhudhisawasdi, V Puapairoj, A Riggins, GJ Loilome, W |
2013 | ||||
| 45. | Inhibitory Effects of Xanthohumol on STAT3 Activation and Cancer Development in Cholangiocarcinoma Xenograft Model | Hasaya Dokduang Watcharin Loilome Nisana Namwat Anchalee Techasen Chawalit Pairojkul Narong Khuntikeo Yoshinori Murakami Puangrat Yongvanit |
2013 | ||||
| 46. | Overexpression of microRNA-21 regulating PDCD4 during tumorigenesis of liver fluke-associated cholangiocarcinoma contributes to tumor growth and metastasis | Chusorn, P Namwat, N Loilome, W Techasen, A Pairojkul, C Khuntikeo, N Dechakhamphu, A Talabnin, C Chan-On, W Ong, CK Teh, BT Yongvanit, P |
2013 | ||||
| 47. | Oxidized alpha-1 antitrypsin as a predictive risk marker of opisthorchiasis-associated cholangiocarcinoma | Jamnongkan, W. Techasen, A. Thanan, R. Duenngai, K. Sithithaworn, P. Mairiang, E. Loilome, W. Namwat, N. Pairojkul, C. Yongvanit, P. |
2013 | ||||
| 48. | Survey of activated kinase proteins reveals potential targets for cholangiocarcinoma treatment | Hasaya Dokduang Sirinun Juntana Anchalee Techasen Nisana Namwat Puangrat Yongvanit Narong Khuntikeo Gregory J. Riggins Watcharin Loilome |
2013 | ||||
| 49. | The expression of PGE2 biosynthesis-related enzymes and PGE2 receptors in cholangiocarcinoma | Jurairat Jongthawin Anchalee Techasen Puangrat Yongvanit Watcharin Loilome Chavalit Pairojkul Narong Khuntikeo Nisana Namwat |
2013 | ||||
| 50. | Activated macrophages promote Wnt/β-catenin signaling in cholangiocarcinoma cells. | Loilome, W. Bungkanjana, P. Techasen, A. Namwat, N. Yongvanit, P. Puapairoj, A. Khuntikeo, N. |
2014 | ||||
| 51. | Association of CYP39A1, RUNX2 and Oxidized Alpha-1 Antitrypsin Expression in Relation to Cholangiocarcinoma Progression | Khenjanta, C. Thanan, R. Jusakul, A. Techasen, A. Jamnongkan, W. Namwat, N. Loilome, W. Pairojkul, C. Yongvanit, P. |
2014 | ||||
| 52. | BMP-7 blocks the effects of TGF-β-induced EMT in cholangiocarcinoma | Kassaporn Duangkumpha Anchalee Techasen Watcharin Loilome Nisana Namwat Raynoo Thanan Narong Khuntikeo Puangrat Yongvanit |
2014 | ||||
| 53. | Circulating miR-192 in liver fluke-associated cholangiocarcinoma patients: a prospective prognostic indicator | Loilome, W. Yongvanit, P. Chusorn, P. Techasen, A. Boonmars, T. Khuntikeo, N. Chamadol, N. Pairojkul, C. Namwat, N. |
2014 | ||||
| 54. | Expression of 14-3-3 Sigma Protein in Cholangiocarcinoma Progression | Yingpinyapat Kittirat Suyanee Thongchot Watcharin Loilome Anchalee Techasen Puangrat Yongvanit Nisana Namwat |
2014 | ||||
| 55. | Expression Patterns of Selenoprotein P in Human Cholangiocarcinoma | Xurui Dai Suyanee Thongchot Watcharin Loilome Anchalee Techasen Puangrat Yongvanit Nisana Namwat |
2014 | ||||
| 56. | Gene Silencing of Translationally Controlled Tumor Protein (TCTP) | Nattaporn Phanthaphol Watcharin Loilome Anchalee Techasen Puangrat Yongvanit Nisana Namwat |
2014 | ||||
| 57. | Genetic and environmental determinants of risk for cholangiocarcinoma in Thailand. | Miwa, M Honjo, S You, G Tanaka, M Uchida, K Srivatanakul, P Khuhaprema, T Loilome, W Techasen, A Wongkham, C Limpaiboon, T Yongvanit, P Wongkham, S |
2014 | ||||
| 58. | High expression of HIF-1α, BNIP3 and PI3KC3: Hypoxia-induced autophagy predicts cholangiocarcinoma survival and metastasis | Thongchot, S Yongvanit, P Loilome, W Seubwai, W Phunicom, K Tassaneeyakul, W Pairojkul, C Promkotra, W Techasen, A Namwat, N |
2014 | ||||
| 59. | Histological confirmation of periductal fibrosis from ultrasound diagnosis in cholangiocarcinoma patients | Chamadol, N Pairojkul, C Khuntikeo, N Laopaiboon, V Loilome, W Sithithaworn, P Yongvanit, P |
2014 | ||||
| 60. | Increased EphB2 expression predicts cholangiocarcinoma metastasis | Khansaard, W Techasen, A Namwat, N Yongvanit, P Khuntikeo, N Puapairoj, A Loilome, W |
2014 | ||||
| 61. | Inhibitory effect of xanthohumol on STAT3 activation and cholangiocarcinoma development | H. Dokduang W. Loilome N. Namwat C. Pairojkul M. Sakurai-Yageta Y. Murakami P. Yongvanit |
2014 | ||||
| 62. | Loss of E-cadherin promotes migration and invasion of cholangiocarcinoma cells and serves as a potential marker of metastasis. | Anchalee Techasen Watcharin Loilome Nisana Namwat Narong Khuntikeo Anucha Puapairoj Patcharee Jearanaikoon Hideyuki Saya Puangrat Yongvanit |
2014 | ||||
| 63. | Milk fat globule epidermal growth factor 8 serves a novel biomarker of opisthorchiasis-associated cholangiocarcinoma. | Boonmars, T. Loilome, W. Yongvanit, P. Khuntikeo, N. Nielsen, P.S. |
2014 | ||||
| 64. | Opisthorchis viverrini Infection Activates the PI3K/AKT/PTEN and Wnt/beta-catenin Signaling Pathways in a Cholangiocarcinogenesis Model | Yothaisong, S. Thanee, M. Namwat, N. Yongvanit, P. Boonmars, T. Puapairoj, A. Loilome, W. |
2014 | ||||
| 65. | PGE2 signaling and its biosynthesis-related enzymes in cholangiocarcinoma progression | Jongthawin, J Chusorn, P Techasen, A Loilome, W Boonmars, T Thanan, R Puapairoj, A Khuntikeo, N Tassaneeyakul, W Yongvanit, P Namwat, N |
2014 | ||||
| 66. | Risk biomarkers for assessment and chemoprevention of liver fluke-associated cholangiocarcinoma. | Puangrat Yongvanit Somchai Pinlaor Watcharin Loilome |
2014 | ||||
| 67. | STATs profiling reveals predominantly-activated STAT3 in cholangiocarcinoma genesis and progression | Dokduang, H. Techasen, A. Namwat, N. Khuntikeo, N. Pairojkul, C. Murakami, Y. Loilome, W. Yongvanit, P. |
2014 | ||||
| 68. | Survey of activated kinase proteins reveals PI3K/Akt and Wnt/beta-catenin signaling pathways as potential targets for cholangiocarcinoma treatment | W. Loilome H. Dokduang S. Yothaisong P. Bungkanjana S. Juntana A. Techasen N. Namwat P. Yongvanit N. Khuntikeo A. Puapairoj |
2014 | ||||
| 69. | TPRG1L is a novel microRNA-21 target: a possible linkage between miR-21 and cellular senescence in liver fluke-associated cholangiocarcinoma | P. Chusorn N. Namwat W. Loilome A. Techasen C. Pairojkul N. Khuntikeo B. Tean Teh I. Lee P. Yongvanit |
2014 | ||||
| 70. | Tumor necrosis factor-α modulates epithelial mesenchymal transition mediators ZEB2 and S100A4 to promote cholangiocarcinoma progression. | Anchalee Techasen Nisana Namwat Watcharin Loilome Kassaporn Duangkumpha Anucha Puapairoj Hideyuki Saya Puangrat Yongvanit |
2014 | ||||
| 71. | Advances in the Diagnosis of Human Opisthorchiasis: Development of Opisthorchis viverrini Antigen Detection in Urine. | Chanika Worasith Christine Kamamia Anna Yakovleva Kunyarat Duenngai Chompunoot Wangboon Jiraporn Sithithaworn Nattaya Watwiengkam Nisana Namwat Anchalee Techasen Watcharin Loilome Puangrat Yongvanit Alex Loukas Paiboon Sithithaworn Jeffrey M. Bethony |
2015 | ||||
| 72. | A Promising Serum Autoantibody Marker, Anti-Heat Shock Protein 90α, for Cholangiocarcinoma. | Boonjaraspinyo, S. Juasook, A. Boonmars, T. Aukkanimart, R. Silsirivanit, A. Loilome, W. Sriraj, P. |
2015 | ||||
| 73. | Chloroquine exerts anti-metastatic activities under hypoxic conditions in cholangiocarcinoma cells | Thongchot, S Loilome, W Yongvanit, P Dokduang, H Thanan, R Techasen, A Namwat, N |
2015 | ||||
| 74. | Cohort profile: cholangiocarcinoma screening and care program (CASCAP). | Narong Khuntikeo Nittaya Chamadol Puangrat Yongvanit Watcharin Loilome Nisana Namwat Paiboon Sithithaworn Ross H. Andrews Trevor N. Petney Supannee Promthet Kavin Thinkhamrop Chaiwat Tawarungruang Bandit Thinkhamrop |
2015 | ||||
| 75. | Oxidative stress induced LAT1/CD98 expression via PI3K/AKT signaling pathway in cholangiocarcinoma: a potential therapeutic target | Supak Yothaisong Watcharin Loilome Promsuk Jutabha Hasaya Dokduang Hitoshi Endou Naohiko Anzai |
2015 | ||||
| 76. | Quantitative changes in tumor-associated M2 Macrophages characterize cholangiocarcinoma and their association with metastasis | Thanee, M Loilome, W Techasen, A Namwat, N Boonmars, T Pairojkul, C Yongvanit, P |
2015 | ||||
| 77. | A Comprehensive Public Health Conceptual Framework and Strategy to Effectively Combat Cholangiocarcinoma in Thailand | Khuntikeo, N. Loilome, W. Thinkhamrop, B. Chamadol, N. Yongvanit, P. |
2016 | ||||
| 78. | CD44 variant-dependent redox status regulation in liver fluke-associated cholangiocarcinoma: A target for cholangiocarcinoma treatment | Thanee, M. Loilome, W. Techasen, A. Namwat, N. Khuntikeo, N. Titapun, A. Pairojkul, C. Saya, H. Yongvanit, P. |
2016 | ||||
| 79. | Combination of Praziquantel and Aspirin Minimizes Liver Pathology of Hamster Opisthorchis viverrini Infection Associated Cholangiocarcinoma | Pakkayanee Sudsarn Thidarut Boonmars Wipaporn Ruangjirachuporn Nisana Namwat Watcharin Loilome Pranee Sriraj Ratchadawan Aukkanimart Wonkchalee Nadchanan Songsri Jiraporn |
2016 | ||||
| 80. | Potential of selenium compounds as new anticancer agents for cholangiocarcinoma | Dai, X Thongchot, S Dokduang, H Loilome, W Khuntikeo, N Titapun, A Ungarreevittaya, P Yongvanit, P Techasen, A Namwat, N |
2016 | ||||
| 81. | Xanthohumol inhibits STAT3 activation pathway leaDing to growth suppression and apoptosis induction in human cholangiocarcinoma cells | Dokduang, H Yongvanit, P Namwat, N Pairojkul, C Sangkhamanon, S Yageta, MS Murakami, Y Loilome, W |
2016 | ||||
| 82. | Carcinogenic liver fluke and others contaminated in pickled fish of northeastern Thailand | Aukkanimart, R Boonmars, T Sriraj, P Sripan, P Songsri, J Ratanasuwan, P Laummaunwai, P Suwanantrai, A Aunpromma, S Khueangchaingkhwang, S Pumhirunroj, B Artchayasawat, A Khuntikeo, N Loilome, W Namwat, N Yongvanit, P Boonjaraspinyo, S |
2017 | ||||
| 83. | Establishment of cholangiocarcinoma cell lines from patients in the endemic area of liver fluke infection in Thailand | Senggunprai, L. Namwat, N. Kongpetch, S. Chamgramol, Y. Loilome, W. Khansaard, W. Jusakul, A. Prawan, A. Pairojkul, C. Yongvanit, P. Kukongviriyapan, V. |
2017 | ||||
| 84. | Imbalanced adaptive responses associated with microsatellite instability in cholangiocarcinoma. | Loilome, W. Yongvanit, P. Namwat, N. Techasen, A. Khuntikeo, N. |
2017 | ||||
| 85. | Increase in L-type amino acid transporter 1 expression during cholangiocarcinogenesis caused by liver fluke infection and its prognostic significance | Supak Yothaisong Nisana Namwat Puangrat Yongvanit Narong Khuntikeo Anucha Puapairoj Promsuk Jutabha Naohiko Anzai Wichittra Tassaneeyakul Panot Tangsucharit Watcharin Loilome |
2017 | ||||
| 86. | Inhibition of L-type amino acid transporter 1 activity as a new therapeutic target for cholangiocarcinoma treatment | Yothaisong, S. Dokduang, H. Namwat, N. Yongvanit, P. Loilome, W. |
2017 | ||||
| 87. | Nimotuzumab inhibits cholangiocarcinoma cell metastasis via suppression of the epithelial-mesenchymal transition process | Sureerat Padthaisong Malinee Thanee Anchalee Techasen Nisana Namwat Puangrat Yongvanit Aekkaphod Liwatthakun Khittisak Hankla Sakkarn Sangkhamanon Watcharin Loilome |
2017 | ||||
| 88. | Opisthorchiasis and cholangiocarcinoma in Southeast Asia: an unresolved problem | Hughes, T O'Connor, T Techasen, A Namwat, N Loilome, W Andrews, RH Khuntikeo, N Yongvanit, P Sithithaworn, P Taylor-Robinson, SD |
2017 | ||||
| 89. | Prolonged oxidative stress down-regulates Early B cell factor 1 with inhibition of its tumor suppressive function against cholangiocarcinoma genesis. | Armartmuntree, N Murata, M Techasen, A Yongvanit, P Loilome, W Namwat, N Pairojkul, C Sakonsinsiri, C Pinlaor, S Thanan, R |
2017 | ||||
| 90. | Protein kinases as targets for Opisthorchis viverrini- associated cholangiocarcinoma therapy | Loilome, W Dokduang, H |
2017 | ||||
| 91. | Simplified Techniques for Killing the Carcinogenic, Opisthorchis Viverrini Metacercariae in Cyprinid Fish | Boonmars, T. Songsri, J. Aukkanimart, R. Sriraj, P. Rattanasuwan, P. Suwannatrai, A. Aunpromma, S. Khuntikeo, N. Loilome, W. Namwat, N. Yongvanit, P. Boonjaraspinyo, S. |
2017 | ||||
| 92. | Teleconsultation ultrasonography: a new weapon to combat cholangiocarcinoma. | Nittaya Chamado Vallop Laopaiboon Jiraporn Srinakarin Watcharin Loilome Puangrat Yongvanit Bandit Thinkhamrop Narong Khuntikeo |
2017 | ||||
| 93. | Upregulation of endothelial nitric oxide synthase (eNOS) and its upstream regulators in Opisthorchis viverrini associated cholangiocarcinoma and its clinical significance | Suksawat, M Techasen, A Namwat, N Yongvanit, P Khuntikeo, N Titapun, A Koonmee, S Loilome, W |
2017 | ||||
| 94. | Upregulation of TCTP is associated with cholangiocarcinoma progression and metastasis | Techasen, A. Thongchot, S. Thanan, R. Khuntikeo, N. Yongvanit, P. |
2017 | ||||
| 95. | Upregulation of transferrin receptor-1 induces cholangiocarcinoma progression via induction of labile iron pool | Jamnongkan, W Thanan, R Techasen, A Namwat, N Loilome, W Intarawichian, P Titapun, A Yongvanit, P |
2017 | ||||
| 96. | Upregulation of transferrin receptor-I induces cholangiocarcinoma progression via induction of labile iron pool | Wassana Jamnongkan Raynoo Thanan Anchalee Techasen Nisana Namwat Watcharin Loilome Piyapharom Intarawichian Attapol Titapun Puangrat Yongvanit |
2017 | ||||
| 97. | Urinary microRNA-192 and microRNA-21 as potential indicators for liver fluke-associated cholangiocarcinoma risk group | Loilome, W. Yongvanit, P. Thongchot, S. Namwat, N. Sithithaworn, P. Boonmars, T. Koonmee, S. Titapun, A. Khuntikeo, N. Chamadol, N. Techasen, A. |
2017 | ||||
| 98. | Antifibrotic effect of xanthohumol in combination with praziquantel is associated with altered redox status and reduced iron accumulation during liver fluke-associated cholangiocarcinogenesis. | Jamnongkan, W. Thanee, M. Yongvanit, P. Loilome, W. Thanan, R. Namwat, N. Techasen, A. |
2018 | ||||
| 99. | CD44 variant-dependent redox status regulation in cholangiocarcinoma: A target for cholangiocarcinoma treatment | Malinee Thanee Watcharin Loilome Anchalee Techasen Nisana Namwat Attapon Titapun Narong Khuntikeo Shogo Okazaki Eiji Sugihara Hideyuki Saya Puangrat Yongvanit |
2018 | ||||
| 100. | Cellular senescence and inhibitory effects of PRIMA-1MET in cholangiocarcinoma | Chayanit Piyawajanusorn Watcharin Loilome Yingpinyapat Kittirat Suyanee Thongchot Nisana Namwat |
2018 | ||||
| 101. | Current perspectives on opisthorchiasis control and cholangiocarcinoma detection in Southeast Asia | Khuntikeo, N Titapun, A Loilome, W Yongvanit, P Thinkhamrop, B Chamadol, N Boonmars, T Nethanomsak, T Andrews, RH Petney, TN Sithithaworn, P |
2018 | ||||
| 102. | Diagnostic performance of urinary IgG antibody detection: A novel approach for population screening of strongyloidiasis. | Eamudomkarn, C. Sithithaworn, P. Sithithaworn, J. Kaewkes, S. Techasen, A. Loilome, Yongvanit, P. Saichua, P. Itoh, M. |
2018 | ||||
| 103. | Dihydroartemisinin induces apoptosis and autophagy-dependent cell death in cholangiocarcinoma through a DAPK1-BECLIN1 pathway | Suyanee Thongchot Chiara Vidoni Alessandra Ferraresi Watcharin Loilome Puangrat Yongvanit Nisana Namwat Ciro Isidoro |
2018 | ||||
| 104. | Effect of xanthohumol in combination with praziquantel on oxidative stress-induced cholangiocarcinogenesis | Anchalee Techasen Wassana Jamnongkan Malinee Thanee Puangrat Yongvanit Watcharin Loilome Raynoo Thanan Phongsaran Kimawaha Tidarat Boonmars Runglawan Silakit Nisana Namwat |
2018 | ||||
| 105. | Elevated Levels of Urinary 8-oxodG Correlate with Persistent Periductal Fibrosis after Praziquantel Treatment in Chronic Opisthorchiasis | Yongvanit, P. Loilome, Thanan, R. Eamudomkarn, C. Chamadol, N. Mairiang, E. Sithithaworn, J. Saichua, P. Sripa, B. Khuntikeo, N. Sithithaworn, P. |
2018 | ||||
| 106. | Erratum to “Resveratrol interrupts the pro-invasive communication between Cancer associated Fibroblasts and Cholangiocarcinoma cells” (Cancer Letters (2018) 430 (160–171), (S0304383518303641) (10.1016/j.canlet.2018.05.031)) | Thongchot, S. Loilome, Yongvanit, P. |
2018 | ||||
| 107. | Erratum to "Resveratrol interrupts the pro-invasive communication between Cancer associated Fibroblasts and Cholangiocarcinoma cells" [Cancer Letters 430C (2018) 160-171]. | Thongchot, S Ferraresi, A Vidoni, C Loilome, W Yongvanit, P Namwat, N Isidoro, C |
2018 | ||||
| 108. | Evaluation of a short term effect of praziquantel treatment in opisthorchiasis-induced hepatobiliary inflammation by urinary 8-oxodG. | Wangboon, C Worasith, C Thanan, R Eamudomkarn, C Techasen, A Sithithaworn, J Loilome, W Chamadol, N Pinlaor, S Jumnainsong, A Yongvanit, P Khuntikeo, N Bethony, JM Sithithaworn, P |
2018 | ||||
| 109. | Increasing of 5-lipoxygenase expression associated with cholangiocarcinoma development | Sasikamon Korphai Anchalee Techasen Nisana Namwat Watcharin Loilome |
2018 | ||||
| 110. | Inhibition of endothelial nitric oxide synthase in cholangiocarcinoma cell lines - a new strategy for therapy. | Manida Suksawat Anchalee Techasen Nisana Namwat Thianrut Boonsong Attapol Titapun Piti Ungarreevittaya Puangrat Yongvanit Watcharin Loilome |
2018 | ||||
| 111. | Inhibition of endothelial nitric oxide synthase in cholangiocarcinoma cell lines – a new strategy for therapy | Techasen, A. Namwat, N. Titapun, A. Ungarreevittaya, P. Yongvanit, P. |
2018 | ||||
| 112. | Inhibitory effect of EGFR/HER2 inhibitor, varlitinib on cholangiocarcinoma cell growth | Hasaya Dokduang Manida Suksawat Sureerat Padthaisong Wassana Jamnongkarn Malinee Thanee Anchalee Techasen Nisana Namwat Narong Khuntikeao Watcharin Loilome |
2018 | ||||
| 113. | Inhibitory effect of NVP-BKM120 on cholangiocarcinoma cell growth. | Sureerat Padthaisong Hasaya Dokduang Supak Yothaisong Anchalee Techasen Nisana Namwat Puangrat Yongvanit Narong Khuntikeo Attapol Titapun Sakkarn Sangkhamanon Watcharin Loilome |
2018 | ||||
| 114. | Oxidative stress down-regulates Early B cell factor 1 resulting in cholangiocarcinoma genesis | Napat Armartmuntree Mariko Murata Anchalee Techasen Watcharin Loilome Nisana Namwat Chawalit Pairojkul Chadamas Sakonsinsiri Somchai Pinlaor Raynoo Thanan |
2018 | ||||
| 115. | Pan-class I PI3K inhibitor inhibits cholangiocarcinoma cell growth | Sureerat Padthaisong Hasaya Dokduang Supak Yothaisong Anchalee Techasen Nisana Namwat Puangrat Yongvanit Narong Khuntikeo Attapon Titapun Sakkarn Sangkhamanon Watcharin Loilome |
2018 | ||||
| 116. | Potential role of HIF-1-responsive microRNA210/HIF3 axis on gemcitabine resistance in cholangiocarcinoma cells | Silakit, R Kitirat, Y Thongchot, S Loilome, W Techasen, A Ungarreevittaya, P Khuntikeo, N Yongvanit, P Yang, JH Kim, NH Yook, JI Namwat, N |
2018 | ||||
| 117. | Progranulin modulates cholangiocarcinoma cell proliferation, apoptosis, and motility via the PI3K/pAkt pathway | Daya, M Loilome, W Techasen, A Thanee, M Sa-Ngiamwibool, P Titapun, A Yongvanit, P Namwat, N |
2018 | ||||
| 118. | Prolonged oxidative stress down-regulates Early B cell factor 1 with inhibition of its tumor suppressive function against cholangiocarcinoma genesis | Armartmuntree, N. Techasen, A. Yongvanit, P. Loilome, W. Pairojkul, C. Sakonsinsiri, C. Pinlaor, S. Thanan, R. |
2018 | ||||
| 119. | Resveratrol interrupts the pro-invasive communication between cancer associated fibroblasts and cholangiocarcinoma cells. | Thongchot, S. Loilome, Yongvanit, P. |
2018 | ||||
| 120. | Resveratrol interrupts the pro -invasive communication between Cancer associated Fibroblasts and Cholangiocarcinoma cells (vol 430C, pg 160, 2018) | Suyanee Thongchot Alessandra Ferraresi Chiara Vidoni Watcharin Loilome Puangrat Yongvanit Nisana Namwat Ciro Isidoro |
2018 | ||||
| 121. | Suppression of 14-3-3ζ in cholangiocarcinoma cells inhibits proliferation through attenuated akt activity, enhancing chemosensitivity to gemcitabine | Techasen, A. Thongchot, S. Loilome, W. Thanan, R. Yongvanit, P. Titapun, A. Khuntikeo, N. Namwat, N. |
2018 | ||||
| 122. | Suppression of 14-3-3ζ in cholangiocarcinoma cells inhibits proliferation through attenuated Akt activity, enhancing chemosensitivity to gemcitabine. | Kittirat, Y Techasen, A Thongchot, S Loilome, W Thanan, R Yongvanit, P Sungkhamanon, S Titapun, A Khuntikeo, N Namwat, N |
2018 | ||||
| 123. | Suppression of 14-3-3 zeta in cholangiocarcinoma cells inhibits proliferation through attenuated Akt activity, enhancing chemosensitivity to gemcitabine | Yingpinyapat Kittirat Anchalee Techasen Suyanee Thongchot Watcharin Loilome Raynoo Thanan Puangrat Yongvanit Sakkarn Sungkhamanon Attapol Titapun Narong Khuntikeo Nisana Namwat |
2018 | ||||
| 124. | TGF- beta 1: A Potential EMT-Biomarker for prediction of cholangiocarcinoma | Phongsaran Kimawaha Apinya Jusakul Puangrat Yongvanit Watcharin Loilome Nisana Namwat Narong Khuntikeo Anchalee Techasen |
2018 | ||||
| 125. | The Socioeconomic Burden of Cholangiocarcinoma Associated With Opisthorchis viverrini Sensu Lato Infection in Northeast Thailand: A Preliminary Analysis | Khuntikeo, N. Thinkhamrop, B. Andrews, R.H. Yongvanit, P. Loilome, Chamadol, N. Kosuwan, W. Sithithaworn, P. |
2018 | ||||
| 126. | Zileuton suppresses cholangiocarcinoma cell proliferation and migration through inhibition of the Akt signaling pathway | Thanee, M. Techasen, A. Klanrit, Titapun, A. Loilome, |
2018 | ||||
| 127. | Characterisation of the Urinary Metabolic Profile of Liver Fluke-Associated Cholangiocarcinoma | Munirah Alsaleh Paiboon Sithithaworn Narong Khuntikeo Watcharin Loilome Puangrat Yongvanit Nittaya Chamadol Thomas Hughes Thomas O'Connor Ross H. Andrews Elaine Holmes Simon D. Taylor-Robinson |
2019 | ||||
| 128. | Cholangiocarcinoma: A guide for the nonspecialist | Alsaleh, M Leftley, Z Barbera, TA Sithithaworn, P Khuntikeo, N Loilome, W Yongvanit, P Cox, IJ Chamodol, N Syms, RR Andrews, RH Taylor-Robinson, SD |
2019 | ||||
| 129. | Comparing the performance of urine and copro-antigen detection in evaluating Opisthorchis viverrini infection in communities with different transmission levels in Northeast Thailand. | Chanika Worasith Chompunoot Wangboon Kunyarat Duenngai Nadda Kiatsopit Kulthida Kopolrat Anchalee Techasen Jiraporn Sithithaworn Narong Khuntikeo Watcharin Loilome Nisana Namwat Puangrat Yongvanit Elizabeth J. Carlton Paiboon Sithithaworn |
2019 | ||||
| 130. | Detection of the G1138A mutation in the FGFR3 gene for the diagnosis of achondroplasia by allele-specific polymerase chain reaction | Imtawil, K.J. Loilome, W. Tangrassameeprasert, R. Wichajarn, K. |
2019 | ||||
| 131. | Discovery and Qualification of Serum Protein Biomarker Candidates for Cholangiocarcinoma Diagnosis. | Duangkumpha, K. Phetcharaburanin, J. Yongvanit, P. Thanan, R. Techasen, A. Khuntikeo, N. Chamadol, N. Mulvenna, J.P. Loilome, |
2019 | ||||
| 132. | Discovery of Serotransferrin Glycoforms: Novel Markers for Diagnosis of Liver Periductal Fibrosis and Prediction of Cholangiocarcinoma | Jamnongkan, W. Techasen, A. Loilome, Sithithaworn, P. Khuntikeo, N. Pairojkul, C. Chamadol, N. Thanan, R. Yongvanit, P. |
2019 | ||||
| 133. | Evaluation of anticancer potential of Thai medicinal herb extracts against cholangiocarcinoma cell lines. | Bundit Promraksa Jutarop Phetcharaburanin Nisana Namwat Anchalee Techasen Patcharee Boonsiri Watcharin Loilome |
2019 | ||||
| 134. | Evaluation of a short term effect of praziquantel treatment in opisthorchiasis-induced hepatobiliary inflammation by urinary 8-oxodG | Thanan, R. Eamudomkarn, C. Techasen, A. Sithithaworn, J. Loilome, Chamadol, N. Pinlaor, S. Jumnainsong, A. Yongvanit, P. Khuntikeo, N. Sithithaworn, P. |
2019 | ||||
| 135. | In vitro and molecular chemosensitivity in human cholangiocarcinoma tissues | Suksawat, M Klanrit, P Phetcharaburanin, J Namwat, N Khuntikeo, N Titapun, A Jarearnrat, A Sa-Ngiamwibool, P Techasen, A Loilome, W |
2019 | ||||
| 136. | Mass Spectrometry: A Guide for the Clinician. | Andrews, R.H. Sithithaworn, P. Khuntikeo, N. Loilome, W. Yongvanit, P. |
2019 | ||||
| 137. | PRIMA-1 Induces Cellular Senescence and Apoptotic Cell Death in Cholangiocarcinoma Cells. | Piyawajanusorn, C Kittirat, Y Sa-Ngiamwibool, P Titapun, A Loilome, W Namwat, N |
2019 | ||||
| 138. | PRIMA-1(MET) Induces Cellular Senescence and Apoptotic Cell Death in Cholangiocarcinoma Cells | Titapun, A. Loilome, |
2019 | ||||
| 139. | Urine proteomics study reveals potential biomarkers for the differential diagnosis of cholangiocarcinoma and periductal fibrosis | Duangkumpha, K Stoll, T Phetcharaburanin, J Yongvanit, P Thanan, R Techasen, A Namwat, N Khuntikeo, N Chamadol, N Roytrakul, S Mulvenna, J Mohamed, A Shah, AK Hill, MM Loilome, W |
2019 | ||||
| 140. | 1H NMR metabolic phenotyping of Dipterocarpus alatus as a novel tool for age and growth determination. | Phetcharaburanin, J Deewai, S Kulthawatsiri, T Moolpia, K Suksawat, M Promraksa, B Klanrit, P Namwat, N Loilome, W Poopasit, K Katekaew, S Phetcharaburanin, P |
2020 | ||||
| 141. | A comparison of the proportion of early stage cholangiocarcinoma found in an ultrasound-screening program compared to walk-in patients. | Khuntikeo, N. Koonmee, S. Chamadol, N. Laopaiboon, V. Titapun, A. Yongvanit, P. Loilome, Andrews, R.H. Thinkhamrop, K. Tawarungruang, C. Thinkhamrop, B. |
2020 | ||||
| 142. | alterations and their clinical significance in cholangiocarcinoma. | Namjan, A Techasen, A Loilome, W Sa-Ngaimwibool, P Jusakul, A |
2020 | ||||
| 143. | A panel of protein kinase high expression is associated with postoperative recurrence in cholangiocarcinoma | Thanee, M. Namwat, N. Phetcharaburanin, J. Klanrit, P. Khuntikeo, N. Titapun, A. Loilome, W. |
2020 | ||||
| 144. | ARID1A alterations and their clinical significance in cholangiocarcinoma | Techasen, A. Loilome, W. Jusakul, A. |
2020 | ||||
| 145. | AuNPs-LISA, an efficient detection assay for Opisthorchis viverrini (Ov) antigen in urine | Wichit Taron Wassana Jamnongkan Anchalee Techasen Jutarop Phetcharaburanin Nisana Namwat Paiboon Sithithaworn Narong Khuntikeo Siriboon Mukdasai Somphou Sayasone Watcharin Loilome Wittaya Ngeontae |
2020 | ||||
| 146. | Characterisation of the Serum Metabolic Signature of Cholangiocarcinoma in a United Kingdom Cohort | Sithithaworn, P. Khuntikeo, N. Loilome, W. Yongvanit, P. |
2020 | ||||
| 147. | Circulating TGF-β1 as the potential epithelial mesenchymal transition-biomarker for diagnosis of cholangiocarcinoma | Kimawaha, P Jusakul, A Junsawang, P Loilome, W Khuntikeo, N Techasen, A |
2020 | ||||
| 148. | Curative effect of xanthohumol supplementation during liver fluke-associated cholangiocarcinogenesis: Potential involvement of autophagy | Suyanee Thongchot Malinee Thanee Watcharin Loilome Anchalee Techasen Thidarat Boonmars Prakasit Sa-Ngiamwibool Attapol Titapun Puangrat Yongvanit Ciro Isidoro Nisana Namwat |
2020 | ||||
| 149. | Curative effect of xanthohumol supplementation during liver fluke-associated cholangiocarcinogenesis: Potential involvement of autophagy. | Thongchot, S Thanee, M Loilome, W Techasen, A Boonmars, T Sa-Ngiamwibool, P Titapun, A Yongvanit, P Isidoro, C Namwat, N |
2020 | ||||
| 150. | H-1 NMR metabolic phenotyping of Dipterocarpus alatus as a novel tool for age and growth determination | Jutarop Phetcharaburanin Suthicha Deewai Thanaporn Kulthawatsiri Komkid Moolpia Manida Suksawat Bundit Promraksa Poramate Klanrit Nisana Namwat Watcharin Loilome Kitisak Poopasit Somporn Katekaew Penprapa Phetcharaburanin |
2020 | ||||
| 151. | In vitro and in vivo Anti-Tumor Effects of Pan-HER Inhibitor Varlitinib on Cholangiocarcinoma Cell Lines. | Hasaya Dokduang Wassana Jamnongkarn Bundit Promraksa Manida Suksawat Sureerat Padthaisong Malinee Thanee Jutarop Phetcharaburanin Nisana Namwat Sakkarn Sangkhamanon Attapol Titapun Narong Khuntikeo Poramate Klanrit Watcharin Loilome |
2020 | ||||
| 152. | Liver fluke-infected cyprinoid fish in northeastern thailand (2016-2017) | Benjamabhorn Pumhirunroj Ratchadawan Aukkanimart Thidarut Boonmars Pranee Sriraj Parichart Boueroy Atchara Artchayasawat Jiraporn Songsri Panupan Sripan Kanpicha Chomphumee Panaratana Ratanasuwan Porntip Laummaunwai Sukhonthip Khueangchaingkhwang Apiporn Suwanatri Surasit Aunpromma Chatanun Eamudomkarn Narong Khuntikeo Watcharin Loilome Nisana Namwat Puangrat Yongvanit |
2020 | ||||
| 153. | Overexpression of a panel of cancer stem cell markers enhances the predictive capability of the progression and recurrence in the early stage cholangiocarcinoma | Padthaisong, S Thanee, M Namwat, N Phetcharaburanin, J Klanrit, P Khuntikeo, N Titapun, A Sungkhamanon, S Saya, H Loilome, W |
2020 | ||||
| 154. | Serum IgG as a Marker for -Associated Cholangiocarcinoma Correlated with HER2 Overexpression. | Titapun, A Techasen, A Sa-Ngiamwibool, P Sithithaworn, P Luvira, V Srisuk, T Jareanrat, A Dokduang, H Loilome, W Thinkhamrop, B Khuntikeo, N |
2020 | ||||
| 155. | Serum IGG as a marker for opisthorchis viverrini-associated cholangiocarcinoma correlated with HER2 overexpression | Titapun, A. Techasen, A. Sithithaworn, P. Dokduang, H. Loilome, W. Thinkhamrop, B. Khuntikeo, N. |
2020 | ||||
| 156. | 1H NMR metabolic phenotyping of Dipterocarpus alatus as a novel tool for age and growth determination | Phetcharaburanin, J. Moolpia, K. Suksawat, M. Promraksa, B. Klanrit, P. Namwat, N. Loilome, W. Poopasit, K. Katekaew, S. Phetcharaburanin, P. |
2020 | ||||
| 157. | Synchrotron FTIR microspectroscopy revealed apoptosis-induced biomolecular changes of cholangiocarcinoma cells treated with ursolic acid | Pornpattra Maphanao Raynoo Thanan Watcharin Loilome Sirinart Chio-Srichan Molin Wongwattanakul Chadamas Sakonsinsiri |
2020 | ||||
| 158. | A fluorescence AuNPs-LISA: A new approach for Opisthorchis viverrini (Ov) antigen detection with a simple fluorescent enhancement strategy by surfactant micelle in urine samples | Wichit Taron Wassana Jamnongkan Jutarop Phetcharaburanin Poramate Klanrit Nisana Namwat Anchalee Techasen Paiboon Sithithaworn Narong Khuntikeo Thidarut Boonmars Watcharin Loilome Wittaya Ngeontae |
2021 | ||||
| 159. | Arctigenin inhibits cholangiocarcinoma progression by regulating cell migration and cell viability via the N-cadherin and apoptosis pathway. | Jusakul, A. Kongpetch, S. Kimawaha, P. Klanrit, P. Loilome, W. Namwat, N. Techasen, A. |
2021 | ||||
| 160. | Bacterial challenge-associated metabolic phenotypes in Hermetia illucens defining nutritional and functional benefits | Ho, PN Klanrit, P Hanboonsong, Y Yordpratum, U Suksawat, M Kulthawatsiri, T Jirahiranpat, A Deewai, S Mackawan, P Sermswan, RW Namwat, N Loilome, W Khampitak, T Wangwiwatsin, A Phetcharaburanin, J |
2021 | ||||
| 161. | Cancer-Associated Fibroblast-Derived IL-6 Determines Unfavorable Prognosis in Cholangiocarcinoma by Affecting Autophagy-Associated Chemoresponse | Suyanee Thongchot Chiara Vidoni Alessandra Ferraresi Watcharin Loilome Narong Khuntikeo Sakkarn Sangkhamanon Attapol Titapun Ciro Isidoro Nisana Namwat |
2021 | ||||
| 162. | Cancer‐associated fibroblast‐derived il‐6 determines unfavorable prognosis in cholangiocarcinoma by affecting autophagy‐associated chemoresponse | Thongchot, S. Loilome, W. Khuntikeo, N. Titapun, A. Namwat, N. |
2021 | ||||
| 163. | CD44 modulates metabolic pathways and altered ROS-mediated Akt signal promoting cholangiocarcinoma progression | Thanee, M. Dokduang, H. Phetcharaburanin, J. Klanrit, P. Titapun, A. Namwat, N. Khuntikeo, N. Wangwiwatsin, A. Saya, H. Loilome, W. |
2021 | ||||
| 164. | Diagnostic and Prognostic Value of Circulating Cell-Free DNA for Cholangiocarcinoma | Preawwalee Wintachai Jing Quan Lim Anchalee Techasen Worachart Lert-Itthiporn Sarinya Kongpetch Watcharin Loilome Jarin Chindaprasirt Attapol Titapun Nisana Namwat Narong Khuntikeo Apinya Jusakul |
2021 | ||||
| 165. | Diagnostic and prognostic value of circulating cell‐free dna for cholangiocarcinoma | Wintachai, P. Techasen, A. Lert-Itthiporn, W. Kongpetch, S. Loilome, W. Titapun, A. Namwat, N. Khuntikeo, N. Jusakul, A. |
2021 | ||||
| 166. | High Levels of Serum IgG for and CD44 Expression Predict Worse Prognosis for Cholangiocarcinoma Patients after Curative Resection. | Titapun, A Luvira, V Srisuk, T Jareanrat, A Thanasukarn, V Thanee, M Sa-Ngiamwibool, P Padthaisong, S Duangkumpha, K Suksawat, M Loilome, W Sithithaworn, P Techasen, A Thinkhamrop, B Dzienny, A Caglayan, A Park, D Mahmud, S Khuntikeo, N |
2021 | ||||
| 167. | High levels of serum igg for opisthorchis viverrini and cd44 expression predict worse prognosis for cholangiocarcinoma patients after curative resection | Attapol Titapun Vor Luvira Tharatip Srisuk Apiwat Jareanrat Vasin Thanasukarn Malinee Thanee Prakasit Sa-Ngiamwibool Sureerat Padthaisong Kassaporn Duangkumpha Manida Suksawat Watcharin Loilome Paiboon Sithithaworn Anchalee Techasen Bandit Thinkhamrop Alexa Dzienny Ayse Caglayan David Park Simran Mahmud Narong Khuntikeo |
2021 | ||||
| 168. | Integration of global metabolomics and lipidomics approaches reveals the molecular mechanisms and the potential biomarkers for postoperative recurrence in early-stage cholangiocarcinoma | Padthaisong, S Phetcharaburanin, J Klanrit, P Li, JV Namwat, N Khuntikeo, N Titapun, A Jarearnrat, A Wangwiwatsin, A Mahalapbutr, P Loilome, W |
2021 | ||||
| 169. | Lipidomic Analyses Uncover Apoptotic and Inhibitory Effects of Pyrvinium Pamoate on Cholangiocarcinoma Cells via Mitochondrial Membrane Potential Dysfunction | Kittirat, Y. Phetcharaburanin, J. Promraksa, B. Wangwiwatsin, A. Klanrit, P. Sangkhamanon, S. Jarearnrat, A. Thongchot, S. Mahalapbutr, P. Loilome, W. Saya, H. Namwat, N. |
2021 | ||||
| 170. | Mapping of population disparities in the cholangiocarcinoma urinary metabolome | Munirah Alsaleh Zoe Leftley Thomas O'Connor Thomas Hughes Thomas A. Barbera Larry K. Koomson Abigail Zabron Helen Reeves Matthew Cramp Stephen D. Ryder Shaun Greer Martin Prince Paiboon Sithithaworn Narong Khuntikeo Watcharin Loilome Puangrat Yongvanit I. Jane Cox Roger Williams Christopher A. Wadsworth Elaine Holmes Kathryn Nash Ross Andrews Simon D. Taylor-Robinson |
2021 | ||||
| 171. | Metabolic changes of cholangiocarcinoma cells in response to coniferyl alcohol treatment | Bundit Promraksa Praewpan Katrun Jutarop Phetcharaburanin Yingpinyapat Kittirat Nisana Namwat Anchalee Techasen Jia V. Li Watcharin Loilome |
2021 | ||||
| 172. | Metabolic Profiling of Praziquantel-mediated Prevention of -induced Cholangiocyte Transformation in the Hamster Model of Cholangiocarcinoma. | Prommajun, P Phetcharaburanin, J Namwat, N Klanrit, P Sa-Ngiamwibool, P Thanee, M Dokduang, H Kittirat, Y Li, JV Loilome, W |
2021 | ||||
| 173. | Metabolic Profiling of Praziquantel-mediated Prevention of Opisthorchis viverrini-induced Cholangiocyte Transformation in the Hamster Model of Cholangiocarcinoma | Phetcharaburanin, J. Namwat, N. Klanrit, P. Thanee, M. Dokduang, H. Loilome, W. |
2021 | ||||
| 174. | Promoter hypermethylation of early B cell factor 1 (EBF1) is associated with cholangiocarcinoma progression | Napat Armartmuntree Apinya Jusakul Chadamas Sakonsinsiri Watcharin Loilome Somchai Pinlaor Piti Ungarreevittaya Chern Han Yong Anchalee Techasen Kanokwan Imtawil Ratthaphol Kraiklang Nattawan Suwannakul Waleeporn Kaewlert Timpika Chaiprasert Raynoo Thanan Mariko Murata |
2021 | ||||
| 175. | Smartphone-based fluorescent ELISA with simple fluorescent enhancement strategy for Opisthorchis viverrini (Ov) antigen detection in urine samples | Taron, W. Jamnongkan, W. Techasen, A. Phetcharaburanin, J. Klanrit, P. Namwat, N. Khuntikeo, N. Boonmars, T. Sithithaworn, P. Buranachai, C. Loilome, W. Ngeontae, W. |
2021 | ||||
| 176. | Sulfasalazine modifies metabolic profiles and enhances cisplatin chemosensitivity on cholangiocarcinoma cells in in vitro and in vivo models | Thanee, M Padthaisong, S Suksawat, M Dokduang, H Phetcharaburanin, J Klanrit, P Titapun, A Namwat, N Wangwiwatsin, A Sa-Ngiamwibool, P Khuntikeo, N Saya, H Loilome, W |
2021 | ||||
| 177. | Targeting Fatty Acid Synthase Modulates Metabolic Pathways and Inhibits Cholangiocarcinoma Cell Progression | Jittima Tomacha Hasaya Dokduang Sureerat Padthaisong Nisana Namwat Poramate Klanrit Jutarop Phetcharaburanin Arporn Wangwiwatsin Tueanjit Khampitak Supinda Koonmee Attapol Titapun Apiwat Jarearnrat Narong Khuntikeo Watcharin Loilome |
2021 | ||||
| 178. | Therapeutic challenges at the preclinical level for targeted drug development for -associated cholangiocarcinoma. | Loilome, W Dokduang, H Suksawat, M Padthaisong, S |
2021 | ||||
| 179. | Therapeutic challenges at the preclinical level for targeted drug development for Opisthorchis viverrini-associated cholangiocarcinoma | Loilome, W. Dokduang, H. Suksawat, M. Padthaisong, S. |
2021 | ||||
| 180. | Chemotherapeutic resistant cholangiocarcinoma displayed distinct intratumoral microbial composition and metabolic profiles. | Suksawat, M. Phetcharaburanin, J. Wangwiwatsin, A. Klanrit, P. Namwat, N. Khuntikeo, N. Titapun, A. Jarearnrat, A. Sangkhamanon, S. Loilome, W. |
2022 | ||||
| 181. | Effects of day-to-day variation of Opisthorchis viverrini antigen in urine on the accuracy of diagnosing opisthorchiasis in Northeast Thailand | Worasith, C Wongphutorn, P Homwong, C Kopolrat, KY Techasen, A Thanan, R Eamudomkarn, C Wangboon, C Khuntikeo, N Loilome, W Sithithaworn, J Crellen, T Sithithaworn, P |
2022 | ||||
| 182. | Interleukin-6-derived cancer-associated fibroblasts activate STAT3 pathway contributing to gemcitabine resistance in cholangiocarcinoma | Kittirat, Y Suksawat, M Thongchot, S Padthaisong, S Phetcharaburanin, J Wangwiwatsin, A Klanrit, P Sangkhamanon, S Titapun, A Loilome, W Saya, H Namwat, N |
2022 | ||||
| 183. | Metabolic Phenotyping Predicts Gemcitabine and Cisplatin Chemosensitivity in Patients With Cholangiocarcinoma | Suksawat, M Phetcharaburanin, J Klanrit, P Namwat, N Khuntikeo, N Titapun, A Jarearnrat, A Vilayhong, V Sa-Ngiamwibool, P Techasen, A Wangwiwatsin, A Mahalapbutr, P Li, JV Loilome, W |
2022 | ||||
| 184. | Modification of the AJCC/UICC 8th edition staging system for intrahepatic cholangiocarcinoma: proposal for an alternative staging system from cholangiocarcinoma-prevalent Northeast Thailand | Sa-Ngiamwibool, P Aphivatanasiri, C Sangkhamanon, S Intarawichian, P Kunprom, W Thanee, M Prajumwongs, P Loilome, W Khuntikeo, N Titapun, A Jareanrat, A Thanasukarn, V Srisuk, T Luvira, V Eurboonyanun, K Promsorn, J Wee, A Koonmee, S |
2022 | ||||
| 185. | Modification of the eighth AJCC/UICC staging system for perihilar cholangiocarcinoma: An alternative pathological staging system from cholangiocarcinoma-prevalent Northeast Thailand. | Aphivatanasiri, C. Sa-ngiamwibool, P. Sangkhamanon, S. Intarawichian, P. Kunprom, W. Thanee, M. Prajumwongs, P. Khuntikeo, N. Titapun, A. Jareanrat, A. Thanasukarn, V. Srisuk, T. Luvira, V. Eurboonyanun, K. Promsorn, J. Loilome, W. Wee, A. Koonmee, S. |
2022 | ||||
| 186. | Performance of Mini Parasep SF stool concentrator kit, Kato-Katz, and formalin-ethyl acetate concentration methods for diagnosis of opisthorchiasis in Northeast Thailand. | Kopolrat, KY Singthong, S Khuntikeo, N Loilome, W Worasith, C Homwong, C Wangboon, C Yasaka, P Eamudomkarn, C Pitaksakulrat, O Tonkhamhak, K Paeyo, A Crellen, T Sithithaworn, J Sithithaworn, P |
2022 | ||||
| 187. | Performance of Mini Parasep® SF stool concentrator kit, Kato-Katz, and formalin-ethyl acetate concentration methods for diagnosis of opisthorchiasis in Northeast Thailand | Kopolrat, K.Y. Singthong, S. Khuntikeo, N. Loilome, W. Worasith, C. Homwong, C. Wangboon, C. Yasaka, P. Eamudomkarn, C. Pitaksakulrat, O. Tonkhamhak, K. Paeyo, A. Crellen, T. Sithithaworn, J. Sithithaworn, P. |
2022 | ||||
| 188. | Prognostic Significance of Growth Pattern in Predicting Outcome of -Associated Distal Cholangiocarcinoma in Thailand. | Kunprom, W Aphivatanasiri, C Sa-Ngiamwibool, P Sangkhamanon, S Intarawichian, P Bamrungkit, W Thanee, M Prajumwongs, P Loilome, W Khuntikeo, N Titapun, A Jareanrat, A Thanasukarn, V Srisuk, T Luvira, V Eurboonyanun, K Promsorn, J Koonmee, S |
2022 | ||||
| 189. | Prognostic Significance of Growth Pattern in Predicting Outcome of Opisthorchis viverrini-Associated Distal Cholangiocarcinoma in Thailand | Kunprom, W. Aphivatanasiri, C. Sa-Ngiamwibool, P. Sangkhamanon, S. Intarawichian, P. Bamrungkit, W. Thanee, M. Prajumwongs, P. Loilome, W. Khuntikeo, N. Titapun, A. Jareanrat, A. Thanasukarn, V. Srisuk, T. Luvira, V. Eurboonyanun, K. Promsorn, J. Koonmee, S. |
2022 | ||||
| 190. | Prognostic significance of tumor-infiltrating lymphocytes in predicting outcome of distal cholangiocarcinoma in Thailand. | Intarawichian, P Sangpaibool, S Prajumwongs, P Sa-Ngiamwibool, P Sangkhamanon, S Kunprom, W Thanee, M Loilome, W Khuntikeo, N Titapun, A Jareanrat, A Thanasukarn, V Srisuk, T Luvira, V Eurboonyanun, K Promsorn, J Koonmee, S Wee, A Aphivatanasiri, C |
2022 | ||||
| 191. | Smartphone-based portable fluorescence sensor with gold nanoparticle mediation for selective detection of nitrite ions | Ponlakhet, K Phooplub, K Phongsanam, N Phongsraphang, T Phetduang, S Surawanitkun, C Buranachai, C Loilome, W Ngeontae, W |
2022 | ||||
| 192. | Therapeutic targeting of ARID1A and PI3K/AKT pathway alterations in cholangiocarcinoma | Tessiri, S Techasen, A Kongpetch, S Namjan, A Loilome, W Chan-On, W Thanan, R Jusakul, A |
2022 | ||||
| 193. | Accuracy of a new rapid diagnostic test for urinary antigen detection and assessment of drug treatment in opisthorchiasis. | Worasith, C Sithithaworn, J Wongphutorn, P Homwong, C Khongsukwiwat, K Techasen, A Kopolrat, KY Loilome, W Namwat, N Thinkamrop, B Tawarungruang, C Titapun, A Laha, T Andrews, RH Taylor-Robinson, SD Sithithaworn, P |
2023 | ||||
| 194. | Comparison of a Urine Antigen Assay and Multiple Examinations with the Formalin-Ethyl Acetate Concentration Technique for Diagnosis of Opisthorchiasis. | Worasith, C Techasen, A Duenngai, K Intuyod, K Kopolrat, KY Sithithaworn, J Loilome, W Crellen, T Haswell, MR Sithithaworn, P |
2023 | ||||
| 195. | H NMR fecal metabolic phenotyping of periductal fibrosis- and cholangiocarcinoma-specific metabotypes defining perturbation in gut microbial-host co-metabolism. | Treeriya, R Ho, PN Titapun, A Klanrit, P Suksawat, M Kulthawatsiri, T Sirirattanakul, S Loilome, W Namwat, N Wangwiwatsin, A Chamadol, N Khuntikeo, N Phetcharaburanin, J |
2023 | ||||
| 196. | Metabolomic analyses uncover an inhibitory effect of niclosamide on mitochondrial membrane potential in cholangiocarcinoma cells. | Kulthawatsiri, T Kittirat, Y Phetcharaburanin, J Tomacha, J Promraksa, B Wangwiwatsin, A Klanrit, P Titapun, A Loilome, W Namwat, N |
2023 | ||||
| 197. | Preclinical evidence for preventive and curative effects of resveratrol on xenograft cholangiocarcinogenesis. | Thongchot, S Ferraresi, A Vidoni, C Salwa, A Vallino, L Kittirat, Y Loilome, W Namwat, N Isidoro, C |
2023 | ||||
| 198. | Preoperative controlling nutritional status (CONUT) score is an independent prognostic factor in cholangiocarcinoma patients treated with hepatectomy. | Titapun, A Sookprasert, A Sripanuskul, Y Watcharenwong, P Loilome, W Twinprai, P Srisuk, T Prajumwongs, P Chindaprasirt, J |
2023 | ||||
| 199. | The Hallmarks of Liver Fluke Related Cholangiocarcinoma: Insight into Drug Target Possibility. | Loilome, W Namwat, N Jusakul, A Techasen, A Klanrit, P Phetcharaburanin, J Wangwiwatsin, A |
2023 | ||||
| 200. | The impact of hypoxia and oxidative stress on proteo-metabolomic alterations of 3D cholangiocarcinoma models. | Phukhum, P. Phetcharaburanin, J. Chaleekarn, K. Kittirat, Y. Kulthawatsiri, T. Namwat, N. Loilome, W. Khuntikeo, N. Titapun, A. Wangwiwatsin, A. Khampitak, T. Suksawat, M. Klanrit, P. |
2023 | ||||
| 201. | Toward novel treatment against filariasis: Insight into genome-wide co-evolutionary analysis of filarial nematodes and . | Wangwiwatsin, A Kulwong, S Phetcharaburanin, J Namwat, N Klanrit, P Loilome, W Maleewong, W Reid, AJ |
2023 | ||||
| 202. | Toward novel treatment against filariasis: Insight into genome-wide co-evolutionary analysis of filarial nematodes and Wolbachia | Wangwiwatsin, A. Kulwong, S. Phetcharaburanin, J. Namwat, N. Klanrit, P. Loilome, W. Maleewong, W. Reid, A.J. |
2023 | ||||
| 203. | Urinary Metabolic Profiling of Liver Fluke-Induced Cholangiocarcinoma-A Follow-Up Study. | Alsaleh, M Sithithaworn, P Khuntikeo, N Loilome, W Yongvanit, P Hughes, T O'Connor, T Andrews, RH Wadsworth, CA Williams, R Koomson, L Cox, IJ Holmes, E Taylor-Robinson, SD |
2023 | ||||
| 204. | Urinary Metabolic Profiling of Liver Fluke-Induced Cholangiocarcinoma—A Follow-Up Study | Alsaleh, M. Sithithaworn, P. Khuntikeo, N. Loilome, W. Yongvanit, P. Hughes, T. O'Connor, T. |
2023 | ||||
| 205. | Children with Hirschsprung disease exhibited alterations in host-microbial co-metabolism after pull-through operation. | Thaiwatcharamas, K Loilome, W Ho, PN Chusilp, S Tanming, P Klanrit, P Phetcharaburanin, J |
2024 | ||||
| 206. | Improvement of survival outcomes of cholangiocarcinoma by ultrasonography surveillance: Multicenter retrospective cohorts. | Chamadol, N Laopaiboon, V Jareanrat, A Thanasukarn, V Srisuk, T Luvira, V Sarkhampee, P Ungpinitpong, W Khamvijite, P Chumnanua, Y Nethuwakul, N Sodarat, P Thammarit, S Techasen, A Thuanman, J Tawarungruang, C Thinkhamrop, B Sa-Ngiamwibool, P Loilome, W Prajumwongs, P Titapun, A |
2024 | ||||
| 207. | Improving postoperative survival in cholangiocarcinoma: development of surgical strategies with a screening program in the epidemic region. | Thanasukarn, V Srisuk, T Luvira, V Tipwaratorn, T Jareanrat, A Rattanarak, K Kraphunpongsakul, K Khuntikeo, N Chindaprasirt, J Sanlung, T Chamadol, N Koonmee, S Sa-Ngiamwibool, P Klanrit, P Wangwiwatsin, A Namwat, N Loilome, W Muangritdech, N Prajumwongs, P Watanabe, N Ebata, T Titapun, A |
2024 | ||||
| 208. | Integrative multiomics enhancer activity profiling identifies therapeutic vulnerabilities in cholangiocarcinoma of different etiologies. | Hong, JH Yong, CH Heng, HL Chan, JY Lau, MC Chen, J Lee, JY Lim, AH Li, Z Guan, P Chu, PL Boot, A Ng, SR Yao, X Wee, FYT Lim, JCT Liu, W Wang, P Xiao, R Zeng, X Sun, Y Koh, J Kwek, XY Ng, CCY Klanrit, P Zhang, Y Lai, J Tai, DWM Pairojkul, C Dima, S Popescu, I Hsieh, SY Yu, MC Yeong, J Kongpetch, S Jusakul, A Loilome, W Tan, P Tan, J Teh, BT |
2024 | ||||
| 209. | Intraductal magnetic resonance imaging of cholangiocarcinoma - a practical possibility. | Syms, RRA Wadsworth, CA Kardoulaki, E Titapun, A Boonphongsathien, W Sa-Ngiamwibool, P Zhang, S Taylor-Robinson, SD Chamadol, N Loilome, W |
2024 | ||||
| 210. | Spatio-Temporal Analysis of Cholangiocarcinoma in a High Prevalence Area of Northeastern Thailand: A 10-Year Large Scale Screening Program. | Anchalee, N Thinkhamrop, K Suwannatrai, AT Titapun, A Loilome, W Kelly, M |
2024 | ||||
| 211. | Antioxidative and anticancer effects of Tacca chantrieri extract enhancing cisplatin sensitivity in cholangiocarcinoma cells. | Armartmuntree, N Kittirat, Y Promraksa, B Loilome, W Dokduang, H Techasen, A Sansomchai, P Thanee, M O'Connor, T Kongthitilerd, P Padthaisong, S |
2025 | ||||
| 212. | Characterization and identification of extrachromosomal circular DNA in cholangiocarcinoma. | Win, ZZ Dokduang, H Kulwong, S Loilome, W Namwat, N Phetcharaburanin, J Wongsurawat, T Jenjaroenpun, P Klanrit, P Wangwiwatsin, A |
2025 | ||||
| 213. | Characterization of Patient-derived Xenograft Models of Liver Fluke-associated Cholangiocarcinoma: From Establishment to Molecular Profiling. | Dokduang, H Jarernrat, A Titapun, A Sitthirak, S Padthaisong, S Kittirat, Y Sangkamanon, S Sa-Ngiamwibool, P Wangwiwatsin, A Klanrit, P Namwat, N Jusakul, A Murakami, Y Loilome, W |
2025 | ||||
| 214. | Chemical composition and anticancer potential of water extracts derived from ground powder of Thai germinated brown rice (). | Dokduang, H Katenak, A Kittirat, Y Tomacha, J Promraksa, B Taing, L Na Nakorn, S Klanrit, P Namwat, N Titapun, A Loilome, W |
2025 | ||||
| 215. | Development of ready-to-use microtiter plates for enhanced ELISA detection of Opisthorchis viverrini antigens in urine samples. | Taron, W Jamnongkan, W Kamjanlard, C Phetcharaburanin, J Wangwiwatsin, A Klanrit, P Namwat, N Techasen, A Titapun, A Boonmars, T Laummaunwai, P Sithithaworn, P Ngeontae, W Loilome, W |
2025 | ||||
| 216. | Discovery of novel serum peptide biomarkers for cholangiocarcinoma recurrence through MALDI-TOF MS and LC-MS/MS peptidome analysis. | Thanasukarn, V Prajumwongs, P Muangritdech, N Loilome, W Namwat, N Klanrit, P Wangwiwatsin, A Charoenlappanit, S Jaresitthikunchai, J Roytrakul, S Titapun, A |
2025 | ||||
| 217. | Endobiliary radiofrequency ablation in recurrence and unresectable Perihilar cholangiocarcinoma. | Jareanrat, A Thanasukarn, V Srisuk, T Luvira, V Tipwaratorn, T Ahooja, A Loilome, W Prajumwongs, P Titapun, A |
2025 | ||||
| 218. | Establishment and genomic profiling of cholangiocarcinoma cells with functional characterization. | Jaidee, R Jusakul, A Pocasap, P Kukongviriyapan, V Senggunprai, L Prawan, A Loilome, W Titapun, A Jareanrat, A Thanasukarn, V Khuntikeo, N Namwat, N Chamgramol, Y Thanee, M Wichian, P Hong, JH Guan, P Heng, HL Pairojkul, C Teh, BT Kongpetch, S |
2025 | ||||
| 219. | Identification of serum metabolite biomarkers and metabolic reprogramming mechanisms to predict recurrence in cholangiocarcinoma. | Prajumwongs, P Titapun, A Thanasukarn, V Jareanrat, A Khuntikeo, N Namwat, N Klanrit, P Wangwiwatsin, A Chindaprasirt, J Koonmee, S Sa-Ngiamwibool, P Muangritdech, N Roytrakul, S Loilome, W |
2025 | ||||
| 220. | Identifying a unique chromosomal pattern to predict the gemcitabine response in patients with cholangiocarcinoma. | Techa-Ay, S Watcharadetwittaya, S Deenonpoe, R Sa-Ngiamwibool, P Panwoon, C Loilome, W Klanrit, P Techasen, A Chamgramol, Y Suksawat, M Armartmuntree, N O'Connor, T Saya, H Thanee, M |
2025 | ||||
| 221. | Large-scale epidemiology of opisthorchiasis in 21 provinces in Thailand based on diagnosis by fecal egg examination and urine antigen assay and analysis of risk factors for infection. | Kopolrat, KY Worasith, C Wongphutorn, P Techasen, A Eamudomkarn, C Sithithaworn, J Loilome, W Namwat, N Titapun, A Tawarungruang, C Thinkhamrop, B Futrakul, S Taylor-Robinson, SD Haswell, MR Khuntikeo, N Crellen, T Sithithaworn, P |
2025 | ||||
| 222. | Metabolomic analysis of bioactive compounds in dill ( L.) extracts. | Thanuma, J Phetcharaburanin, J Dokduang, H Loilome, W Klanrit, P Wangwiwatsin, A Namwat, N |
2025 | ||||
| 223. | Mitochondrial genomic alterations in cholangiocarcinoma cell lines. | Faipan, A Sitthirak, S Wangwiwatsin, A Namwat, N Klanrit, P Titapun, A Jareanrat, A Thanasukarn, V Khuntikeo, N Boulter, L Dokduang, H Loilome, W |
2025 | ||||
| 224. | Mutations in Cholangiocarcinoma: Prevalence, Prognostic Value, and G12/G13 Detection in Cell-Free DNA. | Thongyoo, P Chindaprasirt, J Aphivatanasiri, C Intarawichian, P Kunprom, W Kongpetch, S Techasen, A Loilome, W Namwat, N Titapun, A Jusakul, A |
2025 | ||||
| 225. | Predicting cisplatin response in cholangiocarcinoma patients using chromosome pattern and related gene expression. | Techa-Ay, S Watcharadetwittaya, S Deenonpoe, R Intuyod, K Kaewlert, W Techasen, A Loilome, W Klanrit, P Suksawat, M Chaleekan, K Sitthirak, S Thanee, M |
2025 | ||||
| 226. | Proteomic profiling reveals common and region-specific protein signatures underlying tumor heterogeneity in cholangiocarcinoma. | Sitthirak, S Roytrakul, S Wangwiwatsin, A Namwat, N Klanrit, P Dokduang, H Sa-Ngiamwibool, P Titapan, A Jareanrat, A Thanasukarn, V Khuntikeo, N Boulter, L Loilome, W |
2025 | ||||
| 227. | The genome sequence of the liver fluke (Poirier, 1886) Stiles & Hassall, 1896. | Wangwiwatsin, A Kulwong, S Phuyao, C Titapun, A Loilome, W Klanrit, P Namwat, N Sithithaworn, P Doyle, SR Berriman, M Crellen, T , , , , |
2025 | ||||
| 228. | Whole exome sequencing of multi-regions reveals tumor heterogeneity in Opisthorchis viverrini-associated cholangiocarcinoma. | Sitthirak, S Wangwiwatsin, A Jusakul, A Namwat, N Klanrit, P Dokduang, H Sa-Ngiamwibool, P Titapun, A Jareanrat, A Thanasukarn, V Khuntikeo, N Teh, BT Boulter, L Murakami, Y Loilome, W |
2025 | Count | 139 | 164 | 139 | 11 |
| Title | Authors | Year | Publication name | Cited count | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| < 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | รวม | ||||||
| 1. | Altered gene expression in Opisthorchis viverrini-associated cholangiocarcinoma in hamster model | Loilome, W. Yongvanit, P. Wongkham, C. Tepsiri, N.N. Sripa, B. Sithithaworn, P. Miwa, M. |
2006 |
Molecular Carcinogenesis 5 (45), pp. 279-287 |
||||||||
| 2. | Characterization of 5-fluorouracil-resistant cholangiocarcinoma cell lines | Namwat, N. Amimanan, P. Loilome, W. Jearanaikoon, P. Sripa, B. Bhudhisawasdi, V. Tassaneeyakul, W. |
2008 |
Chemotherapy 5 (54), pp. 343-351 |
||||||||
| 3. | Glioblastoma cell growth is suppressed by disruption of fibroblast growth factor pathway signaling | Loilome, W. | 2009 |
Journal of Neuro-Oncology 3 (94), pp. 359-366 |
||||||||
| 4. | Apoptotic activity of caged xanthones from Garcinia hanburyi in cholangiocarcinoma cell lines | Hahnvajanawong, C. Boonyanugomol, W. Nasomyon, T. Loilome, W. Namwat, N. Anantachoke, N. Tassaneeyakul, W. Sripa, B. Namwat, W. Reutrakul, V. |
2010 |
World Journal of Gastroenterology 18 (16), pp. 2235-2243 |
||||||||
| 5. | Erratum: Glioblastoma cell growth is suppressed by disruption of fibroblast growth factor pathway signaling (Journal of Neuro-Oncology DOI:10.1007/s11060- 009-9885-5) | Loilome, W. | 2010 |
Journal of Neuro-Oncology 3 (97), pp. 459 |
||||||||
| 6. | Myristoylated alanine-rich C kinase substrate phosphorylation promotes cholangiocarcinoma cell migration and metastasis via the protein kinase C-dependent pathway | Techasen, A. Loilome, W. Namwat, N. Takahashi, E. Puapairoj, A. Miwa, M. Saya, H. Yongvanit, P. |
2010 |
Cancer Science 3 (101), pp. 658-665 |
||||||||
| 7. | Downregulation of reversion-inducing-cysteine-rich protein with Kazal motifs (RECK) is associated with enhanced expression of matrix metalloproteinases and cholangiocarcinoma metastases | Namwat, N. Puetkasichonpasutha, J. Loilome, W. Yongvanit, P. Techasen, A. Puapairoj, A. Sripa, B. Tassaneeyakul, W. Khuntikeo, N. Wongkham, S. |
2011 |
Journal of Gastroenterology 5 (46), pp. 664-675 |
||||||||
| 8. | Mechanisms of oxysterol-induced carcinogenesis | Jusakul, A. Yongvanit, P. Loilome, W. Namwat, N. |
2011 |
Lipids in Health and Disease (10), pp. |
||||||||
| 9. | PRKAR1A is overexpressed and represents a possible therapeutic target in human cholangiocarcinoma | Loilome, W. Juntana, S. Namwat, N. Bhudhisawasdi, V. Puapairoj, A. Sripa, B. Miwa, M. Saya, H. Yongvanit, P. |
2011 |
International Journal of Cancer 1 (129), pp. 34-44 |
||||||||
| 10. | Anti-inflammatory agents suppress the prostaglandin e2 production and migration ability of Cholangiocarcinoma cell lines | Jongthawin, J. Techasen, A. Loilome, W. Yongvanit, P. Namwat, N. |
2012 |
Asian Pacific Journal of Cancer Prevention SUPPL.1 (13), pp. 47-51 |
||||||||
| 11. | Anti-inflammatory, antioxidant and hepatoprotective effects of Thunbergia laurifolia Linn. on experimental opisthorchiasis | Wonkchalee, O. Boonmars, T. Aromdee, C. Laummaunwai, P. Khunkitti, W. Vaeteewoottacharn, K. Sriraj, P. Aukkanimart, R. Loilome, W. Chamgramol, Y. Pairojkul, C. Juasook, A. Sudsarn, P. |
2012 |
Parasitology Research 1 (111), pp. 353-359 |
||||||||
| 12. | Anti-inflammatory effect of prednisolone on the growth of human liver fluke in experimental opisthorchiasis | Juasook, A. Boonmars, T. Kaewkes, S. Loilome, W. Veteewuthacharn, K. Yongvanit, P. |
2012 |
Parasitology Research 6 (110), pp. 2271-2279 |
||||||||
| 13. | Cytokines Released from activated human macrophages induce epithelial mesenchymal transition markers of Cholangiocarcinoma cells | Techasen, A. Loilome, W. Namwat, N. Dokduang, H. Jongthawin, J. Yongvanit, P. |
2012 |
Asian Pacific Journal of Cancer Prevention SUPPL.1 (13), pp. 115-118 |
||||||||
| 14. | Down-regulated expression of HSP70 in correlation with clinicopathology of cholangiocarcinoma | Boonjaraspinyo, S. Boonmars, T. Kaewkes, S. Laummaunwai, P. Pinlaor, S. Loilome, W. Yongvanit, P. Puapairoj, A. Bhudhisawasdi, V. |
2012 |
Pathology and Oncology Research 2 (18), pp. 227-237 |
||||||||
| 15. | Evaluation of Tyrosine Kinase Inhibitor Combinations for Glioblastoma Therapy | Loilome, W. | 2012 |
PLoS ONE 10 (7), pp. |
||||||||
| 16. | Expression of oxysterol binding protein isoforms in opisthorchiasis-associated cholangiocarcinoma: A potential molecular marker for tumor metastasis | Loilome, W. Wechagama, P. Namwat, N. Jusakul, A. Sripa, B. Miwa, M. Yongvanit, P. |
2012 |
Parasitology International 1 (61), pp. 136-139 |
||||||||
| 17. | Expression profiles of oncomir miR-21 and tumor suppressor let-7a in the progression of Opisthorchiasis-associated cholangiocarcinoma | Namwat, N. Chusorn, P. Loilome, W. Techasen, A. Puetkasichonpasutha, J. Pairojkul, C. Khuntikeo, N. Yongvanit, P. |
2012 |
Asian Pacific Journal of Cancer Prevention SUPPL.1 (13), pp. 65-69 |
||||||||
| 18. | Hepatic cytochrome P450 2A6 and 2E1 status in peri-tumor tissues of patients with Opisthorchis viverrini-associated cholangiocarcinoma | Yongvanit, P. Phanomsri, E. Namwat, N. Kampan, J. Tassaneeyakul, W. Loilome, W. Puapairoj, A. Khuntikeo, N. |
2012 |
Parasitology International 1 (61), pp. 162-166 |
||||||||
| 19. | Identification of biliary bile acids in patients with benign biliary diseases, hepatocellular carcinoma and cholangiocarcinoma | Jusakul, A. Khuntikeo, N. Ioannou, G.N. Loilome, W. Namwat, N. Bhudhisawasdi, V. Pugkhem, A. Pairojkul, C. Yongvanit, P. |
2012 |
Asian Pacific Journal of Cancer Prevention SUPPL.1 (13), pp. 77-82 |
||||||||
| 20. | Impaired antioxidant enzyme activity and increased DNA repair enzyme expression in hamster liver tissues related to cholangiocarcinoma development | Loilome, W. Namwat, N. Techasen, A. Puapairoj, A. Pinitsoontorn, C. Yongvanit, P. |
2012 |
Asian Pacific Journal of Cancer Prevention SUPPL.1 (13), pp. 59-64 |
||||||||
| 21. | Increased expression of TLR-2, COX-2, and SOD-2 genes in the peripheral blood leukocytes of opisthorchiasis patients induced by Opisthorchis viverrini antigen | Yongvanit, P. Thanan, R. Pinlaor, S. Sithithaworn, P. Loilome, W. Namwat, N. Techasen, A. Dechakhamphu, S. |
2012 |
Parasitology Research 5 (110), pp. 1969-1977 |
||||||||
| 22. | Liver fluke-induced hepatic oxysterols stimulate DNA damage and apoptosis in cultured human cholangiocytes | Jusakul, A. Loilome, W. Namwat, N. Dechakhamphu, S. Sukontawarin, P. Pinlaor, S. Lee, S.P. Yongvanit, P. |
2012 |
Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis 1-2 (731), pp. 48-57 |
||||||||
| 23. | Opisthorchis viverrini-antigen induces expression of MARCKS during inflammation-associated cholangiocarcinogenesis | Techasen, A. Loilome, W. Namwat, N. Duenngai, K. Cha'on, U. Thanan, R. Sithithaworn, P. Miwa, M. Yongvanit, P. |
2012 |
Parasitology International 1 (61), pp. 140-144 |
||||||||
| 24. | Overexpression of PDGFA and its receptor during carcinogenesis of Opisthorchis viverrini-associated cholangiocarcinoma | Boonjaraspinyo, S. Boonmars, T. Kaewkes, S. Loilome, W. Sithithaworn, P. Yongvanit, P. Bhudhisawasdi, V. |
2012 |
Parasitology International 1 (61), pp. 145-150 |
||||||||
| 25. | Platelet-derived growth factor may be a potential diagnostic and prognostic marker for cholangiocarcinoma | Boonjaraspinyo, S. Boonmars, T. Loilome, W. Sithithaworn, P. Pinlaor, S. Yongvanit, P. Nielsen, P.S. Pairojkul, C. Khuntikeo, N. |
2012 |
Tumor Biology 5 (33), pp. 1785-1802 |
||||||||
| 26. | PRKAR1A overexpression is associated with increased ECPKA autoantibody in liver fluke-associated cholangiocarcinoma: application for assessment of the risk group. | Loilome, W. Yooyuen, S. Namwat, N. Sithithaworn, P. Puapairoj, A. Kano, J. Miwa, M. Yongvanit, P. |
2012 |
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 6 (33), pp. 2289-2298 |
||||||||
| 27. | Suppression of PRKAR1A expression enhances antiproliferative and apoptotic effects of protein kinase inhibitors and chemotherapeutic drugs on cholangiocarcinoma Cells | Loilome, W. Juntana, S. Pinitsoontorn, C. Namwat, N. Tassaneeyakul, W. Yongvanit, P. |
2012 |
Asian Pacific Journal of Cancer Prevention SUPPL.1 (13), pp. 143-147 |
||||||||
| 28. | Tumor necrosis factor-α (TNF-α) stimulates the epithelial-mesenchymal transition regulator Snail in cholangiocarcinoma | Techasen, A. Namwat, N. Loilome, W. Bungkanjana, P. Khuntikeo, N. Puapairoj, A. Jearanaikoon, P. Saya, H. Yongvanit, P. |
2012 |
Medical Oncology 5 (29), pp. 3083-3091 |
||||||||
| 29. | Anti-apoptotic phenotypes of cholestan-3β,5α,6β-triol- resistant human cholangiocytes: Characteristics contributing to the genesis of cholangiocarcinoma | Jusakul, A. Loilome, W. Namwat, N. Techasen, A. Ioannou, G.N. Yongvanit, P. |
2013 |
Journal of Steroid Biochemistry and Molecular Biology (138), pp. 368-375 |
||||||||
| 30. | Immunosuppressive prednisolone enhances early cholangiocarcinoma in Syrian hamsters with liver fluke infection and administration of N-nitrosodimethylamine | Juasook, A. Boonmars, T. Loilome, W. Veteewuthacharn, K. Namwat, N. Namwat, N. Sudsarn, P. Wonkchalee, O. Sriraj, P. Aukkanimart, R. |
2013 |
Pathology and Oncology Research 1 (19), pp. 55-62 |
||||||||
| 31. | Increased activation of PI3K/AKT signaling pathway is associated with cholangiocarcinoma metastasis and PI3K/mTOR inhibition presents a possible therapeutic strategy | Yothaisong, S. Dokduang, H. Techasen, A. Namwat, N. Yongvanit, P. Bhudhisawasdi, V. Puapairoj, A. Loilome, W. |
2013 |
Tumor Biology 6 (34), pp. 3637-3648 |
||||||||
| 32. | Overexpression of microRNA-21 regulating PDCD4 during tumorigenesis of liver fluke-associated cholangiocarcinoma contributes to tumor growth and metastasis | Chusorn, P. Namwat, N. Loilome, W. Techasen, A. Pairojkul, C. Khuntikeo, N. Talabnin, C. Chan-On, W. Yongvanit, P. |
2013 |
Tumor Biology 3 (34), pp. 1579-1588 |
||||||||
| 33. | Oxidized alpha-1 antitrypsin as a predictive risk marker of opisthorchiasis-associated cholangiocarcinoma | Jamnongkan, W. Techasen, A. Thanan, R. Duenngai, K. Sithithaworn, P. Mairiang, E. Loilome, W. Namwat, N. Pairojkul, C. Yongvanit, P. |
2013 |
Tumor Biology 2 (34), pp. 695-704 |
||||||||
| 34. | Survey of activated kinase proteins reveals potential targets for cholangiocarcinoma treatment | Dokduang, H. Juntana, S. Techasen, A. Namwat, N. Yongvanit, P. Khuntikeo, N. Loilome, W. |
2013 |
Tumor Biology 6 (34), pp. 3519-3528 |
||||||||
| 35. | Activated macrophages promote Wnt/β-catenin signaling in cholangiocarcinoma cells | Loilome, W. Bungkanjana, P. Techasen, A. Namwat, N. Yongvanit, P. Puapairoj, A. Khuntikeo, N. |
2014 |
Tumor Biology 6 (35), pp. 5357-5367 |
||||||||
| 36. | Association of CYP39A1, RUNX2 and oxidized alpha-1 antitrypsin expression in relation to cholangiocarcinoma progression | Khenjanta, C. Thanan, R. Jusakul, A. Techasen, A. Jamnongkan, W. Namwat, N. Loilome, W. Pairojkul, C. Yongvanit, P. |
2014 |
Asian Pacific Journal of Cancer Prevention 23 (15), pp. 10187-10192 |
||||||||
| 37. | BMP-7 blocks the effects of TGF-β-induced EMT in cholangiocarcinoma | Duangkumpha, K. Techasen, A. Loilome, W. Namwat, N. Thanan, R. Khuntikeo, N. Yongvanit, P. |
2014 |
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 10 (35), pp. 9667-9676 |
||||||||
| 38. | Circulating miR-192 in liver fluke-associated cholangiocarcinoma patients: A prospective prognostic indicator | Loilome, W. Yongvanit, P. Chusorn, P. Techasen, A. Boonmars, T. Khuntikeo, N. Chamadol, N. Pairojkul, C. Namwat, N. |
2014 |
Journal of Hepato-Biliary-Pancreatic Sciences 12 (21), pp. 864-872 |
||||||||
| 39. | High expression of HIF-1α, BNIP3 and PI3KC3: Hypoxia-induced autophagy predicts cholangiocarcinoma survival and metastasis | Thongchot, S. Yongvanit, P. Loilome, W. Seubwai, W. Phunicom, K. Tassaneeyakul, W. Pairojkul, C. Promkotra, W. Techasen, A. Namwat, N. |
2014 |
Asian Pacific Journal of Cancer Prevention 14 (15), pp. 5873-5878 |
||||||||
| 40. | Histological confirmation of periductal fibrosis from ultrasound diagnosis in cholangiocarcinoma patients | Chamadol, N. Pairojkul, C. Khuntikeo, N. Laopaiboon, V. Loilome, W. Sithithaworn, P. Yongvanit, P. |
2014 |
Journal of Hepato-Biliary-Pancreatic Sciences 5 (21), pp. 316-322 |
||||||||
| 41. | Increased EphB2 expression predicts cholangiocarcinoma metastasis | Khansaard, W. Techasen, A. Namwat, N. Yongvanit, P. Khuntikeo, N. Puapairoj, A. Loilome, W. |
2014 |
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 10 (35), pp. 10031-10041 |
||||||||
| 42. | Loss of E-cadherin promotes migration and invasion of cholangiocarcinoma cells and serves as a potential marker of metastasis | Techasen, A. Loilome, W. Namwat, N. Khuntikeo, N. Puapairoj, A. Jearanaikoon, P. Saya, H. Yongvanit, P. |
2014 |
Tumor Biology 9 (35), pp. 8645-8652 |
||||||||
| 43. | Milk fat globule epidermal growth factor 8 serves a novel biomarker of opisthorchiasis-associated cholangiocarcinoma | Boonmars, T. Loilome, W. Yongvanit, P. Khuntikeo, N. Nielsen, P.S. |
2014 |
Tumor Biology 3 (35), pp. 1985-1995 |
||||||||
| 44. | Opisthorchis viverrini infection activates the PI3K/AKT/PTEN and Wnt/β-catenin signaling pathways in a cholangiocarcinogenesis model | Yothaisong, S. Thanee, M. Namwat, N. Yongvanit, P. Boonmars, T. Puapairoj, A. Loilome, W. |
2014 |
Asian Pacific Journal of Cancer Prevention 23 (15), pp. 10463-10468 |
||||||||
| 45. | PGE2 signaling and its biosynthesis-related enzymes in cholangiocarcinoma progression | Jongthawin, J. Chusorn, P. Techasen, A. Loilome, W. Boonmars, T. Thanan, R. Puapairoj, A. Khuntikeo, N. Tassaneeyakul, W. Yongvanit, P. Namwat, N. |
2014 |
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 8 (35), pp. 8051-8064 |
||||||||
| 46. | Risk biomarkers for assessment and chemoprevention of liver fluke-associated cholangiocarcinoma | Yongvanit, P. Pinlaor, S. Loilome, W. |
2014 |
Journal of Hepato-Biliary-Pancreatic Sciences 5 (21), pp. 309-315 |
||||||||
| 47. | STATs profiling reveals predominantly-activated STAT3 in cholangiocarcinoma genesis and progression | Dokduang, H. Techasen, A. Namwat, N. Khuntikeo, N. Pairojkul, C. Murakami, Y. Loilome, W. Yongvanit, P. |
2014 |
Journal of Hepato-Biliary-Pancreatic Sciences 10 (21), pp. 767-776 |
||||||||
| 48. | Tumor necrosis factor-α modulates epithelial mesenchymal transition mediators ZEB2 and S100A4 to promote cholangiocarcinoma progression | Techasen, A. Namwat, N. Loilome, W. Duangkumpha, K. Puapairoj, A. Saya, H. Yongvanit, P. |
2014 |
Journal of Hepato-Biliary-Pancreatic Sciences 9 (21), pp. 703-711 |
||||||||
| 49. | A promising serum autoantibody marker, anti-heat shock protein 90α, for cholangiocarcinoma | Boonjaraspinyo, S. Juasook, A. Boonmars, T. Aukkanimart, R. Silsirivanit, A. Loilome, W. Sriraj, P. |
2015 |
Asian Pacific Journal of Cancer Prevention 14 (16), pp. 5779-5785 |
||||||||
| 50. | Chloroquine exerts anti-metastatic activities under hypoxic conditions in cholangiocarcinoma cells | Thongchot, S. Loilome, W. Yongvanit, P. Dokduang, H. Thanan, R. Techasen, A. Namwat, N. |
2015 |
Asian Pacific Journal of Cancer Prevention 5 (16), pp. 2031-2035 |
||||||||
| 51. | Cohort profile: Cholangiocarcinoma screening and care program (CASCAP) | Khuntikeo, N. Chamadol, N. Yongvanit, P. Loilome, W. Namwat, N. Sithithaworn, P. Andrews, R.H. Petney, T.N. Promthet, S.S. Thinkhamrop, K. Tawarungruang, C. Thinkhamrop, B. |
2015 |
BMC Cancer 1 (15), pp. |
||||||||
| 52. | Quantitative changes in tumor-associated M2 Macrophages characterize cholangiocarcinoma and their association with metastasis | Thanee, M. Loilome, W. Techasen, A. Namwat, N. Boonmars, T. Pairojkul, C. Yongvanit, P. |
2015 |
Asian Pacific Journal of Cancer Prevention 7 (16), pp. 3043-3050 |
||||||||
| 53. | A Comprehensive Public Health Conceptual Framework and Strategy to Effectively Combat Cholangiocarcinoma in Thailand | Khuntikeo, N. Loilome, W. Thinkhamrop, B. Chamadol, N. Yongvanit, P. |
2016 |
PLoS Neglected Tropical Diseases 1 (10), pp. |
||||||||
| 54. | A Comprehensive Public Health Conceptual Framework and Strategy to Effectively Combat Cholangiocarcinoma in Thailand | Khuntikeo, N. Loilome, W. Thinkhamrop, B. Chamadol, N. Yongvanit, P. |
2016 |
PLoS Neglected Tropical Diseases 1 (10), pp. |
||||||||
| 55. | CD44 variant-dependent redox status regulation in liver fluke-associated cholangiocarcinoma: A target for cholangiocarcinoma treatment | Thanee, M. Loilome, W. Techasen, A. Namwat, N. Khuntikeo, N. Titapun, A. Pairojkul, C. Saya, H. Yongvanit, P. |
2016 |
Cancer Science (), pp. |
||||||||
| 56. | CD44 variant-dependent redox status regulation in liver fluke-associated cholangiocarcinoma: A target for cholangiocarcinoma treatment | Thanee, M. Loilome, W. Techasen, A. Namwat, N. Khuntikeo, N. Titapun, A. Pairojkul, C. Saya, H. Yongvanit, P. |
2016 |
Cancer Science 7 (107), pp. 991-1000 |
||||||||
| 57. | Combination of Praziquantel and Aspirin Minimizes Liver Pathology of Hamster Opisthorchis viverrini Infection Associated Cholangiocarcinoma | Sudsarn, P. Boonmars, T. Ruangjirachuporn, W. Namwat, N. Loilome, W. Sriraj, P. Aukkanimart, R. Jiraporn, S. |
2016 |
Pathology and Oncology Research 1 (22), pp. 57-65 |
||||||||
| 58. | Potential of selenium compounds as new anticancer agents for cholangiocarcinoma | Thongchot, S. Dokduang, H. Loilome, W. Khuntikeo, N. Titapun, A. Ungarreevittaya, P. Yongvanit, P. Techasen, A. Namwat, N. |
2016 |
Anticancer Research 11 (36), pp. 5981-5988 |
||||||||
| 59. | Xanthohumol inhibits STAT3 activation pathway leaDing to growth suppression and apoptosis induction in human cholangiocarcinoma cells | Dokduang, H. Yongvanit, P. Namwat, N. Pairojkul, C. Loilome, W. |
2016 |
Oncology Reports 4 (35), pp. 2065-2072 |
||||||||
| 60. | Carcinogenic liver fluke and others contaminated in pickled fish of northeastern Thailand | Aukkanimart, R. Boonmars, T. Sriraj, P. Songsri, J. Laummaunwai, P. Aunpromma, S. Khuntikeo, N. Loilome, W. Namwat, N. Yongvanit, P. Boonjaraspinyo, S. |
2017 |
Asian Pacific Journal of Cancer Prevention 2 (18), pp. 529-533 |
||||||||
| 61. | Establishment of cholangiocarcinoma cell lines from patients in the endemic area of liver fluke infection in Thailand | Senggunprai, L. Namwat, N. Kongpetch, S. Chamgramol, Y. Loilome, W. Khansaard, W. Jusakul, A. Prawan, A. Pairojkul, C. Yongvanit, P. Kukongviriyapan, V. |
2017 |
Tumor Biology 11 (39), pp. |
||||||||
| 62. | Imbalanced adaptive responses associated with microsatellite instability in cholangiocarcinoma | Loilome, W. Yongvanit, P. Namwat, N. Techasen, A. Khuntikeo, N. |
2017 |
Oncology Letters 2 (13), pp. 639-646 |
||||||||
| 63. | Increase in L-type amino acid transporter 1 expression during cholangiocarcinogenesis caused by liver fluke infection and its prognostic significance | Namwat, N. Yongvanit, P. Loilome, W. Khuntikeo, N. Tassaneeyakul, W. Tangsucharit, P. Yothaisong, S. |
2017 |
Parasitology International 4 (66), pp. 471-478 |
||||||||
| 64. | Inhibition of l-type amino acid transporter 1 activity as a new therapeutic target for cholangiocarcinoma treatment | Yothaisong, S. Dokduang, H. Namwat, N. Yongvanit, P. Loilome, W. |
2017 |
Tumor Biology 3 (39), pp. |
||||||||
| 65. | Nimotuzumab inhibits cholangiocarcinoma cell metastasis via suppression of the epithelial-mesenchymal transition process | Thanee, M. Techasen, A. Namwat, N. Yongvanit, P. Loilome, W. |
2017 |
Anticancer Research 7 (37), pp. 3591-3597 |
||||||||
| 66. | Opisthorchiasis and cholangiocarcinoma in Southeast Asia: An unresolved problem | Techasen, A. Loilome, W. Khuntikeo, N. Yongvanit, P. Sithithaworn, P. |
2017 |
International Journal of General Medicine (10), pp. 227-237 |
||||||||
| 67. | Protein kinases as targets for Opisthorchis viverrini- associated cholangiocarcinoma therapy | Loilome, W. Dokduang, H. |
2017 |
Current Pharmaceutical Design 29 (23), pp. 4281-4289 |
||||||||
| 68. | Simplified techniques for killing the carcinogenic, Opisthorchis viverrini metacercariae in cyprinid fish | Boonmars, T. Songsri, J. Aukkanimart, R. Sriraj, P. Rattanasuwan, P. Suwannatrai, A. Aunpromma, S. Khuntikeo, N. Loilome, W. Namwat, N. Yongvanit, P. Boonjaraspinyo, S. |
2017 |
Asian Pacific Journal of Cancer Prevention 6 (18), pp. 1507-1511 |
||||||||
| 69. | Teleconsultation ultrasonography: A new weapon to combat cholangiocarcinoma | Chamadol, N. Laopaiboon, V. Srinakarin, J. Loilome, Yongvanit, P. Thinkhamrop, B. Khuntikeo, N. |
2017 |
ESMO Open 3 (2), pp. |
||||||||
| 70. | Upregulation of endothelial nitric oxide synthase (eNOS) and its upstream regulators in Opisthorchis viverrini associated cholangiocarcinoma and its clinical significance | Techasen, A. Namwat, N. Yongvanit, P. Khuntikeo, N. Titapun, A. Koonmee, S. Loilome, W. |
2017 |
Parasitology International 4 (66), pp. 486-493 |
||||||||
| 71. | Upregulation of TCTP is associated with cholangiocarcinoma progression and metastasis | Techasen, A. Thongchot, S. Thanan, R. Khuntikeo, N. Yongvanit, P. |
2017 |
Oncology Letters 5 (14), pp. 5973-5979 |
||||||||
| 72. | Upregulation of transferrin receptor-1 induces cholangiocarcinoma progression via induction of labile iron pool | Jamnongkan, W. Thanan, R. Techasen, A. Namwat, N. Loilome, W. Intarawichian, P. Titapun, A. Yongvanit, P. |
2017 |
Tumor Biology 7 (39), pp. 1-10 |
||||||||
| 73. | Urinary microRNA-192 and microRNA-21 as potential indicators for liver fluke-associated cholangiocarcinoma risk group | Loilome, W. Yongvanit, P. Thongchot, S. Namwat, N. Sithithaworn, P. Boonmars, T. Koonmee, S. Titapun, A. Khuntikeo, N. Chamadol, N. Techasen, A. |
2017 |
Parasitology International 4 (66), pp. 479-485 |
||||||||
| 74. | Antifibrotic effect of xanthohumol in combination with praziquantel is associated with altered redox status and reduced iron accumulation during liver fluke-associated cholangiocarcinogenesis | Jamnongkan, W. Thanee, M. Yongvanit, P. Loilome, W. Thanan, R. Namwat, N. Techasen, A. |
2018 |
PeerJ 1 (2018), pp. |
||||||||
| 75. | Current perspectives on opisthorchiasis control and cholangiocarcinoma detection in Southeast Asia | Khuntikeo, N. Titapun, A. Loilome, Yongvanit, P. Thinkhamrop, B. Chamadol, N. Boonmars, T. Andrews, R.H. Sithithaworn, P. |
2018 |
Frontiers in Medicine APR (5), pp. |
||||||||
| 76. | Current perspectives on opisthorchiasis control and cholangiocarcinoma detection in southeast asia | Khuntikeo, N. Titapun, A. Loilome, Yongvanit, P. Thinkhamrop, B. Chamadol, N. Boonmars, T. Andrews, R.H. Sithithaworn, P. |
2018 |
Frontiers in Medicine APR (5), pp. |
||||||||
| 77. | Diagnostic performance of urinary IgG antibody detection: A novel approach for population screening of strongyloidiasis | Eamudomkarn, C. Sithithaworn, P. Sithithaworn, J. Kaewkes, S. Techasen, A. Loilome, Yongvanit, P. Saichua, P. Itoh, M. |
2018 |
PLoS ONE 7 (13), pp. |
||||||||
| 78. | Dihydroartemisinin induces apoptosis and autophagy-dependent cell death in cholangiocarcinoma through a DAPK1-BECLIN1 pathway | Thongchot, S. Loilome, Yongvanit, P. |
2018 |
Molecular Carcinogenesis 12 (57), pp. 1735-1750 |
||||||||
| 79. | Elevated levels of urinary 8-oxodG correlate with persistent periductal fibrosis after praziquantel treatment in chronic opisthorchiasis | Yongvanit, P. Loilome, Thanan, R. Eamudomkarn, C. Chamadol, N. Mairiang, E. Sithithaworn, J. Saichua, P. Sripa, B. Khuntikeo, N. Sithithaworn, P. |
2018 |
American Journal of Tropical Medicine and Hygiene 6 (98), pp. 1763-1769 |
||||||||
| 80. | Erratum to “Resveratrol interrupts the pro-invasive communication between Cancer associated Fibroblasts and Cholangiocarcinoma cells” (Cancer Letters (2018) 430 (160–171), (S0304383518303641) (10.1016/j.canlet.2018.05.031)) | Thongchot, S. Loilome, Yongvanit, P. |
2018 |
Cancer Letters (434), pp. 206-207 |
||||||||
| 81. | Inhibition of endothelial nitric oxide synthase in cholangiocarcinoma cell lines – a new strategy for therapy | Techasen, A. Namwat, N. Titapun, A. Ungarreevittaya, P. Yongvanit, P. |
2018 |
FEBS Open Bio 4 (8), pp. 513-522 |
||||||||
| 82. | Inhibitory effect of nvp-bkm120 on cholangiocarcinoma cell growth | Dokduang, H. Yothaisong, S. Techasen, A. Yongvanit, P. Khuntikeo, N. Titapun, A. Loilome, |
2018 |
Oncology Letters 2 (16), pp. 1627-1633 |
||||||||
| 83. | Potential role of HIF-1-responsive microRNA210/HIF3 axis on gemcitabine resistance in cholangiocarcinoma cells | Thongchot, S. Loilome, Techasen, A. Ungarreevittaya, P. Khuntikeo, N. Yongvanit, P. |
2018 |
PLoS ONE 6 (13), pp. |
||||||||
| 84. | Progranulin modulates cholangiocarcinoma cell proliferation, apoptosis, and motility via the PI3K/pAkt pathway | Loilome, W. Techasen, A. Thanee, M. Titapun, A. Yongvanit, P. Namwat, N. |
2018 |
OncoTargets and Therapy (11), pp. 395-408 |
||||||||
| 85. | Prolonged oxidative stress down-regulates Early B cell factor 1 with inhibition of its tumor suppressive function against cholangiocarcinoma genesis | Armartmuntree, N. Techasen, A. Yongvanit, P. Loilome, W. Pairojkul, C. Sakonsinsiri, C. Pinlaor, S. Thanan, R. |
2018 |
Redox Biology (14), pp. 637-644 |
||||||||
| 86. | Resveratrol interrupts the pro-invasive communication between cancer associated fibroblasts and cholangiocarcinoma cells | Thongchot, S. Loilome, Yongvanit, P. |
2018 |
Cancer Letters (430), pp. 160-171 |
||||||||
| 87. | Suppression of 14-3-3ζ in cholangiocarcinoma cells inhibits proliferation through attenuated akt activity, enhancing chemosensitivity to gemcitabine | Techasen, A. Thongchot, S. Loilome, W. Thanan, R. Yongvanit, P. Titapun, A. Khuntikeo, N. Namwat, N. |
2018 |
Oncology Letters 1 (15), pp. 347-353 |
||||||||
| 88. | The Socioeconomic Burden of Cholangiocarcinoma Associated With Opisthorchis viverrini Sensu Lato Infection in Northeast Thailand: A Preliminary Analysis | Khuntikeo, N. Thinkhamrop, B. Andrews, R.H. Yongvanit, P. Loilome, Chamadol, N. Kosuwan, W. Sithithaworn, P. |
2018 |
Advances in Parasitology (102), pp. 141-163 |
||||||||
| 89. | Zileuton suppresses cholangiocarcinoma cell proliferation and migration through inhibition of the akt signaling pathway | Thanee, M. Techasen, A. Klanrit, Titapun, A. Loilome, |
2018 |
OncoTargets and Therapy (11), pp. 7019-7029 |
||||||||
| 90. | Characterisation of the Urinary Metabolic Profile of Liver Fluke-Associated Cholangiocarcinoma | Sithithaworn, P. Khuntikeo, N. Loilome, W. Yongvanit, P. Chamadol, N. Andrews, R.H. |
2019 |
Journal of Clinical and Experimental Hepatology 6 (9), pp. 657-675 |
||||||||
| 91. | Cholangiocarcinoma: A guide for the nonspecialist | Sithithaworn, P. Khuntikeo, N. Loilome, W. Yongvanit, P. Andrews, R.H. |
2019 |
International Journal of General Medicine (12), pp. 13-23 |
||||||||
| 92. | Comparing the performance of urine and copro-antigen detection in evaluating opisthorchis viverrini infection in communities with different transmission levels in Northeast Thailand | Duenngai, K. Kiatsopit, N. Kopolrat, K. Techasen, A. Sithithaworn, J. Khuntikeo, N. Loilome, Yongvanit, P. Sithithaworn, P. |
2019 |
PLoS Neglected Tropical Diseases 2 (13), pp. |
||||||||
| 93. | Detection of the G1138A mutation in the FGFR3 gene for the diagnosis of achondroplasia by allele-specific polymerase chain reaction | Imtawil, K.J. Loilome, W. Tangrassameeprasert, R. Wichajarn, K. |
2019 |
Journal of the Medical Association of Thailand 6 (102), pp. 118-121 |
||||||||
| 94. | Discovery and Qualification of Serum Protein Biomarker Candidates for Cholangiocarcinoma Diagnosis | Duangkumpha, K. Phetcharaburanin, J. Yongvanit, P. Thanan, R. Techasen, A. Khuntikeo, N. Chamadol, N. Mulvenna, J.P. Loilome, |
2019 |
Journal of Proteome Research 9 (18), pp. 3305-3316 |
||||||||
| 95. | Discovery of serotransferrin glycoforms: Novel markers for diagnosis of liver periductal fibrosis and prediction of cholangiocarcinoma | Jamnongkan, W. Techasen, A. Loilome, Sithithaworn, P. Khuntikeo, N. Pairojkul, C. Chamadol, N. Thanan, R. Yongvanit, P. |
2019 |
Biomolecules 10 (9), pp. |
||||||||
| 96. | Evaluation of anticancer potential of Thai medicinal herb extracts against cholangiocarcinoma cell lines | Promraksa, B. Phetcharaburanin, J. Techasen, A. Boonsiri, P. Loilome, |
2019 |
PLoS ONE 5 (14), pp. |
||||||||
| 97. | Evaluation of a short term effect of praziquantel treatment in opisthorchiasis-induced hepatobiliary inflammation by urinary 8-oxodG | Thanan, R. Eamudomkarn, C. Techasen, A. Sithithaworn, J. Loilome, Chamadol, N. Pinlaor, S. Jumnainsong, A. Yongvanit, P. Khuntikeo, N. Sithithaworn, P. |
2019 |
Acta Tropica (189), pp. 124-128 |
||||||||
| 98. | In vitro and molecular chemosensitivity in human cholangiocarcinoma tissues | Klanrit, Phetcharaburanin, J. Khuntikeo, N. Titapun, A. Techasen, A. Loilome, |
2019 |
PLoS ONE 9 (14), pp. |
||||||||
| 99. | Mass Spectrometry: A Guide for the Clinician | Andrews, R.H. Sithithaworn, P. Khuntikeo, N. Loilome, W. Yongvanit, P. |
2019 |
Journal of Clinical and Experimental Hepatology 5 (9), pp. 597-606 |
||||||||
| 100. | PRIMA-1MET induces cellular senescence and apoptotic cell death in cholangiocarcinoma cells | Titapun, A. Loilome, |
2019 |
Cancer Genomics and Proteomics 6 (16), pp. 543-552 |
||||||||
| 101. | Urine proteomics study reveals potential biomarkers for the differential diagnosis of cholangiocarcinoma and periductal fibrosis | Duangkumpha, K. Phetcharaburanin, J. Yongvanit, P. Thanan, R. Techasen, A. Khuntikeo, N. Chamadol, N. Mulvenna, J.P. Loilome, |
2019 |
PLoS ONE 8 (14), pp. |
||||||||
| 102. | A comparison of the proportion of early stage cholangiocarcinoma found in an ultrasound-screening program compared to walk-in patients | Khuntikeo, N. Koonmee, S. Chamadol, N. Laopaiboon, V. Titapun, A. Yongvanit, P. Loilome, Andrews, R.H. Thinkhamrop, K. Tawarungruang, C. Thinkhamrop, B. |
2020 |
HPB 6 (22), pp. 874-883 |
||||||||
| 103. | A panel of protein kinase high expression is associated with postoperative recurrence in cholangiocarcinoma | Thanee, M. Namwat, N. Phetcharaburanin, J. Klanrit, P. Khuntikeo, N. Titapun, A. Loilome, W. |
2020 |
BMC Cancer 1 (20), pp. |
||||||||
| 104. | ARID1A alterations and their clinical significance in cholangiocarcinoma | Techasen, A. Loilome, W. Jusakul, A. |
2020 |
PeerJ (8), pp. |
||||||||
| 105. | AuNPs-LISA, an efficient detection assay for Opisthorchis viverrini (Ov) antigen in urine | Jamnongkan, W. Techasen, A. Phetcharaburanin, J. Sithithaworn, P. Khuntikeo, N. Mukdasai, S. Sayasone, S. Loilome, W. Ngeontae, W. |
2020 |
Talanta (209), pp. |
||||||||
| 106. | Characterisation of the Serum Metabolic Signature of Cholangiocarcinoma in a United Kingdom Cohort | Sithithaworn, P. Khuntikeo, N. Loilome, W. Yongvanit, P. |
2020 |
Journal of Clinical and Experimental Hepatology 1 (10), pp. 17-29 |
||||||||
| 107. | Circulating TGF-β1 as the potential epithelial mesenchymal transition-biomarker for diagnosis of cholangiocarcinoma | Jusakul, A. Junsawang, P. Loilome, W. Khuntikeo, N. Techasen, A. |
2020 |
Journal of Gastrointestinal Oncology 2 (11), pp. 304-318 |
||||||||
| 108. | Curative effect of xanthohumol supplementation during liver fluke-associated cholangiocarcinogenesis: Potential involvement of autophagy | Thongchot, S. Thanee, M. Loilome, W. Techasen, A. Titapun, A. Yongvanit, P. Namwat, N. |
2020 |
Journal of Traditional and Complementary Medicine 3 (10), pp. 230-235 |
||||||||
| 109. | In vitro and in vivo anti-tumor effects of pan-her inhibitor varlitinib on cholangiocarcinoma cell lines | Dokduang, H. Promraksa, B. Thanee, M. Phetcharaburanin, J. Namwat, N. Titapun, A. Khuntikeo, N. Klanrit, P. Loilome, W. |
2020 |
Drug Design, Development and Therapy (14), pp. 2319-2334 |
||||||||
| 110. | Liver fluke-infected cyprinoid fish in northeastern thailand (2016-2017) | Pumhirunroj, B. Aukkanimart, R. Boonmars, T. Sriraj, P. Boueroy, P. Artchayasawat, A. Songsri, J. Sripan, P. Ratanasuwan, P. Laummaunwai, P. Khueangchaingkhwang, S. Aunpromma, S. Eamudomkarn, C. Khuntikeo, N. Loilome, W. Namwat, N. Yongvanit, P. |
2020 |
Southeast Asian Journal of Tropical Medicine and Public Health 1 (51), pp. 1-7 |
||||||||
| 111. | Overexpression of a panel of cancer stem cell markers enhances the predictive capability of the progression and recurrence in the early stage cholangiocarcinoma | Thanee, M. Phetcharaburanin, J. Klanrit, P. Khuntikeo, N. Titapun, A. Saya, H. Loilome, W. |
2020 |
Journal of Translational Medicine 1 (18), pp. |
||||||||
| 112. | Serum IGG as a marker for opisthorchis viverrini-associated cholangiocarcinoma correlated with HER2 overexpression | Titapun, A. Techasen, A. Sithithaworn, P. Dokduang, H. Loilome, W. Thinkhamrop, B. Khuntikeo, N. |
2020 |
International Journal of General Medicine (13), pp. 1271-1283 |
||||||||
| 113. | <sup>1</sup>H NMR metabolic phenotyping of Dipterocarpus alatus as a novel tool for age and growth determination | Phetcharaburanin, J. Moolpia, K. Suksawat, M. Promraksa, B. Klanrit, P. Namwat, N. Loilome, W. Poopasit, K. Katekaew, S. Phetcharaburanin, P. |
2020 |
PLoS ONE 12 December (15), pp. |
||||||||
| 114. | Synchrotron FTIR microspectroscopy revealed apoptosis-induced biomolecular changes of cholangiocarcinoma cells treated with ursolic acid | Thanan, R. Loilome, W. Chio-Srichan, S. Sakonsinsiri, C. |
2020 |
Biochimica et Biophysica Acta - General Subjects 12 (1864), pp. |
||||||||
| 115. | A fluorescence AuNPs-LISA: A new approach for Opisthorchis viverrini (Ov) antigen detection with a simple fluorescent enhancement strategy by surfactant micelle in urine samples | Jamnongkan, W. Phetcharaburanin, J. Klanrit, P. Namwat, N. Techasen, A. Sithithaworn, P. Khuntikeo, N. Boonmars, T. Loilome, W. Ngeontae, W. |
2021 |
Spectrochimica Acta - Part A: Molecular and Biomolecular Spectroscopy (254), pp. |
||||||||
| 116. | Arctigenin inhibits cholangiocarcinoma progression by regulating cell migration and cell viability via the N-cadherin and apoptosis pathway | Jusakul, A. Kongpetch, S. Kimawaha, P. Klanrit, P. Loilome, W. Namwat, N. Techasen, A. |
2021 |
Naunyn-Schmiedeberg's Archives of Pharmacology 10 (394), pp. 2049-2059 |
||||||||
| 117. | Bacterial challenge-associated metabolic phenotypes in Hermetia illucens defining nutritional and functional benefits | Klanrit, P. Hanboonsong, Y. Yordpratum, U. Suksawat, M. Sermswan, R.W. Namwat, N. Loilome, W. Khampitak, T. Wangwiwatsin, A. Phetcharaburanin, J. |
2021 |
Scientific Reports 1 (11), pp. |
||||||||
| 118. | Cancer‐associated fibroblast‐derived il‐6 determines unfavorable prognosis in cholangiocarcinoma by affecting autophagy‐associated chemoresponse | Thongchot, S. Loilome, W. Khuntikeo, N. Titapun, A. Namwat, N. |
2021 |
Cancers 9 (13), pp. |
||||||||
| 119. | CD44 modulates metabolic pathways and altered ROS-mediated Akt signal promoting cholangiocarcinoma progression | Thanee, M. Dokduang, H. Phetcharaburanin, J. Klanrit, P. Titapun, A. Namwat, N. Khuntikeo, N. Wangwiwatsin, A. Saya, H. Loilome, W. |
2021 |
PLoS ONE 3 March (16), pp. |
||||||||
| 120. | Diagnostic and prognostic value of circulating cell‐free dna for cholangiocarcinoma | Wintachai, P. Techasen, A. Lert-Itthiporn, W. Kongpetch, S. Loilome, W. Titapun, A. Namwat, N. Khuntikeo, N. Jusakul, A. |
2021 |
Diagnostics 6 (11), pp. |
||||||||
| 121. | High levels of serum igg for opisthorchis viverrini and cd44 expression predict worse prognosis for cholangiocarcinoma patients after curative resection | Titapun, A. Thanee, M. Padthaisong, S. Duangkumpha, K. Suksawat, M. Loilome, W. Sithithaworn, P. Techasen, A. Thinkhamrop, B. Khuntikeo, N. |
2021 |
International Journal of General Medicine (14), pp. 2191-2204 |
||||||||
| 122. | Lipidomic Analyses Uncover Apoptotic and Inhibitory Effects of Pyrvinium Pamoate on Cholangiocarcinoma Cells via Mitochondrial Membrane Potential Dysfunction | Kittirat, Y. Phetcharaburanin, J. Promraksa, B. Wangwiwatsin, A. Klanrit, P. Sangkhamanon, S. Jarearnrat, A. Thongchot, S. Mahalapbutr, P. Loilome, W. Saya, H. Namwat, N. |
2021 |
Frontiers in Public Health (9), pp. |
||||||||
| 123. | Mapping of population disparities in the cholangiocarcinoma urinary metabolome | Sithithaworn, P. Khuntikeo, N. Loilome, W. Yongvanit, P. Andrews, R.H. |
2021 |
Scientific Reports 1 (11), pp. |
||||||||
| 124. | Metabolic changes of cholangiocarcinoma cells in response to coniferyl alcohol treatment | Promraksa, B. Katrun, P. Phetcharaburanin, J. Namwat, N. Techasen, A. Loilome, W. |
2021 |
Biomolecules 3 (11), pp. 1-15 |
||||||||
| 125. | Metabolic profiling of praziquantel-mediated prevention of opisthorchis viverrini-induced cholangiocyte transformation in the hamster model of cholangiocarcinoma | Phetcharaburanin, J. Namwat, N. Klanrit, P. Thanee, M. Dokduang, H. Loilome, W. |
2021 |
Cancer Genomics and Proteomics 1 (18), pp. 29-42 |
||||||||
| 126. | Promoter hypermethylation of early B cell factor 1 (EBF1) is associated with cholangiocarcinoma progression | Armartmuntree, N. Jusakul, A. Sakonsinsiri, C. Loilome, W. Pinlaor, S. Ungarreevittaya, P. Techasen, A. Imtawil, K.J. Kraiklang, R. Suwannakul, N. Thanan, R. |
2021 |
Journal of Cancer 9 (12), pp. 2673-2686 |
||||||||
| 127. | Smartphone-based fluorescent ELISA with simple fluorescent enhancement strategy for Opisthorchis viverrini (Ov) antigen detection in urine samples | Taron, W. Jamnongkan, W. Techasen, A. Phetcharaburanin, J. Klanrit, P. Namwat, N. Khuntikeo, N. Boonmars, T. Sithithaworn, P. Buranachai, C. Loilome, W. Ngeontae, W. |
2021 |
Sensors and Actuators B: Chemical (348), pp. |
||||||||
| 128. | Targeting Fatty Acid Synthase Modulates Metabolic Pathways and Inhibits Cholangiocarcinoma Cell Progression | Dokduang, H. Padthaisong, S. Namwat, N. Klanrit, P. Phetcharaburanin, J. Wangwiwatsin, A. Khampitak, T. Koonmee, S. Titapun, A. Khuntikeo, N. Loilome, W. |
2021 |
Frontiers in Pharmacology (12), pp. |
||||||||
| 129. | Therapeutic challenges at the preclinical level for targeted drug development for Opisthorchis viverrini-associated cholangiocarcinoma | Loilome, W. Dokduang, H. Suksawat, M. Padthaisong, S. |
2021 |
Expert Opinion on Investigational Drugs 9 (30), pp. 985-1006 |
||||||||
| 130. | Chemotherapeutic resistant cholangiocarcinoma displayed distinct intratumoral microbial composition and metabolic profiles | Suksawat, M. Phetcharaburanin, J. Wangwiwatsin, A. Klanrit, P. Namwat, N. Khuntikeo, N. Titapun, A. Jarearnrat, A. Sangkhamanon, S. Loilome, W. |
2022 |
PeerJ (10), pp. |
||||||||
| 131. | Effects of day-to-day variation of Opisthorchis viverrini antigen in urine on the accuracy of diagnosing opisthorchiasis in Northeast Thailand | Worasith, C. Wongphutorn, P. Homwong, C. Kopolrat, K.Y. Techasen, A. Thanan, R. Eamudomkarn, C. Wangboon, C. Khuntikeo, N. Loilome, W. Sithithaworn, J. Crellen, T. Sithithaworn, P. |
2022 |
PLoS ONE 7 July (17), pp. |
||||||||
| 132. | Interleukin-6-derived cancer-associated fibroblasts activate STAT3 pathway contributing to gemcitabine resistance in cholangiocarcinoma | Kittirat, Y. Suksawat, M. Thongchot, S. Padthaisong, S. Phetcharaburanin, J. Wangwiwatsin, A. Klanrit, P. Sangkhamanon, S. Titapun, A. Loilome, W. Saya, H. Namwat, N. |
2022 |
Frontiers in Pharmacology (13), pp. |
||||||||
| 133. | Metabolic Phenotyping Predicts Gemcitabine and Cisplatin Chemosensitivity in Patients With Cholangiocarcinoma | Suksawat, M. Phetcharaburanin, J. Klanrit, P. Namwat, N. Khuntikeo, N. Titapun, A. Techasen, A. Wangwiwatsin, A. Mahalapbutr, P. Loilome, W. |
2022 |
Frontiers in Public Health (10), pp. |
||||||||
| 134. | Modification of the AJCC/UICC 8th edition staging system for intrahepatic cholangiocarcinoma: proposal for an alternative staging system from cholangiocarcinoma-prevalent Northeast Thailand | Sa-Ngiamwibool, P. Aphivatanasiri, C. Sangkhamanon, S. Intarawichian, P. Kunprom, W. Thanee, M. Prajumwongs, P. Loilome, W. Khuntikeo, N. Titapun, A. Jareanrat, A. Thanasukarn, V. Srisuk, T. Luvira, V. Eurboonyanun, K. Promsorn, J. Wee, A. Koonmee, S. |
2022 |
HPB 11 (24), pp. 1944-1956 |
||||||||
| 135. | Modification of the eighth AJCC/UICC staging system for perihilar cholangiocarcinoma: An alternative pathological staging system from cholangiocarcinoma-prevalent Northeast Thailand | Aphivatanasiri, C. Sa-ngiamwibool, P. Sangkhamanon, S. Intarawichian, P. Kunprom, W. Thanee, M. Prajumwongs, P. Khuntikeo, N. Titapun, A. Jareanrat, A. Thanasukarn, V. Srisuk, T. Luvira, V. Eurboonyanun, K. Promsorn, J. Loilome, W. Wee, A. Koonmee, S. |
2022 |
Frontiers in Medicine (9), pp. |
||||||||
| 136. | Performance of Mini Parasep<sup>®</sup> SF stool concentrator kit, Kato-Katz, and formalin-ethyl acetate concentration methods for diagnosis of opisthorchiasis in Northeast Thailand | Kopolrat, K.Y. Singthong, S. Khuntikeo, N. Loilome, W. Worasith, C. Homwong, C. Wangboon, C. Yasaka, P. Eamudomkarn, C. Pitaksakulrat, O. Tonkhamhak, K. Paeyo, A. Crellen, T. Sithithaworn, J. Sithithaworn, P. |
2022 |
Parasites and Vectors 1 (15), pp. |
||||||||
| 137. | Prognostic Significance of Growth Pattern in Predicting Outcome of Opisthorchis viverrini-Associated Distal Cholangiocarcinoma in Thailand | Kunprom, W. Aphivatanasiri, C. Sa-Ngiamwibool, P. Sangkhamanon, S. Intarawichian, P. Bamrungkit, W. Thanee, M. Prajumwongs, P. Loilome, W. Khuntikeo, N. Titapun, A. Jareanrat, A. Thanasukarn, V. Srisuk, T. Luvira, V. Eurboonyanun, K. Promsorn, J. Koonmee, S. |
2022 |
Frontiers in Public Health (10), pp. |
||||||||
| 138. | Smartphone-based portable fluorescence sensor with gold nanoparticle mediation for selective detection of nitrite ions | Surawanitkun, C. Buranachai, C. Loilome, W. Ngeontae, W. |
2022 |
Food Chemistry (384), pp. |
||||||||
| 139. | Therapeutic targeting of ARID1A and PI3K/AKT pathway alterations in cholangiocarcinoma | Techasen, A. Kongpetch, S. Namjan, A. Loilome, W. Chan-On, W. Thanan, R. Jusakul, A. |
2022 |
PeerJ (10), pp. |
||||||||
| 140. | The impact of hypoxia and oxidative stress on proteo-metabolomic alterations of 3D cholangiocarcinoma models | Phukhum, P. Phetcharaburanin, J. Chaleekarn, K. Kittirat, Y. Kulthawatsiri, T. Namwat, N. Loilome, W. Khuntikeo, N. Titapun, A. Wangwiwatsin, A. Khampitak, T. Suksawat, M. Klanrit, P. |
2023 |
Scientific Reports 1 (13), pp. |
||||||||
| 141. | Toward novel treatment against filariasis: Insight into genome-wide co-evolutionary analysis of filarial nematodes and Wolbachia | Wangwiwatsin, A. Kulwong, S. Phetcharaburanin, J. Namwat, N. Klanrit, P. Loilome, W. Maleewong, W. Reid, A.J. |
2023 |
Frontiers in Microbiology (14), pp. |
||||||||
| 142. | Urinary Metabolic Profiling of Liver Fluke-Induced Cholangiocarcinoma—A Follow-Up Study | Alsaleh, M. Sithithaworn, P. Khuntikeo, N. Loilome, W. Yongvanit, P. Hughes, T. O'Connor, T. |
2023 |
Journal of Clinical and Experimental Hepatology 2 (13), pp. 203-217 |
||||||||
| Title | Authors | Year | Journal title | ||
|---|---|---|---|---|---|
| 1. | Altered gene expression in Opisthorchis viverrini-associated cholangiocarcinoma in hamster model. | Loilome, W Yongvanit, P Wongkham, C Tepsiri, N Sripa, B Sithithaworn, P Hanai, S Miwa, M |
2006 |
Molecular carcinogenesis 5 (45), pp. 279-87 |
|
| 2. | Characterization of 5-fluorouracil-resistant cholangiocarcinoma cell lines. | Namwat, N Amimanan, P Loilome, W Jearanaikoon, P Sripa, B Bhudhisawasdi, V Tassaneeyakul, W |
2008 |
Chemotherapy 5 (54), pp. 343-51 |
|
| 3. | Glioblastoma cell growth is suppressed by disruption of Fibroblast Growth Factor pathway signaling. | Loilome, W Joshi, AD ap Rhys, CM Piccirillo, S Vescovi, AL Angelo, VL Gallia, GL Riggins, GJ |
2009 |
Journal of neuro-oncology 3 (94), pp. 359-66 |
|
| 4. | Myristoylated alanine-rich C kinase substrate phosphorylation promotes cholangiocarcinoma cell migration and metastasis via the protein kinase C-dependent pathway. | Techasen, A Loilome, W Namwat, N Takahashi, E Sugihara, E Puapairoj, A Miwa, M Saya, H Yongvanit, P |
2010 |
Cancer science 3 (101), pp. 658-65 |
|
| 5. | Apoptotic activity of caged xanthones from Garcinia hanburyi in cholangiocarcinoma cell lines. | Hahnvajanawong, C Boonyanugomol, W Nasomyon, T Loilome, W Namwat, N Anantachoke, N Tassaneeyakul, W Sripa, B Namwat, W Reutrakul, V |
2010 |
World journal of gastroenterology : WJG 18 (16), pp. 2235-43 |
|
| 6. | Mechanisms of oxysterol-induced carcinogenesis. | Jusakul, A Yongvanit, P Loilome, W Namwat, N Kuver, R |
2011 |
Lipids in health and disease (10), pp. 44 |
|
| 7. | Downregulation of reversion-inducing-cysteine-rich protein with Kazal motifs (RECK) is associated with enhanced expression of matrix metalloproteinases and cholangiocarcinoma metastases. | Namwat, N Puetkasichonpasutha, J Loilome, W Yongvanit, P Techasen, A Puapairoj, A Sripa, B Tassaneeyakul, W Khuntikeo, N Wongkham, S |
2011 |
Journal of gastroenterology 5 (46), pp. 664-75 |
|
| 8. | PRKAR1A is overexpressed and represents a possible therapeutic target in human cholangiocarcinoma. | Loilome, W Juntana, S Namwat, N Bhudhisawasdi, V Puapairoj, A Sripa, B Miwa, M Saya, H Riggins, GJ Yongvanit, P |
2011 |
International journal of cancer. Journal international du cancer 1 (129), pp. 34-44 |
|
| 9. | Impaired antioxidant enzyme activity and increased DNA repair enzyme expression in hamster liver tissues related to cholangiocarcinoma development. | Loilome, W Kadsanit, S Namwat, N Techasen, A Puapairoj, A Dechakhamphu, A Pinitsoontorn, C Yongvanit, P |
2012 |
Asian Pacific journal of cancer prevention : APJCP (13), pp. 59-64 |
|
| 10. | Anti-inflammatory, antioxidant and hepatoprotective effects of Thunbergia laurifolia Linn. on experimental opisthorchiasis. | Wonkchalee, O Boonmars, T Aromdee, C Laummaunwai, P Khunkitti, W Vaeteewoottacharn, K Sriraj, P Aukkanimart, R Loilome, W Chamgramol, Y Pairojkul, C Wu, Z Juasook, A Sudsarn, P |
2012 |
Parasitology research 1 (111), pp. 353-9 |
|
| 11. | Platelet-derived growth factor may be a potential diagnostic and prognostic marker for cholangiocarcinoma. | Boonjaraspinyo, S Boonmars, T Wu, Z Loilome, W Sithithaworn, P Nagano, I Pinlaor, S Yongvanit, P Nielsen, PS Pairojkul, C Khuntikeo, N |
2012 |
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 5 (33), pp. 1785-802 |
|
| 12. | Overexpression of PDGFA and its receptor during carcinogenesis of Opisthorchis viverrini-associated cholangiocarcinoma. | Boonjaraspinyo, S Wu, Z Boonmars, T Kaewkes, S Loilome, W Sithithaworn, P Nagano, I Takahashi, Y Yongvanit, P Bhudhisawasdi, V |
2012 |
Parasitology international 1 (61), pp. 145-50 |
|
| 13. | Tumor necrosis factor-α (TNF-α) stimulates the epithelial-mesenchymal transition regulator Snail in cholangiocarcinoma. | Techasen, A Namwat, N Loilome, W Bungkanjana, P Khuntikeo, N Puapairoj, A Jearanaikoon, P Saya, H Yongvanit, P |
2012 |
Medical oncology (Northwood, London, England) 5 (29), pp. 3083-91 |
|
| 14. | Opisthorchis viverrini-antigen induces expression of MARCKS during inflammation-associated cholangiocarcinogenesis. | Techasen, A Loilome, W Namwat, N Duenngai, K Cha'on, U Thanan, R Sithithaworn, P Miwa, M Yongvanit, P |
2012 |
Parasitology international 1 (61), pp. 140-4 |
|
| 15. | Expression of oxysterol binding protein isoforms in opisthorchiasis-associated cholangiocarcinoma: a potential molecular marker for tumor metastasis. | Loilome, W Wechagama, P Namwat, N Jusakul, A Sripa, B Miwa, M Kuver, R Yongvanit, P |
2012 |
Parasitology international 1 (61), pp. 136-9 |
|
| 16. | Down-regulated expression of HSP70 in correlation with clinicopathology of cholangiocarcinoma. | Boonjaraspinyo, S Boonmars, T Kaewkes, S Laummaunwai, P Pinlaor, S Loilome, W Yongvanit, P Wu, Z Puapairoj, A Bhudhisawasdi, V |
2012 |
Pathology oncology research : POR 2 (18), pp. 227-37 |
|
| 17. | Hepatic cytochrome P450 2A6 and 2E1 status in peri-tumor tissues of patients with Opisthorchis viverrini-associated cholangiocarcinoma. | Yongvanit, P Phanomsri, E Namwat, N Kampan, J Tassaneeyakul, W Loilome, W Puapairoj, A Khuntikeo, N |
2012 |
Parasitology international 1 (61), pp. 162-6 |
|
| 18. | PRKAR1A overexpression is associated with increased ECPKA autoantibody in liver fluke-associated cholangiocarcinoma: application for assessment of the risk group. | Loilome, W Yooyuen, S Namwat, N Sithithaworn, P Puapairoj, A Kano, J Noguchi, M Miwa, M Yongvanit, P |
2012 |
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 6 (33), pp. 2289-98 |
|
| 19. | Expression profiles of oncomir miR-21 and tumor suppressor let-7a in the progression of opisthorchiasis-associated cholangiocarcinoma. | Namwat, N Chusorn, P Loilome, W Techasen, A Puetkasichonpasutha, J Pairojkul, C Khuntikeo, N Yongvanit, P |
2012 |
Asian Pacific journal of cancer prevention : APJCP (13), pp. 65-9 |
|
| 20. | Evaluation of tyrosine kinase inhibitor combinations for glioblastoma therapy. | Joshi, AD Loilome, W Siu, IM Tyler, B Gallia, GL Riggins, GJ |
2012 |
PloS one 10 (7), pp. e44372 |
|
| 21. | Liver fluke-induced hepatic oxysterols stimulate DNA damage and apoptosis in cultured human cholangiocytes. | Jusakul, A Loilome, W Namwat, N Haigh, WG Kuver, R Dechakhamphu, S Sukontawarin, P Pinlaor, S Lee, SP Yongvanit, P |
2012 |
Mutation research 1 (731), pp. 48-57 |
|
| 22. | Increased expression of TLR-2, COX-2, and SOD-2 genes in the peripheral blood leukocytes of opisthorchiasis patients induced by Opisthorchis viverrini antigen. | Yongvanit, P Thanan, R Pinlaor, S Sithithaworn, P Loilome, W Namwat, N Techasen, A Dechakhamphu, S |
2012 |
Parasitology research 5 (110), pp. 1969-77 |
|
| 23. | Anti-inflammatory effect of prednisolone on the growth of human liver fluke in experimental opisthorchiasis. | Juasook, A Boonmars, T Kaewkes, S Loilome, W Veteewuthacharn, K Wu, Z Yongvanit, P |
2012 |
Parasitology research 6 (110), pp. 2271-9 |
|
| 24. | Identification of biliary bile acids in patients with benign biliary diseases, hepatocellular carcinoma and cholangiocarcinoma. | Jusakul, A Khuntikeo, N Haigh, WG Kuver, R Ioannou, GN Loilome, W Namwat, N Bhudhisawasdi, V Pugkhem, A Pairojkul, C Yongvanit, P |
2012 |
Asian Pacific journal of cancer prevention : APJCP (13), pp. 77-82 |
|
| 25. | Suppression of PRKAR1A expression enhances anti-proliferative and apoptotic effects of protein kinase inhibitors and chemotherapeutic drugs on cholangiocarcinoma cells. | Loilome, W Juntana, S Pinitsoontorn, C Namwat, N Tassaneeyakul, W Yongvanit, P |
2012 |
Asian Pacific journal of cancer prevention : APJCP (13), pp. 143-7 |
|
| 26. | Anti-inflammatory agents suppress the prostaglandin E2 production and migration ability of cholangiocarcinoma cell lines. | Jongthawin, J Techasen, A Loilome, W Yongvanit, P Namwat, N |
2012 |
Asian Pacific journal of cancer prevention : APJCP (13), pp. 47-51 |
|
| 27. | Cytokines released from activated human macrophages induce epithelial mesenchymal transition markers of cholangiocarcinoma cells. | Techasen, A Loilome, W Namwat, N Dokduang, H Jongthawin, J Yongvanit, P |
2012 |
Asian Pacific journal of cancer prevention : APJCP (13), pp. 115-8 |
|
| 28. | Immunosuppressive prednisolone enhances early cholangiocarcinoma in Syrian hamsters with liver fluke infection and administration of N-nitrosodimethylamine. | Juasook, A Boonmars, T Wu, Z Loilome, W Veteewuthacharn, K Namwat, N Sudsarn, P Wonkchalee, O Sriraj, P Aukkanimart, R |
2013 |
Pathology oncology research : POR 1 (19), pp. 55-62 |
|
| 29. | Anti-apoptotic phenotypes of cholestan-3β,5α,6β-triol-resistant human cholangiocytes: characteristics contributing to the genesis of cholangiocarcinoma. | Jusakul, A Loilome, W Namwat, N Techasen, A Kuver, R Ioannou, GN Savard, C Haigh, WG Yongvanit, P |
2013 |
The Journal of steroid biochemistry and molecular biology (138), pp. 368-75 |
|
| 30. | Increased activation of PI3K/AKT signaling pathway is associated with cholangiocarcinoma metastasis and PI3K/mTOR inhibition presents a possible therapeutic strategy. | Yothaisong, S Dokduang, H Techasen, A Namwat, N Yongvanit, P Bhudhisawasdi, V Puapairoj, A Riggins, GJ Loilome, W |
2013 |
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 6 (34), pp. 3637-48 |
|
| 31. | Survey of activated kinase proteins reveals potential targets for cholangiocarcinoma treatment. | Dokduang, H Juntana, S Techasen, A Namwat, N Yongvanit, P Khuntikeo, N Riggins, GJ Loilome, W |
2013 |
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 6 (34), pp. 3519-28 |
|
| 32. | Overexpression of microRNA-21 regulating PDCD4 during tumorigenesis of liver fluke-associated cholangiocarcinoma contributes to tumor growth and metastasis. | Chusorn, P Namwat, N Loilome, W Techasen, A Pairojkul, C Khuntikeo, N Dechakhamphu, A Talabnin, C Chan-On, W Ong, CK Teh, BT Yongvanit, P |
2013 |
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 3 (34), pp. 1579-88 |
|
| 33. | Oxidized alpha-1 antitrypsin as a predictive risk marker of opisthorchiasis-associated cholangiocarcinoma. | Jamnongkan, W Techasen, A Thanan, R Duenngai, K Sithithaworn, P Mairiang, E Loilome, W Namwat, N Pairojkul, C Yongvanit, P |
2013 |
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 2 (34), pp. 695-704 |
|
| 34. | Association of CYP39A1, RUNX2 and oxidized alpha-1 antitrypsin expression in relation to cholangiocarcinoma progression. | Khenjanta, C Thanan, R Jusakul, A Techasen, A Jamnongkan, W Namwat, N Loilome, W Pairojkul, C Yongvanit, P |
2014 |
Asian Pacific journal of cancer prevention : APJCP 23 (15), pp. 10187-92 |
|
| 35. | Circulating miR-192 in liver fluke-associated cholangiocarcinoma patients: a prospective prognostic indicator. | Silakit, R Loilome, W Yongvanit, P Chusorn, P Techasen, A Boonmars, T Khuntikeo, N Chamadol, N Pairojkul, C Namwat, N |
2014 |
Journal of hepato-biliary-pancreatic sciences 12 (21), pp. 864-72 |
|
| 36. | High expression of HIF-1α, BNIP3 and PI3KC3: hypoxia-induced autophagy predicts cholangiocarcinoma survival and metastasis. | Thongchot, S Yongvanit, P Loilome, W Seubwai, W Phunicom, K Tassaneeyakul, W Pairojkul, C Promkotra, W Techasen, A Namwat, N |
2014 |
Asian Pacific journal of cancer prevention : APJCP 14 (15), pp. 5873-8 |
|
| 37. | STATs profiling reveals predominantly-activated STAT3 in cholangiocarcinoma genesis and progression. | Dokduang, H Techasen, A Namwat, N Khuntikeo, N Pairojkul, C Murakami, Y Loilome, W Yongvanit, P |
2014 |
Journal of hepato-biliary-pancreatic sciences 10 (21), pp. 767-76 |
|
| 38. | Increased EphB2 expression predicts cholangiocarcinoma metastasis. | Khansaard, W Techasen, A Namwat, N Yongvanit, P Khuntikeo, N Puapairoj, A Loilome, W |
2014 |
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 10 (35), pp. 10031-41 |
|
| 39. | BMP-7 blocks the effects of TGF-β-induced EMT in cholangiocarcinoma. | Duangkumpha, K Techasen, A Loilome, W Namwat, N Thanan, R Khuntikeo, N Yongvanit, P |
2014 |
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 10 (35), pp. 9667-76 |
|
| 40. | Tumor necrosis factor-α modulates epithelial mesenchymal transition mediators ZEB2 and S100A4 to promote cholangiocarcinoma progression. | Techasen, A Namwat, N Loilome, W Duangkumpha, K Puapairoj, A Saya, H Yongvanit, P |
2014 |
Journal of hepato-biliary-pancreatic sciences 9 (21), pp. 703-11 |
|
| 41. | Loss of E-cadherin promotes migration and invasion of cholangiocarcinoma cells and serves as a potential marker of metastasis. | Techasen, A Loilome, W Namwat, N Khuntikeo, N Puapairoj, A Jearanaikoon, P Saya, H Yongvanit, P |
2014 |
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 9 (35), pp. 8645-52 |
|
| 42. | PGE2 signaling and its biosynthesis-related enzymes in cholangiocarcinoma progression. | Jongthawin, J Chusorn, P Techasen, A Loilome, W Boonmars, T Thanan, R Puapairoj, A Khuntikeo, N Tassaneeyakul, W Yongvanit, P Namwat, N |
2014 |
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 8 (35), pp. 8051-64 |
|
| 43. | Histological confirmation of periductal fibrosis from ultrasound diagnosis in cholangiocarcinoma patients. | Chamadol, N Pairojkul, C Khuntikeo, N Laopaiboon, V Loilome, W Sithithaworn, P Yongvanit, P |
2014 |
Journal of hepato-biliary-pancreatic sciences 5 (21), pp. 316-22 |
|
| 44. | Risk biomarkers for assessment and chemoprevention of liver fluke-associated cholangiocarcinoma. | Yongvanit, P Pinlaor, S Loilome, W |
2014 |
Journal of hepato-biliary-pancreatic sciences 5 (21), pp. 309-15 |
|
| 45. | Activated macrophages promote Wnt/β-catenin signaling in cholangiocarcinoma cells. | Loilome, W Bungkanjana, P Techasen, A Namwat, N Yongvanit, P Puapairoj, A Khuntikeo, N Riggins, GJ |
2014 |
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 6 (35), pp. 5357-67 |
|
| 46. | Genetic and environmental determinants of risk for cholangiocarcinoma in Thailand. | Miwa, M Honjo, S You, G Tanaka, M Uchida, K Srivatanakul, P Khuhaprema, T Loilome, W Techasen, A Wongkham, C Limpaiboon, T Yongvanit, P Wongkham, S |
2014 |
World journal of gastrointestinal pathophysiology 4 (5), pp. 570-8 |
|
| 47. | Milk fat globule epidermal growth factor 8 serves a novel biomarker of opisthorchiasis-associated cholangiocarcinoma. | Wu, Z Boonmars, T Nagano, I Loilome, W Yongvanit, P Khuntikeo, N Nielsen, PS Paorojkul, C Takahashi, Y Maekawa, Y |
2014 |
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 3 (35), pp. 1985-95 |
|
| 48. | Opisthorchis viverrini infection activates the PI3K/ AKT/PTEN and Wnt/β-catenin signaling pathways in a Cholangiocarcinogenesis model. | Yothaisong, S Thanee, M Namwat, N Yongvanit, P Boonmars, T Puapairoj, A Loilome, W |
2014 |
Asian Pacific journal of cancer prevention : APJCP 23 (15), pp. 10463-8 |
|
| 49. | Quantitative changes in tumor-associated M2 macrophages characterize cholangiocarcinoma and their association with metastasis. | Thanee, M Loilome, W Techasen, A Namwat, N Boonmars, T Pairojkul, C Yongvanit, P |
2015 |
Asian Pacific journal of cancer prevention : APJCP 7 (16), pp. 3043-50 |
|
| 50. | Chloroquine exerts anti-metastatic activities under hypoxic conditions in cholangiocarcinoma cells. | Thongchot, S Loilome, W Yongvanit, P Dokduang, H Thanan, R Techasen, A Namwat, N |
2015 |
Asian Pacific journal of cancer prevention : APJCP 5 (16), pp. 2031-5 |
|
| 51. | Advances in the Diagnosis of Human Opisthorchiasis: Development of Opisthorchis viverrini Antigen Detection in Urine. | Worasith, C Kamamia, C Yakovleva, A Duenngai, K Wangboon, C Sithithaworn, J Watwiengkam, N Namwat, N Techasen, A Loilome, W Yongvanit, P Loukas, A Sithithaworn, P Bethony, JM |
2015 |
PLoS neglected tropical diseases 10 (9), pp. e0004157 |
|
| 52. | Cohort profile: cholangiocarcinoma screening and care program (CASCAP). | , Khuntikeo, N Chamadol, N Yongvanit, P Loilome, W Namwat, N Sithithaworn, P Andrews, RH Petney, TN Promthet, S Thinkhamrop, K Tawarungruang, C Thinkhamrop, B , , , , , , , , , |
2015 |
BMC cancer (15), pp. 459 |
|
| 53. | A Promising Serum Autoantibody Marker, Anti-Heat Shock Protein 90α, for Cholangiocarcinoma. | Boonjaraspinyo, S Juasook, A Boonmars, T Aukkanimart, R Silsirivanit, A Loilome, W Sriraj, P Wu, Z Ratanasuwan, P |
2015 |
Asian Pacific journal of cancer prevention : APJCP 14 (16), pp. 5779-85 |
|
| 54. | Combination of Praziquantel and Aspirin Minimizes Liver Pathology of Hamster Opisthorchis viverrini Infection Associated Cholangiocarcinoma. | Sudsarn, P Boonmars, T Ruangjirachuporn, W Namwat, N Loilome, W Sriraj, P Aukkanimart, R Nadchanan, W Jiraporn, S |
2016 |
Pathology oncology research : POR 1 (22), pp. 57-65 |
|
| 55. | Potential of Selenium Compounds as New Anticancer Agents for Cholangiocarcinoma. | Dai, X Thongchot, S Dokduang, H Loilome, W Khuntikeo, N Titapun, A Ungarreevittaya, P Yongvanit, P Techasen, A Namwat, N |
2016 |
Anticancer research 11 (36), pp. 5981-5988 |
|
| 56. | CD44 variant-dependent redox status regulation in liver fluke-associated cholangiocarcinoma: A target for cholangiocarcinoma treatment. | Thanee, M Loilome, W Techasen, A Sugihara, E Okazaki, S Abe, S Ueda, S Masuko, T Namwat, N Khuntikeo, N Titapun, A Pairojkul, C Saya, H Yongvanit, P |
2016 |
Cancer science 7 (107), pp. 991-1000 |
|
| 57. | A Comprehensive Public Health Conceptual Framework and Strategy to Effectively Combat Cholangiocarcinoma in Thailand. | Khuntikeo, N Loilome, W Thinkhamrop, B Chamadol, N Yongvanit, P |
2016 |
PLoS neglected tropical diseases 1 (10), pp. e0004293 |
|
| 58. | Xanthohumol inhibits STAT3 activation pathway leading to growth suppression and apoptosis induction in human cholangiocarcinoma cells. | Dokduang, H Yongvanit, P Namwat, N Pairojkul, C Sangkhamanon, S Yageta, MS Murakami, Y Loilome, W |
2016 |
Oncology reports 4 (35), pp. 2065-72 |
|
| 59. | Upregulation of transferrin receptor-1 induces cholangiocarcinoma progression via induction of labile iron pool. | Jamnongkan, W Thanan, R Techasen, A Namwat, N Loilome, W Intarawichian, P Titapun, A Yongvanit, P |
2017 |
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 7 (39), pp. 1010428317717655 |
|
| 60. | Urinary microRNA-192 and microRNA-21 as potential indicators for liver fluke-associated cholangiocarcinoma risk group. | Silakit, R Loilome, W Yongvanit, P Thongchot, S Sithithaworn, P Boonmars, T Koonmee, S Titapun, A Khuntikeo, N Chamadol, N Techasen, A Namwat, N |
2017 |
Parasitology international 4 (66), pp. 479-485 |
|
| 61. | Carcinogenic Liver Fluke and Others Contaminated in Pickled Fish of Northeastern Thailand | Aukkanimart, R Boonmars, T Sriraj, P Sripan, P Songsri, J Ratanasuwan, P Laummaunwai, P Suwanantrai, A Aunpromma, S Khueangchaingkhwang, S Pumhirunroj, B Artchayasawat, A Khuntikeo, N Loilome, W Namwat, N Yongvanit, P Boonjaraspinyo, S |
2017 |
Asian Pacific journal of cancer prevention : APJCP 2 (18), pp. 529-533 |
|
| 62. | Imbalanced adaptive responses associated with microsatellite instability in cholangiocarcinoma. | Loilome, W Kadsanit, S Muisook, K Yongvanit, P Namwat, N Techasen, A Puapairoj, A Khuntikeo, N Phonjit, P |
2017 |
Oncology letters 2 (13), pp. 639-646 |
|
| 63. | Inhibition of l-type amino acid transporter 1 activity as a new therapeutic target for cholangiocarcinoma treatment. | Yothaisong, S Dokduang, H Anzai, N Hayashi, K Namwat, N Yongvanit, P Sangkhamanon, S Jutabha, P Endou, H Loilome, W |
2017 |
Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine 3 (39), pp. 1010428317694545 |
|
| 64. | Simplified Techniques for Killing the Carcinogenic, Opisthorchis Viverrini Metacercariae in Cyprinid Fish | Sripan, P Boonmars, T Songsri, J Aukkanimart, R Sriraj, P Rattanasuwan, P Boueroy, P Suwannatrai, A Aunpromma, S Khuntikeo, N Loilome, W Namwat, N Yongvanit, P PhyoWai, A Khueangchaingkhwang, S Zhilang, W Pumhirunroj, B Artchayasawat, A Boonjaraspinyo, S |
2017 |
Asian Pacific journal of cancer prevention : APJCP 6 (18), pp. 1507-1511 |
|
| 65. | Nimotuzumab Inhibits Cholangiocarcinoma Cell Metastasis via Suppression of the Epithelial-Mesenchymal Transition Process. | Padthaisong, S Thanee, M Techasen, A Namwat, N Yongvanit, P Liwatthakun, A Hankla, K Sangkhamanon, S Loilome, W |
2017 |
Anticancer research 7 (37), pp. 3591-3597 |
|
| 66. | Opisthorchiasis and cholangiocarcinoma in Southeast Asia: an unresolved problem. | Hughes, T O'Connor, T Techasen, A Namwat, N Loilome, W Andrews, RH Khuntikeo, N Yongvanit, P Sithithaworn, P Taylor-Robinson, SD |
2017 |
International journal of general medicine (10), pp. 227-237 |
|
| 67. | Prolonged oxidative stress down-regulates Early B cell factor 1 with inhibition of its tumor suppressive function against cholangiocarcinoma genesis. | Armartmuntree, N Murata, M Techasen, A Yongvanit, P Loilome, W Namwat, N Pairojkul, C Sakonsinsiri, C Pinlaor, S Thanan, R |
2017 |
Redox biology (14), pp. 637-644 |
|
| 68. | Teleconsultation ultrasonography: a new weapon to combat cholangiocarcinoma. | Chamadol, N Laopaiboon, V Srinakarin, J Loilome, W Yongvanit, P Thinkhamrop, B Khuntikeo, N |
2017 |
ESMO open 3 (2), pp. e000231 |
|
| 69. | Protein Kinases as Targets for Opisthorchis viverrini- Associated Cholangiocarcinoma Therapy. | Loilome, W Dokduang, H |
2017 |
Current pharmaceutical design 29 (23), pp. 4281-4289 |
|
| 70. | Upregulation of endothelial nitric oxide synthase (eNOS) and its upstream regulators in Opisthorchis viverrini associated cholangiocarcinoma and its clinical significance. | Suksawat, M Techasen, A Namwat, N Yongvanit, P Khuntikeo, N Titapun, A Koonmee, S Loilome, W |
2017 |
Parasitology international 4 (66), pp. 486-493 |
|
| 71. | Increase in L-type amino acid transporter 1 expression during cholangiocarcinogenesis caused by liver fluke infection and its prognostic significance. | Yothaisong, S Namwat, N Yongvanit, P Khuntikeo, N Puapairoj, A Jutabha, P Anzai, N Tassaneeyakul, W Tangsucharit, P Loilome, W |
2017 |
Parasitology international 4 (66), pp. 471-478 |
|
| 72. | Dihydroartemisinin induces apoptosis and autophagy-dependent cell death in cholangiocarcinoma through a DAPK1-BECLIN1 pathway. | Thongchot, S Vidoni, C Ferraresi, A Loilome, W Yongvanit, P Namwat, N Isidoro, C |
2018 |
Molecular carcinogenesis 12 (57), pp. 1735-1750 |
|
| 73. | Zileuton suppresses cholangiocarcinoma cell proliferation and migration through inhibition of the Akt signaling pathway. | Khophai, S Thanee, M Techasen, A Namwat, N Klanrit, P Titapun, A Jarearnrat, A Sa-Ngiamwibool, P Loilome, W |
2018 |
OncoTargets and therapy (11), pp. 7019-7029 |
|
| 74. | The Socioeconomic Burden of Cholangiocarcinoma Associated With Opisthorchis viverrini Sensu Lato Infection in Northeast Thailand: A Preliminary Analysis. | Khuntikeo, N Thinkhamrop, B Bundhamcharoen, K Andrews, RH Grundy-Warr, C Yongvanit, P Loilome, W Chamadol, N Kosuwan, W Sithithaworn, P Petney, TN |
2018 |
Advances in parasitology (102), pp. 141-163 |
|
| 75. | Inhibition of endothelial nitric oxide synthase in cholangiocarcinoma cell lines - a new strategy for therapy. | Suksawat, M Techasen, A Namwat, N Boonsong, T Titapun, A Ungarreevittaya, P Yongvanit, P Loilome, W |
2018 |
FEBS open bio 4 (8), pp. 513-522 |
|
| 76. | Current Perspectives on Opisthorchiasis Control and Cholangiocarcinoma Detection in Southeast Asia. | Khuntikeo, N Titapun, A Loilome, W Yongvanit, P Thinkhamrop, B Chamadol, N Boonmars, T Nethanomsak, T Andrews, RH Petney, TN Sithithaworn, P |
2018 |
Frontiers in medicine (5), pp. 117 |
|
| 77. | Resveratrol interrupts the pro-invasive communication between cancer associated fibroblasts and cholangiocarcinoma cells. | Thongchot, S Ferraresi, A Vidoni, C Loilome, W Yongvanit, P Namwat, N Isidoro, C |
2018 |
Cancer letters (430), pp. 160-171 |
|
| 78. | Elevated Levels of Urinary 8-oxodG Correlate with Persistent Periductal Fibrosis after Praziquantel Treatment in Chronic Opisthorchiasis. | Wangboon, C Yongvanit, P Loilome, W Thanan, R Worasith, C Eamudomkarn, C Chamadol, N Mairiang, E Sithithaworn, J Saichua, P Sripa, B Khuntikeo, N Bethony, JM Sithithaworn, P |
2018 |
The American journal of tropical medicine and hygiene 6 (98), pp. 1763-1769 |
|
| 79. | Potential role of HIF-1-responsive microRNA210/HIF3 axis on gemcitabine resistance in cholangiocarcinoma cells. | Silakit, R Kitirat, Y Thongchot, S Loilome, W Techasen, A Ungarreevittaya, P Khuntikeo, N Yongvanit, P Yang, JH Kim, NH Yook, JI Namwat, N |
2018 |
PloS one 6 (13), pp. e0199827 |
|
| 80. | Diagnostic performance of urinary IgG antibody detection: A novel approach for population screening of strongyloidiasis. | Eamudomkarn, C Sithithaworn, P Kamamia, C Yakovleva, A Sithithaworn, J Kaewkes, S Techasen, A Loilome, W Yongvanit, P Wangboon, C Saichua, P Itoh, M M Bethony, J |
2018 |
PloS one 7 (13), pp. e0192598 |
|
| 81. | Inhibitory effect of NVP-BKM120 on cholangiocarcinoma cell growth. | Padthaisong, S Dokduang, H Yothaisong, S Techasen, A Namwat, N Yongvanit, P Khuntikeo, N Titapun, A Sangkhamanon, S Loilome, W |
2018 |
Oncology letters 2 (16), pp. 1627-1633 |
|
| 82. | Antifibrotic effect of xanthohumol in combination with praziquantel is associated with altered redox status and reduced iron accumulation during liver fluke-associated cholangiocarcinogenesis. | Jamnongkan, W Thanee, M Yongvanit, P Loilome, W Thanan, R Kimawaha, P Boonmars, T Silakit, R Namwat, N Techasen, A |
2018 |
PeerJ (6), pp. e4281 |
|
| 83. | Progranulin modulates cholangiocarcinoma cell proliferation, apoptosis, and motility via the PI3K/pAkt pathway. | Daya, M Loilome, W Techasen, A Thanee, M Sa-Ngiamwibool, P Titapun, A Yongvanit, P Namwat, N |
2018 |
OncoTargets and therapy (11), pp. 395-408 |
|
| 84. | Suppression of 14-3-3ζ in cholangiocarcinoma cells inhibits proliferation through attenuated Akt activity, enhancing chemosensitivity to gemcitabine. | Kittirat, Y Techasen, A Thongchot, S Loilome, W Thanan, R Yongvanit, P Sungkhamanon, S Titapun, A Khuntikeo, N Namwat, N |
2018 |
Oncology letters 1 (15), pp. 347-353 |
|
| 85. | Erratum to "Resveratrol interrupts the pro-invasive communication between Cancer associated Fibroblasts and Cholangiocarcinoma cells" [Cancer Letters 430C (2018) 160-171]. | Thongchot, S Ferraresi, A Vidoni, C Loilome, W Yongvanit, P Namwat, N Isidoro, C |
2018 |
Cancer letters (434), pp. 206-207 |
|
| 86. | Evaluation of a short term effect of praziquantel treatment in opisthorchiasis-induced hepatobiliary inflammation by urinary 8-oxodG. | Wangboon, C Worasith, C Thanan, R Eamudomkarn, C Techasen, A Sithithaworn, J Loilome, W Chamadol, N Pinlaor, S Jumnainsong, A Yongvanit, P Khuntikeo, N Bethony, JM Sithithaworn, P |
2018 |
Acta tropica (189), pp. 124-128 |
|
| 87. | Discovery and Qualification of Serum Protein Biomarker Candidates for Cholangiocarcinoma Diagnosis. | Duangkumpha, K Stoll, T Phetcharaburanin, J Yongvanit, P Thanan, R Techasen, A Namwat, N Khuntikeo, N Chamadol, N Roytrakul, S Mulvenna, J Mohamed, A Shah, AK Hill, MM Loilome, W |
2019 |
Journal of proteome research 9 (18), pp. 3305-3316 |
|
| 88. | Cholangiocarcinoma: a guide for the nonspecialist. | Alsaleh, M Leftley, Z Barbera, TA Sithithaworn, P Khuntikeo, N Loilome, W Yongvanit, P Cox, IJ Chamodol, N Syms, RR Andrews, RH Taylor-Robinson, SD |
2019 |
International journal of general medicine (12), pp. 13-23 |
|
| 89. | Comparing the performance of urine and copro-antigen detection in evaluating Opisthorchis viverrini infection in communities with different transmission levels in Northeast Thailand. | Worasith, C Wangboon, C Duenngai, K Kiatsopit, N Kopolrat, K Techasen, A Sithithaworn, J Khuntikeo, N Loilome, W Namwat, N Yongvanit, P Carlton, EJ Sithithaworn, P |
2019 |
PLoS neglected tropical diseases 2 (13), pp. e0007186 |
|
| 90. | Evaluation of anticancer potential of Thai medicinal herb extracts against cholangiocarcinoma cell lines. | Promraksa, B Phetcharaburanin, J Namwat, N Techasen, A Boonsiri, P Loilome, W |
2019 |
PloS one 5 (14), pp. e0216721 |
|
| 91. | Urine proteomics study reveals potential biomarkers for the differential diagnosis of cholangiocarcinoma and periductal fibrosis. | Duangkumpha, K Stoll, T Phetcharaburanin, J Yongvanit, P Thanan, R Techasen, A Namwat, N Khuntikeo, N Chamadol, N Roytrakul, S Mulvenna, J Mohamed, A Shah, AK Hill, MM Loilome, W |
2019 |
PloS one 8 (14), pp. e0221024 |
|
| 92. | In vitro and molecular chemosensitivity in human cholangiocarcinoma tissues. | Suksawat, M Klanrit, P Phetcharaburanin, J Namwat, N Khuntikeo, N Titapun, A Jarearnrat, A Sa-Ngiamwibool, P Techasen, A Loilome, W |
2019 |
PloS one 9 (14), pp. e0222140 |
|
| 93. | PRIMA-1 Induces Cellular Senescence and Apoptotic Cell Death in Cholangiocarcinoma Cells. | Piyawajanusorn, C Kittirat, Y Sa-Ngiamwibool, P Titapun, A Loilome, W Namwat, N |
2019 |
Cancer genomics & proteomics 6 (16), pp. 543-552 |
|
| 94. | Mass Spectrometry: A Guide for the Clinician. | Alsaleh, M Barbera, TA Andrews, RH Sithithaworn, P Khuntikeo, N Loilome, W Yongvanit, P Cox, IJ Syms, RRA Holmes, E Taylor-Robinson, SD |
2019 |
Journal of clinical and experimental hepatology 5 (9), pp. 597-606 |
|
| 95. | Curative effect of xanthohumol supplementation during liver fluke-associated cholangiocarcinogenesis: Potential involvement of autophagy. | Thongchot, S Thanee, M Loilome, W Techasen, A Boonmars, T Sa-Ngiamwibool, P Titapun, A Yongvanit, P Isidoro, C Namwat, N |
2020 |
Journal of traditional and complementary medicine 3 (10), pp. 230-235 |
|
| 96. | In vitro and in vivo Anti-Tumor Effects of Pan-HER Inhibitor Varlitinib on Cholangiocarcinoma Cell Lines. | Dokduang, H Jamnongkarn, W Promraksa, B Suksawat, M Padthaisong, S Thanee, M Phetcharaburanin, J Namwat, N Sangkhamanon, S Titapun, A Khuntikeo, N Klanrit, P Loilome, W |
2020 |
Drug design, development and therapy (14), pp. 2319-2334 |
|
| 97. | A comparison of the proportion of early stage cholangiocarcinoma found in an ultrasound-screening program compared to walk-in patients. | Khuntikeo, N Koonmee, S Sa-Ngiamwibool, P Chamadol, N Laopaiboon, V Titapun, A Yongvanit, P Loilome, W Namwat, N Andrews, RH Petney, TN Thinkhamrop, K Chaichaya, N Tawarungruang, C Thuanman, J Thinkhamrop, B |
2020 |
HPB : the official journal of the International Hepato Pancreato Biliary Association 6 (22), pp. 874-883 |
|
| 98. | Circulating TGF-β1 as the potential epithelial mesenchymal transition-biomarker for diagnosis of cholangiocarcinoma. | Kimawaha, P Jusakul, A Junsawang, P Loilome, W Khuntikeo, N Techasen, A |
2020 |
Journal of gastrointestinal oncology 2 (11), pp. 304-318 |
|
| 99. | alterations and their clinical significance in cholangiocarcinoma. | Namjan, A Techasen, A Loilome, W Sa-Ngaimwibool, P Jusakul, A |
2020 |
PeerJ (8), pp. e10464 |
|
| 100. | 1H NMR metabolic phenotyping of Dipterocarpus alatus as a novel tool for age and growth determination. | Phetcharaburanin, J Deewai, S Kulthawatsiri, T Moolpia, K Suksawat, M Promraksa, B Klanrit, P Namwat, N Loilome, W Poopasit, K Katekaew, S Phetcharaburanin, P |
2020 |
PloS one 12 (15), pp. e0243432 |
|
| 101. | A panel of protein kinase high expression is associated with postoperative recurrence in cholangiocarcinoma. | Padthaisong, S Thanee, M Namwat, N Phetcharaburanin, J Klanrit, P Khuntikeo, N Titapun, A Loilome, W |
2020 |
BMC cancer 1 (20), pp. 154 |
|
| 102. | Overexpression of a panel of cancer stem cell markers enhances the predictive capability of the progression and recurrence in the early stage cholangiocarcinoma. | Padthaisong, S Thanee, M Namwat, N Phetcharaburanin, J Klanrit, P Khuntikeo, N Titapun, A Sungkhamanon, S Saya, H Loilome, W |
2020 |
Journal of translational medicine 1 (18), pp. 64 |
|
| 103. | Characterisation of the Serum Metabolic Signature of Cholangiocarcinoma in a United Kingdom Cohort. | Alsaleh, M Leftley, Z Barbera, TA Koomson, LK Zabron, A Crossey, MME Reeves, HL Cramp, M Ryder, S Greer, S Prince, M Sithithaworn, P Shariff, M Khuntikeo, N Loilome, W Yongvanit, P Shen, YL Cox, IJ Williams, R Wadsworth, CA Holmes, E Nash, K Taylor-Robinson, SD |
2020 |
Journal of clinical and experimental hepatology 1 (10), pp. 17-29 |
|
| 104. | AuNPs-LISA, an efficient detection assay for Opisthorchis viverrini (Ov) antigen in urine. | Taron, W Jamnongkan, W Techasen, A Phetcharaburanin, J Namwat, N Sithithaworn, P Khuntikeo, N Mukdasai, S Sayasone, S Loilome, W Ngeontae, W |
2020 |
Talanta (209), pp. 120592 |
|
| 105. | Serum IgG as a Marker for -Associated Cholangiocarcinoma Correlated with HER2 Overexpression. | Titapun, A Techasen, A Sa-Ngiamwibool, P Sithithaworn, P Luvira, V Srisuk, T Jareanrat, A Dokduang, H Loilome, W Thinkhamrop, B Khuntikeo, N |
2020 |
International journal of general medicine (13), pp. 1271-1283 |
|
| 106. | Synchrotron FTIR microspectroscopy revealed apoptosis-induced biomolecular changes of cholangiocarcinoma cells treated with ursolic acid. | Maphanao, P Thanan, R Loilome, W Chio-Srichan, S Wongwattanakul, M Sakonsinsiri, C |
2020 |
Biochimica et biophysica acta. General subjects (), pp. 129708 |
|
| 107. | Lipidomic Analyses Uncover Apoptotic and Inhibitory Effects of Pyrvinium Pamoate on Cholangiocarcinoma Cells via Mitochondrial Membrane Potential Dysfunction. | Kittirat, Y Phetcharaburanin, J Promraksa, B Kulthawatsiri, T Wangwiwatsin, A Klanrit, P Sangkhamanon, S Jarearnrat, A Thongchot, S Mahalapbutr, P Loilome, W Saya, H Namwat, N |
2021 |
Frontiers in public health (9), pp. 766455 |
|
| 108. | Bacterial challenge-associated metabolic phenotypes in Hermetia illucens defining nutritional and functional benefits. | Ho, PN Klanrit, P Hanboonsong, Y Yordpratum, U Suksawat, M Kulthawatsiri, T Jirahiranpat, A Deewai, S Mackawan, P Sermswan, RW Namwat, N Loilome, W Khampitak, T Wangwiwatsin, A Phetcharaburanin, J |
2021 |
Scientific reports 1 (11), pp. 23316 |
|
| 109. | Promoter hypermethylation of early B cell factor 1 (EBF1) is associated with cholangiocarcinoma progression. | Armartmuntree, N Jusakul, A Sakonsinsiri, C Loilome, W Pinlaor, S Ungarreevittaya, P Yong, CH Techasen, A Imtawil, K Kraiklang, R Suwannakul, N Kaewlert, W Chaiprasert, T Thanan, R Murata, M |
2021 |
Journal of Cancer 9 (12), pp. 2673-2686 |
|
| 110. | CD44 modulates metabolic pathways and altered ROS-mediated Akt signal promoting cholangiocarcinoma progression. | Thanee, M Dokduang, H Kittirat, Y Phetcharaburanin, J Klanrit, P Titapun, A Namwat, N Khuntikeo, N Wangwiwatsin, A Saya, H Loilome, W |
2021 |
PloS one 3 (16), pp. e0245871 |
|
| 111. | A fluorescence AuNPs-LISA: A new approach for Opisthorchis viverrini (Ov) antigen detection with a simple fluorescent enhancement strategy by surfactant micelle in urine samples. | Taron, W Jamnongkan, W Phetcharaburanin, J Klanrit, P Namwat, N Techasen, A Sithithaworn, P Khuntikeo, N Boonmars, T Loilome, W Ngeontae, W |
2021 |
Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy (254), pp. 119633 |
|
| 112. | High Levels of Serum IgG for and CD44 Expression Predict Worse Prognosis for Cholangiocarcinoma Patients after Curative Resection. | Titapun, A Luvira, V Srisuk, T Jareanrat, A Thanasukarn, V Thanee, M Sa-Ngiamwibool, P Padthaisong, S Duangkumpha, K Suksawat, M Loilome, W Sithithaworn, P Techasen, A Thinkhamrop, B Dzienny, A Caglayan, A Park, D Mahmud, S Khuntikeo, N |
2021 |
International journal of general medicine (14), pp. 2191-2204 |
|
| 113. | Sulfasalazine modifies metabolic profiles and enhances cisplatin chemosensitivity on cholangiocarcinoma cells in in vitro and in vivo models. | Thanee, M Padthaisong, S Suksawat, M Dokduang, H Phetcharaburanin, J Klanrit, P Titapun, A Namwat, N Wangwiwatsin, A Sa-Ngiamwibool, P Khuntikeo, N Saya, H Loilome, W |
2021 |
Cancer & metabolism 1 (9), pp. 11 |
|
| 114. | Metabolic Profiling of Praziquantel-mediated Prevention of -induced Cholangiocyte Transformation in the Hamster Model of Cholangiocarcinoma. | Prommajun, P Phetcharaburanin, J Namwat, N Klanrit, P Sa-Ngiamwibool, P Thanee, M Dokduang, H Kittirat, Y Li, JV Loilome, W |
2021 |
Cancer genomics & proteomics 1 (18), pp. 29-42 |
|
| 115. | Therapeutic challenges at the preclinical level for targeted drug development for -associated cholangiocarcinoma. | Loilome, W Dokduang, H Suksawat, M Padthaisong, S |
2021 |
Expert opinion on investigational drugs (), pp. 1-22 |
|
| 116. | Integration of global metabolomics and lipidomics approaches reveals the molecular mechanisms and the potential biomarkers for postoperative recurrence in early-stage cholangiocarcinoma. | Padthaisong, S Phetcharaburanin, J Klanrit, P Li, JV Namwat, N Khuntikeo, N Titapun, A Jarearnrat, A Wangwiwatsin, A Mahalapbutr, P Loilome, W |
2021 |
Cancer & metabolism 1 (9), pp. 30 |
|
| 117. | Targeting Fatty Acid Synthase Modulates Metabolic Pathways and Inhibits Cholangiocarcinoma Cell Progression. | Tomacha, J Dokduang, H Padthaisong, S Namwat, N Klanrit, P Phetcharaburanin, J Wangwiwatsin, A Khampitak, T Koonmee, S Titapun, A Jarearnrat, A Khuntikeo, N Loilome, W |
2021 |
Frontiers in pharmacology (12), pp. 696961 |
|
| 118. | Arctigenin inhibits cholangiocarcinoma progression by regulating cell migration and cell viability via the N-cadherin and apoptosis pathway. | Janthamala, S Jusakul, A Kongpetch, S Kimawaha, P Klanrit, P Loilome, W Namwat, N Techasen, A |
2021 |
Naunyn-Schmiedeberg's archives of pharmacology 10 (394), pp. 2049-2059 |
|
| 119. | Mapping of population disparities in the cholangiocarcinoma urinary metabolome. | Alsaleh, M Leftley, Z O'Connor, T Hughes, T Barbera, TA Koomson, LK Zabron, A Reeves, H Cramp, M Ryder, SD Greer, S Prince, M Sithithaworn, P Khuntikeo, N Loilome, W Yongvanit, P Cox, IJ Williams, R Wadsworth, CA Holmes, E Nash, K Andrews, R Taylor-Robinson, SD |
2021 |
Scientific reports 1 (11), pp. 21286 |
|
| 120. | Metabolic Phenotyping Predicts Gemcitabine and Cisplatin Chemosensitivity in Patients With Cholangiocarcinoma. | Suksawat, M Phetcharaburanin, J Klanrit, P Namwat, N Khuntikeo, N Titapun, A Jarearnrat, A Vilayhong, V Sa-Ngiamwibool, P Techasen, A Wangwiwatsin, A Mahalapbutr, P Li, JV Loilome, W |
2022 |
Frontiers in public health (10), pp. 766023 |
|
| 121. | Prognostic significance of tumor-infiltrating lymphocytes in predicting outcome of distal cholangiocarcinoma in Thailand. | Intarawichian, P Sangpaibool, S Prajumwongs, P Sa-Ngiamwibool, P Sangkhamanon, S Kunprom, W Thanee, M Loilome, W Khuntikeo, N Titapun, A Jareanrat, A Thanasukarn, V Srisuk, T Luvira, V Eurboonyanun, K Promsorn, J Koonmee, S Wee, A Aphivatanasiri, C |
2022 |
Frontiers in oncology (12), pp. 1004220 |
|
| 122. | Modification of the AJCC/UICC 8th edition staging system for intrahepatic cholangiocarcinoma: proposal for an alternative staging system from cholangiocarcinoma-prevalent Northeast Thailand. | Sa-Ngiamwibool, P Aphivatanasiri, C Sangkhamanon, S Intarawichian, P Kunprom, W Thanee, M Prajumwongs, P Loilome, W Khuntikeo, N Titapun, A Jareanrat, A Thanasukarn, V Srisuk, T Luvira, V Eurboonyanun, K Promsorn, J Wee, A Koonmee, S |
2022 |
HPB : the official journal of the International Hepato Pancreato Biliary Association 11 (24), pp. 1944-1956 |
|
| 123. | Modification of the eighth AJCC/UICC staging system for perihilar cholangiocarcinoma: An alternative pathological staging system from cholangiocarcinoma-prevalent Northeast Thailand. | Aphivatanasiri, C Sa-Ngiamwibool, P Sangkhamanon, S Intarawichian, P Kunprom, W Thanee, M Prajumwongs, P Khuntikeo, N Titapun, A Jareanrat, A Thanasukarn, V Srisuk, T Luvira, V Eurboonyanun, K Promsorn, J Loilome, W Wee, A Koonmee, S |
2022 |
Frontiers in medicine (9), pp. 893252 |
|
| 124. | Interleukin-6-derived cancer-associated fibroblasts activate STAT3 pathway contributing to gemcitabine resistance in cholangiocarcinoma. | Kittirat, Y Suksawat, M Thongchot, S Padthaisong, S Phetcharaburanin, J Wangwiwatsin, A Klanrit, P Sangkhamanon, S Titapun, A Loilome, W Saya, H Namwat, N |
2022 |
Frontiers in pharmacology (13), pp. 897368 |
|
| 125. | Chemotherapeutic resistant cholangiocarcinoma displayed distinct intratumoral microbial composition and metabolic profiles. | Sitthirak, S Suksawat, M Phetcharaburanin, J Wangwiwatsin, A Klanrit, P Namwat, N Khuntikeo, N Titapun, A Jarearnrat, A Sangkhamanon, S Loilome, W |
2022 |
PeerJ (10), pp. e13876 |
|
| 126. | Effects of day-to-day variation of Opisthorchis viverrini antigen in urine on the accuracy of diagnosing opisthorchiasis in Northeast Thailand. | Worasith, C Wongphutorn, P Homwong, C Kopolrat, KY Techasen, A Thanan, R Eamudomkarn, C Wangboon, C Khuntikeo, N Loilome, W Sithithaworn, J Crellen, T Sithithaworn, P |
2022 |
PloS one 7 (17), pp. e0271553 |
|
| 127. | Performance of Mini Parasep SF stool concentrator kit, Kato-Katz, and formalin-ethyl acetate concentration methods for diagnosis of opisthorchiasis in Northeast Thailand. | Kopolrat, KY Singthong, S Khuntikeo, N Loilome, W Worasith, C Homwong, C Wangboon, C Yasaka, P Eamudomkarn, C Pitaksakulrat, O Tonkhamhak, K Paeyo, A Crellen, T Sithithaworn, J Sithithaworn, P |
2022 |
Parasites & vectors 1 (15), pp. 234 |
|
| 128. | Prognostic Significance of Growth Pattern in Predicting Outcome of -Associated Distal Cholangiocarcinoma in Thailand. | Kunprom, W Aphivatanasiri, C Sa-Ngiamwibool, P Sangkhamanon, S Intarawichian, P Bamrungkit, W Thanee, M Prajumwongs, P Loilome, W Khuntikeo, N Titapun, A Jareanrat, A Thanasukarn, V Srisuk, T Luvira, V Eurboonyanun, K Promsorn, J Koonmee, S |
2022 |
Frontiers in public health (10), pp. 816028 |
|
| 129. | Smartphone-based portable fluorescence sensor with gold nanoparticle mediation for selective detection of nitrite ions. | Ponlakhet, K Phooplub, K Phongsanam, N Phongsraphang, T Phetduang, S Surawanitkun, C Buranachai, C Loilome, W Ngeontae, W |
2022 |
Food chemistry (384), pp. 132478 |
|
| 130. | Therapeutic targeting of ARID1A and PI3K/AKT pathway alterations in cholangiocarcinoma. | Tessiri, S Techasen, A Kongpetch, S Namjan, A Loilome, W Chan-On, W Thanan, R Jusakul, A |
2022 |
PeerJ (10), pp. e12750 |
|
| 131. | Urinary Metabolic Profiling of Liver Fluke-Induced Cholangiocarcinoma-A Follow-Up Study. | Alsaleh, M Sithithaworn, P Khuntikeo, N Loilome, W Yongvanit, P Hughes, T O'Connor, T Andrews, RH Wadsworth, CA Williams, R Koomson, L Cox, IJ Holmes, E Taylor-Robinson, SD |
2023 |
Journal of clinical and experimental hepatology 2 (13), pp. 203-217 |
|
| 132. | H NMR fecal metabolic phenotyping of periductal fibrosis- and cholangiocarcinoma-specific metabotypes defining perturbation in gut microbial-host co-metabolism. | Treeriya, R Ho, PN Titapun, A Klanrit, P Suksawat, M Kulthawatsiri, T Sirirattanakul, S Loilome, W Namwat, N Wangwiwatsin, A Chamadol, N Khuntikeo, N Phetcharaburanin, J |
2023 |
PeerJ (11), pp. e15386 |
|
| 133. | Comparison of a Urine Antigen Assay and Multiple Examinations with the Formalin-Ethyl Acetate Concentration Technique for Diagnosis of Opisthorchiasis. | Worasith, C Techasen, A Duenngai, K Intuyod, K Kopolrat, KY Sithithaworn, J Loilome, W Crellen, T Haswell, MR Sithithaworn, P |
2023 |
The American journal of tropical medicine and hygiene 1 (109), pp. 159-165 |
|
| 134. | Preoperative controlling nutritional status (CONUT) score is an independent prognostic factor in cholangiocarcinoma patients treated with hepatectomy. | Titapun, A Sookprasert, A Sripanuskul, Y Watcharenwong, P Loilome, W Twinprai, P Srisuk, T Prajumwongs, P Chindaprasirt, J |
2023 |
Heliyon 10 (9), pp. e20473 |
|
| 135. | Accuracy of a new rapid diagnostic test for urinary antigen detection and assessment of drug treatment in opisthorchiasis. | Worasith, C Sithithaworn, J Wongphutorn, P Homwong, C Khongsukwiwat, K Techasen, A Kopolrat, KY Loilome, W Namwat, N Thinkamrop, B Tawarungruang, C Titapun, A Laha, T Andrews, RH Taylor-Robinson, SD Sithithaworn, P |
2023 |
Infectious diseases of poverty 1 (12), pp. 102 |
|
| 136. | Metabolomic analyses uncover an inhibitory effect of niclosamide on mitochondrial membrane potential in cholangiocarcinoma cells. | Kulthawatsiri, T Kittirat, Y Phetcharaburanin, J Tomacha, J Promraksa, B Wangwiwatsin, A Klanrit, P Titapun, A Loilome, W Namwat, N |
2023 |
PeerJ (11), pp. e16512 |
|
| 137. | The impact of hypoxia and oxidative stress on proteo-metabolomic alterations of 3D cholangiocarcinoma models. | Phukhum, P Phetcharaburanin, J Chaleekarn, K Kittirat, Y Kulthawatsiri, T Namwat, N Loilome, W Khuntikeo, N Titapun, A Wangwiwatsin, A Khampitak, T Suksawat, M Klanrit, P |
2023 |
Scientific reports 1 (13), pp. 3072 |
|
| 138. | The Hallmarks of Liver Fluke Related Cholangiocarcinoma: Insight into Drug Target Possibility. | Loilome, W Namwat, N Jusakul, A Techasen, A Klanrit, P Phetcharaburanin, J Wangwiwatsin, A |
2023 |
Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer (219), pp. 53-90 |
|
| 139. | Preclinical evidence for preventive and curative effects of resveratrol on xenograft cholangiocarcinogenesis. | Thongchot, S Ferraresi, A Vidoni, C Salwa, A Vallino, L Kittirat, Y Loilome, W Namwat, N Isidoro, C |
2023 |
Cancer letters (582), pp. 216589 |
|
| 140. | Toward novel treatment against filariasis: Insight into genome-wide co-evolutionary analysis of filarial nematodes and . | Wangwiwatsin, A Kulwong, S Phetcharaburanin, J Namwat, N Klanrit, P Loilome, W Maleewong, W Reid, AJ |
2023 |
Frontiers in microbiology (14), pp. 1052352 |
|
| 141. | Children with Hirschsprung disease exhibited alterations in host-microbial co-metabolism after pull-through operation. | Thaiwatcharamas, K Loilome, W Ho, PN Chusilp, S Tanming, P Klanrit, P Phetcharaburanin, J |
2024 |
Pediatric surgery international 1 (40), pp. 87 |
|
| 142. | Intraductal magnetic resonance imaging of cholangiocarcinoma - a practical possibility. | Syms, RRA Wadsworth, CA Kardoulaki, E Titapun, A Boonphongsathien, W Sa-Ngiamwibool, P Zhang, S Taylor-Robinson, SD Chamadol, N Loilome, W |
2024 |
Frontiers in oncology (14), pp. 1306242 |
|
| 143. | Integrative multiomics enhancer activity profiling identifies therapeutic vulnerabilities in cholangiocarcinoma of different etiologies. | Hong, JH Yong, CH Heng, HL Chan, JY Lau, MC Chen, J Lee, JY Lim, AH Li, Z Guan, P Chu, PL Boot, A Ng, SR Yao, X Wee, FYT Lim, JCT Liu, W Wang, P Xiao, R Zeng, X Sun, Y Koh, J Kwek, XY Ng, CCY Klanrit, P Zhang, Y Lai, J Tai, DWM Pairojkul, C Dima, S Popescu, I Hsieh, SY Yu, MC Yeong, J Kongpetch, S Jusakul, A Loilome, W Tan, P Tan, J Teh, BT |
2024 |
Gut 6 (73), pp. 966-984 |
|
| 144. | Improvement of survival outcomes of cholangiocarcinoma by ultrasonography surveillance: Multicenter retrospective cohorts. | Chamadol, N Laopaiboon, V Jareanrat, A Thanasukarn, V Srisuk, T Luvira, V Sarkhampee, P Ungpinitpong, W Khamvijite, P Chumnanua, Y Nethuwakul, N Sodarat, P Thammarit, S Techasen, A Thuanman, J Tawarungruang, C Thinkhamrop, B Sa-Ngiamwibool, P Loilome, W Prajumwongs, P Titapun, A |
2024 |
Heliyon 18 (10), pp. e38191 |
|
| 145. | Improving postoperative survival in cholangiocarcinoma: development of surgical strategies with a screening program in the epidemic region. | Thanasukarn, V Srisuk, T Luvira, V Tipwaratorn, T Jareanrat, A Rattanarak, K Kraphunpongsakul, K Khuntikeo, N Chindaprasirt, J Sanlung, T Chamadol, N Koonmee, S Sa-Ngiamwibool, P Klanrit, P Wangwiwatsin, A Namwat, N Loilome, W Muangritdech, N Prajumwongs, P Watanabe, N Ebata, T Titapun, A |
2024 |
World journal of surgical oncology 1 (22), pp. 287 |
|
| 146. | Spatio-Temporal Analysis of Cholangiocarcinoma in a High Prevalence Area of Northeastern Thailand: A 10-Year Large Scale Screening Program. | Anchalee, N Thinkhamrop, K Suwannatrai, AT Titapun, A Loilome, W Kelly, M |
2024 |
Asian Pacific journal of cancer prevention : APJCP 2 (25), pp. 537-546 |
|
| 147. | Metabolomic analysis of bioactive compounds in dill ( L.) extracts. | Thanuma, J Phetcharaburanin, J Dokduang, H Loilome, W Klanrit, P Wangwiwatsin, A Namwat, N |
2025 |
PeerJ (13), pp. e19567 |
|
| 148. | Development of ready-to-use microtiter plates for enhanced ELISA detection of Opisthorchis viverrini antigens in urine samples. | Taron, W Jamnongkan, W Kamjanlard, C Phetcharaburanin, J Wangwiwatsin, A Klanrit, P Namwat, N Techasen, A Titapun, A Boonmars, T Laummaunwai, P Sithithaworn, P Ngeontae, W Loilome, W |
2025 |
Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy (343), pp. 126589 |
|
| 149. | Characterization and identification of extrachromosomal circular DNA in cholangiocarcinoma. | Win, ZZ Dokduang, H Kulwong, S Loilome, W Namwat, N Phetcharaburanin, J Wongsurawat, T Jenjaroenpun, P Klanrit, P Wangwiwatsin, A |
2025 |
PloS one 5 (20), pp. e0322173 |
|
| 150. | Proteomic profiling reveals common and region-specific protein signatures underlying tumor heterogeneity in cholangiocarcinoma. | Sitthirak, S Roytrakul, S Wangwiwatsin, A Namwat, N Klanrit, P Dokduang, H Sa-Ngiamwibool, P Titapan, A Jareanrat, A Thanasukarn, V Khuntikeo, N Boulter, L Loilome, W |
2025 |
Scientific reports 1 (15), pp. 17228 |
|
| 151. | Mutations in Cholangiocarcinoma: Prevalence, Prognostic Value, and G12/G13 Detection in Cell-Free DNA. | Thongyoo, P Chindaprasirt, J Aphivatanasiri, C Intarawichian, P Kunprom, W Kongpetch, S Techasen, A Loilome, W Namwat, N Titapun, A Jusakul, A |
2025 |
Cancer genomics & proteomics 1 (22), pp. 112-126 |
|
| 152. | Antioxidative and anticancer effects of Tacca chantrieri extract enhancing cisplatin sensitivity in cholangiocarcinoma cells. | Armartmuntree, N Kittirat, Y Promraksa, B Loilome, W Dokduang, H Techasen, A Sansomchai, P Thanee, M O'Connor, T Kongthitilerd, P Padthaisong, S |
2025 |
PloS one 1 (20), pp. e0317111 |
|
| 153. | Discovery of novel serum peptide biomarkers for cholangiocarcinoma recurrence through MALDI-TOF MS and LC-MS/MS peptidome analysis. | Thanasukarn, V Prajumwongs, P Muangritdech, N Loilome, W Namwat, N Klanrit, P Wangwiwatsin, A Charoenlappanit, S Jaresitthikunchai, J Roytrakul, S Titapun, A |
2025 |
Scientific reports 1 (15), pp. 2582 |
|
| 154. | Chemical composition and anticancer potential of water extracts derived from ground powder of Thai germinated brown rice (). | Dokduang, H Katenak, A Kittirat, Y Tomacha, J Promraksa, B Taing, L Na Nakorn, S Klanrit, P Namwat, N Titapun, A Loilome, W |
2025 |
Natural product research (), pp. 1-8 |
|
| 155. | Characterization of Patient-derived Xenograft Models of Liver Fluke-associated Cholangiocarcinoma: From Establishment to Molecular Profiling. | Dokduang, H Jarernrat, A Titapun, A Sitthirak, S Padthaisong, S Kittirat, Y Sangkamanon, S Sa-Ngiamwibool, P Wangwiwatsin, A Klanrit, P Namwat, N Jusakul, A Murakami, Y Loilome, W |
2025 |
Anticancer research 2 (45), pp. 579-592 |
|
| 156. | The genome sequence of the liver fluke (Poirier, 1886) Stiles & Hassall, 1896. | Wangwiwatsin, A Kulwong, S Phuyao, C Titapun, A Loilome, W Klanrit, P Namwat, N Sithithaworn, P Doyle, SR Berriman, M Crellen, T , , , , |
2025 |
Wellcome open research (10), pp. 1 |
|
| 157. | Establishment and genomic profiling of cholangiocarcinoma cells with functional characterization. | Jaidee, R Jusakul, A Pocasap, P Kukongviriyapan, V Senggunprai, L Prawan, A Loilome, W Titapun, A Jareanrat, A Thanasukarn, V Khuntikeo, N Namwat, N Chamgramol, Y Thanee, M Wichian, P Hong, JH Guan, P Heng, HL Pairojkul, C Teh, BT Kongpetch, S |
2025 |
Scientific reports 1 (15), pp. 8621 |
|
| 158. | Identifying a unique chromosomal pattern to predict the gemcitabine response in patients with cholangiocarcinoma. | Techa-Ay, S Watcharadetwittaya, S Deenonpoe, R Sa-Ngiamwibool, P Panwoon, C Loilome, W Klanrit, P Techasen, A Chamgramol, Y Suksawat, M Armartmuntree, N O'Connor, T Saya, H Thanee, M |
2025 |
Scientific reports 1 (15), pp. 11984 |
|
| 159. | Identification of serum metabolite biomarkers and metabolic reprogramming mechanisms to predict recurrence in cholangiocarcinoma. | Prajumwongs, P Titapun, A Thanasukarn, V Jareanrat, A Khuntikeo, N Namwat, N Klanrit, P Wangwiwatsin, A Chindaprasirt, J Koonmee, S Sa-Ngiamwibool, P Muangritdech, N Roytrakul, S Loilome, W |
2025 |
Scientific reports 1 (15), pp. 12782 |
|
| 160. | Whole exome sequencing of multi-regions reveals tumor heterogeneity in Opisthorchis viverrini-associated cholangiocarcinoma. | Sitthirak, S Wangwiwatsin, A Jusakul, A Namwat, N Klanrit, P Dokduang, H Sa-Ngiamwibool, P Titapun, A Jareanrat, A Thanasukarn, V Khuntikeo, N Teh, BT Boulter, L Murakami, Y Loilome, W |
2025 |
Scientific reports 1 (15), pp. 10886 |
|
| 161. | Endobiliary radiofrequency ablation in recurrence and unresectable Perihilar cholangiocarcinoma. | Jareanrat, A Thanasukarn, V Srisuk, T Luvira, V Tipwaratorn, T Ahooja, A Loilome, W Prajumwongs, P Titapun, A |
2025 |
BMC gastroenterology 1 (25), pp. 501 |
|
| 162. | Large-scale epidemiology of opisthorchiasis in 21 provinces in Thailand based on diagnosis by fecal egg examination and urine antigen assay and analysis of risk factors for infection. | Kopolrat, KY Worasith, C Wongphutorn, P Techasen, A Eamudomkarn, C Sithithaworn, J Loilome, W Namwat, N Titapun, A Tawarungruang, C Thinkhamrop, B Futrakul, S Taylor-Robinson, SD Haswell, MR Khuntikeo, N Crellen, T Sithithaworn, P |
2025 |
PLoS neglected tropical diseases 7 (19), pp. e0013095 |
|
| 163. | Predicting cisplatin response in cholangiocarcinoma patients using chromosome pattern and related gene expression. | Techa-Ay, S Watcharadetwittaya, S Deenonpoe, R Intuyod, K Kaewlert, W Techasen, A Loilome, W Klanrit, P Suksawat, M Chaleekan, K Sitthirak, S Thanee, M |
2025 |
Scientific reports 1 (15), pp. 20420 |
|
| 164. | Mitochondrial genomic alterations in cholangiocarcinoma cell lines. | Faipan, A Sitthirak, S Wangwiwatsin, A Namwat, N Klanrit, P Titapun, A Jareanrat, A Thanasukarn, V Khuntikeo, N Boulter, L Dokduang, H Loilome, W |
2025 |
PloS one 6 (20), pp. e0323844 |
| Title | Authors | Year | Journal title | Cited count | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| < 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | รวม | ||||||
| 1. | Altered gene expression in Opisthorchis viverrini-associated cholangiocarcinoma in hamster model | W Loilome P Yongvanit C Wongkham N Tepsiri B Sripa P Sithithaworn S Hanai M Miwa |
2006 |
MOLECULAR CARCINOGENESIS 5.0 (45.0), pp. 279.0-287.0 |
80 | 0 | 0 | 0 | 0 | 0 | 80 | |
| 2. | Altered gene expression levels associating with 5-fluorouracil resistance in cholangiocarcinoma cell lines | Nisana N. Tepsiri Watcharin Loilome Piyawan Amimanan Patcharee Jearanaikoon Wichittra Tassaneeyakul |
2006 |
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (21.0), pp. A95-A95 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 3. | Plasma 8-isoprostane: a new biomarker in opisthorchiasis-associated cholangiocarcinoma | Puangrat Yongvanit Somkid Dechakhamphu Somchai Pinlaor Nisana N. Tepsiri Watcharin Loilome Narong Khantekaew Paiboon Sithithaworn |
2006 |
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (21.0), pp. A187-A188 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 4. | Prkar1a gene overexpression in liver tissue with cholangiocarcinoma | Watcharin Loilome Anucha Puapairoj Nisana N. Tepsiri Paiboon Sithithaworn Masanao Miwa Puangrat Yongvanit |
2006 |
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (21.0), pp. A188-A188 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 5. | Characterization of 5-fluorouracil-resistant cholangiocarcinoma cell lines | Nisana Namwat Piyawan Amimanan Watcharin Loilome Patcharee Jearanaikoon Banchob Sripa Vajarabhongsa Bhudhisawasdi Wichittra Tassaneeyakul |
2008 |
CHEMOTHERAPY 5.0 (54.0), pp. 343.0-351.0 |
48 | 0 | 0 | 0 | 0 | 0 | 48 | |
| 6. | Over-expression of PRKAR1A in hepatic progenitor cells during cholangiocarcinogenesis induced by liver fluke (Opisthorchis, viverrini) | P. Yonavanit N. Namwat W. Loilome R. Thanan E. Phanomsri C. Pairojkul |
2008 |
EJC SUPPLEMENTS 9.0 (6.0), pp. 132.0-133.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 7. | Glioblastoma cell growth is suppressed by disruption of fibroblast growth factor pathway signaling | Watcharin Loilome Avadhut D. Joshi Colette M. J. ap Rhys Sara Piccirillo Vescovi L. Angelo Gary L. Gallia Gregory J. Riggins |
2009 |
JOURNAL OF NEURO-ONCOLOGY 3.0 (94.0), pp. 359.0-366.0 |
61 | 0 | 0 | 0 | 0 | 0 | 61 | |
| 8. | Apoptotic activity of caged xanthones from Garcinia hanburyi in cholangiocarcinoma cell lines | Chariya Hahnvajanawong Wongwarut Boonyanugomol Tapanawan Nasomyon Watcharin Loilome Nisana Namwat Natthinee Anantachoke Wichittra Tassaneeyakul Banchob Sripa Wises Namwat Vichai Reutrakul |
2010 |
WORLD JOURNAL OF GASTROENTEROLOGY 18.0 (16.0), pp. 2235.0-2243.0 |
39 | 0 | 0 | 0 | 0 | 0 | 39 | |
| 9. | Glioblastoma cell growth is suppressed by disruption of fibroblast growth factor pathway signaling (vol 94, pg 359, 2009) | Watcharin Loilome Avadhut D. Joshi Colette M. J. ap Rhys Sara Piccirillo Angelo L. Vescovi Gary L. Gallia Gregory J. Riggins |
2010 |
JOURNAL OF NEURO-ONCOLOGY 3.0 (97.0), pp. 459.0-459.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 10. | Myristoylated alanine-rich C kinase substrate phosphorylation promotes cholangiocarcinoma cell migration and metastasis via the protein kinase C-dependent pathway | Anchalee Techasen Watcharin Loilome Nisana Namwat Eri Takahashi Eiji Sugihara Anucha Puapairoj Masanao Miwa Hideyuki Saya Puangrat Yongvanit |
2010 |
CANCER SCIENCE 3.0 (101.0), pp. 658.0-665.0 |
74 | 0 | 0 | 0 | 0 | 0 | 74 | |
| 11. | Downregulation of reversion-inducing-cysteine-rich protein with Kazal motifs (RECK) is associated with enhanced expression of matrix metalloproteinases and cholangiocarcinoma metastases | N. Namwat J. Puetkasichonpasutha W. Loilome P. Yongvanit A. Techasen A. Puapairoj B. Sripa W. Tassaneeyakul N. Khuntikeo S. Wongkham |
2011 |
JOURNAL OF GASTROENTEROLOGY 5.0 (46.0), pp. 664.0-675.0 |
53 | 0 | 0 | 0 | 0 | 0 | 53 | |
| 12. | Mechanisms of oxysterol-induced carcinogenesis | Apinya Jusakul Puangrat Yongvanit Watcharin Loilome Nisana Namwat Rahul Kuver |
2011 |
LIPIDS IN HEALTH AND DISEASE (10.0), pp. |
58 | 0 | 0 | 0 | 0 | 0 | 58 | |
| 13. | PRKAR1A is overexpressed and represents a possible therapeutic target in human cholangiocarcinoma | Watcharin Loilome Sirinun Juntana Nisana Namwat Vajarabhongsa Bhudhisawasdi Anucha Puapairoj Banchob Sripa Masanao Miwa Hideyuki Saya Gregory J. Riggins Puangrat Yongvanit |
2011 |
INTERNATIONAL JOURNAL OF CANCER 1.0 (129.0), pp. 34.0-44.0 |
58 | 0 | 0 | 0 | 0 | 0 | 58 | |
| 14. | Anti-inflammatory Agents Suppress the Prostaglandin E-2 Production and Migration Ability of Cholangiocarcinoma Cell Lines | Jurairat Jongthawin Anchalee Techasen Watcharin Loilome Puangrat Yongvanit Nisana Namwat |
2012 |
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (13.0), pp. 47.0-51.0 |
17 | 0 | 0 | 0 | 0 | 0 | 17 | |
| 15. | Anti-inflammatory, antioxidant and hepatoprotective effects of Thunbergia laurifolia Linn. on experimental opisthorchiasis | Orasa Wonkchalee Thidarut Boonmars Chantana Aromdee Porntip Laummaunwai Watcharee Khunkitti Kulthida Vaeteewoottacharn Pranee Sriraj Ratchadawan Aukkanimart Watchalin Loilome Yaovaluk Chamgramol Chawalit Pairojkul Zhiliang Wu Amornrat Juasook Pakkayanee Sudsarn |
2012 |
PARASITOLOGY RESEARCH 1.0 (111.0), pp. 353.0-359.0 |
32 | 0 | 0 | 0 | 0 | 0 | 32 | |
| 16. | Anti-inflammatory effect of prednisolone on the growth of human liver fluke in experimental opisthorchiasis | Amornrat Juasook Thidarut Boonmars Sasithorn Kaewkes Watcharin Loilome Kulathida Veteewuthacharn Zhiliang Wu Puangrat Yongvanit |
2012 |
PARASITOLOGY RESEARCH 6.0 (110.0), pp. 2271.0-2279.0 |
10 | 0 | 0 | 0 | 0 | 0 | 10 | |
| 17. | Cytokines Released from Activated Human Macrophages Induce Epithelial Mesenchymal Transition Markers of Cholangiocarcinoma Cells | Anchalee Techasen Watcharin Loilome Nisana Namwat Hasaya Dokduang Jurairat Jongthawin Puangrat Yongvanit |
2012 |
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (13.0), pp. 115.0-118.0 |
51 | 0 | 0 | 0 | 0 | 0 | 51 | |
| 18. | Down-Regulated Expression of HSP70 in Correlation with Clinicopathology of Cholangiocarcinoma | Sirintip Boonjaraspinyo Thidarut Boonmars Sasithorn Kaewkes Porntip Laummaunwai Somchai Pinlaor Watchalin Loilome Puangrat Yongvanit Zhiliang Wu Anucha Puapairoj Vajarabhongsa Bhudhisawasdi |
2012 |
PATHOLOGY & ONCOLOGY RESEARCH 2.0 (18.0), pp. 227.0-237.0 |
17 | 0 | 0 | 0 | 0 | 0 | 17 | |
| 19. | Evaluation of Tyrosine Kinase Inhibitor Combinations for Glioblastoma Therapy | Avadhut D. Joshi Watcharin Loilome I-Mei Siu Betty Tyler Gary L. Gallia Gregory J. Riggins |
2012 |
PLOS ONE 10.0 (7.0), pp. |
42 | 0 | 0 | 0 | 0 | 0 | 42 | |
| 20. | Expression of oxysterol binding protein isoforms in opisthorchiasis-associated cholangiocarcinoma: A potential molecular marker for tumor metastasis | Watcharin Loilome Pairoj Wechagama Nisana Namwat Apinya Jusakul Banchob Sripa Masanao Miwa Rahul Kuver Puangrat Yongvanit |
2012 |
PARASITOLOGY INTERNATIONAL 1.0 (61.0), pp. 136.0-139.0 |
23 | 0 | 0 | 0 | 0 | 0 | 23 | |
| 21. | Expression Profiles of Oncomir miR-21 and Tumor Suppressor let-7a in the Progression of Opisthorchiasis-Associated Cholangiocarcinoma | N. Namwat P. Chusorn W. Loilome A. Techasen J. Puetkasichonpasutha C. Pairojkul N. Khuntikeo P. Yongvanit |
2012 |
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (13.0), pp. 65.0-69.0 |
25 | 0 | 0 | 0 | 0 | 0 | 25 | |
| 22. | Hepatic cytochrome P450 2A6 and 2E1 status in peri-tumor tissues of patients with Opisthorchis viverrini-associated cholangiocarcinoma | Puangrat Yongvanit Emorn Phanomsri Nisana Namwat Jureeporn Kampan Wichittra Tassaneeyakul Watcharin Loilome Anucha Puapairoj Narong Khuntikeo |
2012 |
PARASITOLOGY INTERNATIONAL 1.0 (61.0), pp. 162.0-166.0 |
7 | 0 | 0 | 0 | 0 | 0 | 7 | |
| 23. | Identification of Biliary Bile Acids in Patients with Benign Biliary Diseases, Hepatocellular Carcinoma and Cholangiocarcinoma | Apinya Jusakul Narong Khuntikeo W. Geoffrey Haigh Rahul Kuver George N. Ioannou Watcharin Loilome Nisana Namwat Vajarabhongsa Bhudhisawasdi Ake Pugkhem Chawalit Pairojkul Puangrat Yongvanit |
2012 |
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (13.0), pp. 77.0-82.0 |
8 | 0 | 0 | 0 | 0 | 0 | 8 | |
| 24. | Identification of pathogenic cholesterol oxidation products in hepatic tissue and bile of cholangiocarcinoma patients | A. Jusakul W. G. Haigh C. Savard W. Loilome N. Namwat N. Khuntikeo C. Pairojkul S. Pinlaor R. Kuver P. Yongvanit |
2012 |
FEBS JOURNAL (279.0), pp. 216.0-216.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 25. | Impaired Antioxidant Enzyme Activity and Increased DNA Repair Enzyme Expression in Hamster Liver Tissues Related to Cholangiocarcinoma Development | Watcharin Loilome Sasithorn Kadsanit Nisana Namwat Anchalee Techasen Anucha Puapairoj Ananya Dechakhamphu Chadamas Pinitsoontorn Puangrat Yongvanit |
2012 |
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (13.0), pp. 59.0-64.0 |
3 | 0 | 0 | 0 | 0 | 0 | 3 | |
| 26. | Increased expression of TLR-2, COX-2, and SOD-2 genes in the peripheral blood leukocytes of opisthorchiasis patients induced by Opisthorchis viverrini antigen | Puangrat Yongvanit Raynoo Thanan Somchai Pinlaor Paiboon Sithithaworn Watcharin Loilome Nisana Namwat Anchalee Techasen Somkid Dechakhamphu |
2012 |
PARASITOLOGY RESEARCH 5.0 (110.0), pp. 1969.0-1977.0 |
16 | 0 | 0 | 0 | 0 | 0 | 16 | |
| 27. | Liver fluke-induced hepatic oxysterols stimulate DNA damage and apoptosis in cultured human cholangiocytes | Apinya Jusakul Watcharin Loilome Nisana Namwat W. Geoffrey Haigh Rahul Kuver Somkid Dechakhamphu Pradit Sukontawarin Somchai Pinlaor Sum P. Lee Puangrat Yongvanit |
2012 |
MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS 1-2 (731.0), pp. 48.0-57.0 |
34 | 0 | 0 | 0 | 0 | 0 | 34 | |
| 28. | Opisthorchis viverrini-antigen induces expression of MARCKS during inflammation-associated cholangiocarcinogenesis | Anchalee Techasen Watcharin Loilome Nisana Namwat Kunyarat Duenngai Ubon Cha'on Raynoo Thanan Paiboon Sithithaworn Masanao Miwa Puangrat Yongvanit |
2012 |
PARASITOLOGY INTERNATIONAL 1.0 (61.0), pp. 140.0-144.0 |
12 | 0 | 0 | 0 | 0 | 0 | 12 | |
| 29. | Overexpression of PDGFA and its receptor during carcinogenesis of Opisthorchis viverrini-associated cholangiocarcinoma | Sirintip Boonjaraspinyo Zhiliang Wu Thidarut Boonmars Sasithorn Kaewkes Watchalin Loilome Paiboon Sithithaworn Isao Nagano Yuzo Takahashi Puangrat Yongvanit Vajarabhongsa Bhudhisawasdi |
2012 |
PARASITOLOGY INTERNATIONAL 1.0 (61.0), pp. 145.0-150.0 |
24 | 0 | 0 | 0 | 0 | 0 | 24 | |
| 30. | Platelet-derived growth factor may be a potential diagnostic and prognostic marker for cholangiocarcinoma | Sirintip Boonjaraspinyo Thidarut Boonmars Zhiliang Wu Watcharin Loilome Paiboon Sithithaworn Isao Nagano Somchai Pinlaor Puangrat Yongvanit Phuangphaka Sadee Nielsen Chawalit Pairojkul Narong Khuntikeo |
2012 |
TUMOR BIOLOGY 5.0 (33.0), pp. 1785.0-1802.0 |
38 | 0 | 0 | 0 | 0 | 0 | 38 | |
| 31. | PRKAR1A overexpression is associated with increased ECPKA autoantibody in liver fluke-associated cholangiocarcinoma: application for assessment of the risk group | Watcharin Loilome Sasithorn Yooyuen Nisana Namwat Paiboon Sithithaworn Anucha Puapairoj Junko Kano Masayuki Noguchi Masanao Miwa Puangrat Yongvanit |
2012 |
TUMOR BIOLOGY 6.0 (33.0), pp. 2289.0-2298.0 |
10 | 0 | 0 | 0 | 0 | 0 | 10 | |
| 32. | Suppression of PRKAR1A Expression Enhances Antiproliferative and Apoptotic Effects of Protein Kinase Inhibitors and Chemotherapeutic Drugs on Cholangiocarcinoma Cells | Watcharin Loilome Sirinun Juntana Chadamas Pinitsoontorn Nisana Namwat Wichittra Tassaneeyakul Puangrat Yongvanit |
2012 |
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION (13.0), pp. 143.0-147.0 |
3 | 0 | 0 | 0 | 0 | 0 | 3 | |
| 33. | Tumor Necrosis Factor-alpha (TNF-alpha) stimulates the epithelial-mesenchymal transition regulator Snail in cholangiocarcinoma | A. Techasen N. Namwat W. Loilome |
2012 |
FEBS JOURNAL (279.0), pp. 169.0-170.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 34. | Tumor necrosis factor-alpha (TNF-alpha) stimulates the epithelial-mesenchymal transition regulator Snail in cholangiocarcinoma | Anchalee Techasen Nisana Namwat Watcharin Loilome Pornpan Bungkanjana Narong Khuntikeo Anucha Puapairoj Patcharee Jearanaikoon Hideyuki Saya Puangrat Yongvanit |
2012 |
MEDICAL ONCOLOGY 5.0 (29.0), pp. 3083.0-3091.0 |
74 | 0 | 0 | 0 | 0 | 0 | 74 | |
| 35. | Anti-apoptotic phenotypes of cholestan-3 beta,5 alpha,6 beta-triol-resistant human cholangiocytes: Characteristics contributing to the genesis of cholangiocarcinoma | Apinya Jusakul Watcharin Loilome Nisana Namwat Anchalee Techasen Rahul Kuver George N. Ioannou Christopher Savard W. Geoffrey Haigh Puangrat Yongvanit |
2013 |
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (138.0), pp. 368.0-375.0 |
14 | 0 | 0 | 0 | 0 | 0 | 14 | |
| 36. | Immunosuppressive Prednisolone Enhances Early Cholangiocarcinoma in Syrian Hamsters with Liver Fluke Infection and Administration of N-nitrosodimethylamine | Amornrat Juasook Thidarut Boonmars Zhiliang Wu Watcharin Loilome Kulathida Veteewuthacharn Nissana Namwat Pakkayanee Sudsarn Orasa Wonkchalee Pranee Sriraj Ratchadawan Aukkanimart |
2013 |
PATHOLOGY & ONCOLOGY RESEARCH 1.0 (19.0), pp. 55.0-62.0 |
11 | 0 | 0 | 0 | 0 | 0 | 11 | |
| 37. | Increased activation of PI3K/AKT signaling pathway is associated with cholangiocarcinoma metastasis and PI3K/mTOR inhibition presents a possible therapeutic strategy | Supak Yothaisong Hasaya Dokduang Anchalee Techasen Nisana Namwat Puangrat Yongvanit Vajarabhongsa Bhudhisawasdi Anucha Puapairoj Gregory J. Riggins Watcharin Loilome |
2013 |
TUMOR BIOLOGY 6.0 (34.0), pp. 3637.0-3648.0 |
73 | 0 | 0 | 0 | 0 | 0 | 73 | |
| 38. | Overexpression of microRNA-21 regulating PDCD4 during tumorigenesis of liver fluke-associated cholangiocarcinoma contributes to tumor growth and metastasis | P. Chusorn N. Namwat W. Loilome A. Techasen C. Pairojkul N. Khuntikeo A. Dechakhamphu C. Talabnin W. Chan-On C. K. Ong B. T. Teh P. Yongvanit |
2013 |
TUMOR BIOLOGY 3.0 (34.0), pp. 1579.0-1588.0 |
65 | 0 | 0 | 0 | 0 | 0 | 65 | |
| 39. | Oxidized alpha-1 antitrypsin as a predictive risk marker of opisthorchiasis-associated cholangiocarcinoma | Wassana Jamnongkan Anchalee Techasen Raynoo Thanan Kunyarat Duenngai Paiboon Sithithaworn Eimorn Mairiang Watcharin Loilome Nisana Namwat Chawalit Pairojkul Puangrat Yongvanit |
2013 |
TUMOR BIOLOGY 2.0 (34.0), pp. 695.0-704.0 |
23 | 0 | 0 | 0 | 0 | 0 | 23 | |
| 40. | Survey of activated kinase proteins reveals potential targets for cholangiocarcinoma treatment | Hasaya Dokduang Sirinun Juntana Anchalee Techasen Nisana Namwat Puangrat Yongvanit Narong Khuntikeo Gregory J. Riggins Watcharin Loilome |
2013 |
TUMOR BIOLOGY 6.0 (34.0), pp. 3519.0-3528.0 |
36 | 0 | 0 | 0 | 0 | 0 | 36 | |
| 41. | The expression of PGE2 biosynthesis-related enzymes and PGE2 receptors in cholangiocarcinoma | Jurairat Jongthawin Anchalee Techasen Puangrat Yongvanit Watcharin Loilome Chavalit Pairojkul Narong Khuntikeo Nisana Namwat |
2013 |
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (28.0), pp. 425.0-425.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 42. | Activated macrophages promote Wnt/beta-catenin signaling in cholangiocarcinoma cells | Watcharin Loilome Pornpan Bungkanjana Anchalee Techasen Nisana Namwat Puangrat Yongvanit Anucha Puapairoj Narong Khuntikeo Gregory J. Riggins |
2014 |
TUMOR BIOLOGY 6.0 (35.0), pp. 5357.0-5367.0 |
60 | 0 | 0 | 0 | 0 | 0 | 60 | |
| 43. | Association of CYP39A1, RUNX2 and Oxidized Alpha-1 Antitrypsin Expression in Relation to Cholangiocarcinoma Progression | Chakkaphan Khenjanta Raynoo Thanan Apinya Jusakul Anchalee Techasen Wassana Jamnongkan Nisana Namwat Watcharin Loilome Chawalit Pairojkul Puangrat Yongvanit |
2014 |
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION 23.0 (15.0), pp. 10187.0-10192.0 |
12 | 0 | 0 | 0 | 0 | 0 | 12 | |
| 44. | BMP-7 blocks the effects of TGF-beta-induced EMT in cholangiocarcinoma | Kassaporn Duangkumpha Anchalee Techasen Watcharin Loilome Nisana Namwat Raynoo Thanan Narong Khuntikeo Puangrat Yongvanit |
2014 |
TUMOR BIOLOGY 10.0 (35.0), pp. 9667.0-9676.0 |
49 | 0 | 0 | 0 | 0 | 0 | 49 | |
| 45. | Circulating miR-192 in liver fluke-associated cholangiocarcinoma patients: a prospective prognostic indicator | Runglawan Silakit Watcharin Loilome Puangrat Yongvanit Porncheera Chusorn Anchalee Techasen Thidarut Boonmars Narong Khuntikeo Nittaya Chamadol Chawalit Pairojkul Nisana Namwat |
2014 |
JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES 12.0 (21.0), pp. 864.0-872.0 |
66 | 0 | 0 | 0 | 0 | 0 | 66 | |
| 46. | High Expression of HIF-1 alpha, BNIP3 and PI3KC3: Hypoxia-Induced Autophagy Predicts Cholangiocarcinoma Survival and Metastasis | Suyanee Thongchot Puangrat Yongvanit Watcharin Loilome Wanchana Seubwai Kutcharin Phunicom Wichittra Tassaneeyakul Chawalit Pairojkul Wisuttiphong Promkotra Anchalee Techasen Nisana Namwat |
2014 |
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION 14.0 (15.0), pp. 5873.0-5878.0 |
37 | 0 | 0 | 0 | 0 | 0 | 37 | |
| 47. | Histological confirmation of periductal fibrosis from ultrasound diagnosis in cholangiocarcinoma patients | Nittaya Chamadol Chawalit Pairojkul Narong Khuntikeo Vallop Laopaiboon Watcharin Loilome Paiboon Sithithaworn Paungrat Yongvanit |
2014 |
JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES 5.0 (21.0), pp. 316.0-322.0 |
57 | 0 | 0 | 0 | 0 | 0 | 57 | |
| 48. | Increased EphB2 expression predicts cholangiocarcinoma metastasis | Walaiporn Khansaard Anchalee Techasen Nisana Namwat Puangrat Yongvanit Narong Khuntikeo Anucha Puapairoj Watcharin Loilome |
2014 |
TUMOR BIOLOGY 10.0 (35.0), pp. 10031.0-10041.0 |
26 | 0 | 0 | 0 | 0 | 0 | 26 | |
| 49. | Inhibitory effect of xanthohumol on STAT3 activation and cholangiocarcinoma development | H. Dokduang W. Loilome N. Namwat C. Pairojkul M. Sakurai-Yageta Y. Murakami P. Yongvanit |
2014 |
EUROPEAN JOURNAL OF CANCER (50.0), pp. S197-S197 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 50. | Loss of E-cadherin promotes migration and invasion of cholangiocarcinoma cells and serves as a potential marker of metastasis | Anchalee Techasen Watcharin Loilome Nisana Namwat Narong Khuntikeo Anucha Puapairoj Patcharee Jearanaikoon Hideyuki Saya Puangrat Yongvanit |
2014 |
TUMOR BIOLOGY 9.0 (35.0), pp. 8645.0-8652.0 |
43 | 0 | 0 | 0 | 0 | 0 | 43 | |
| 51. | Milk fat globule epidermal growth factor 8 serves a novel biomarker of opisthorchiasis-associated cholangiocarcinoma | Zhiliang Wu Thidarut Boonmars Isao Nagano Watcharin Loilome Puangrat Yongvanit Narong Khuntikeo Phuangphaka Sadee Nielsen Chawalit Paorojkul Yuzo Takahashi Yoichi Maekawa |
2014 |
TUMOR BIOLOGY 3.0 (35.0), pp. 1985.0-1995.0 |
2 | 0 | 0 | 0 | 0 | 0 | 2 | |
| 52. | Opisthorchis viverrini Infection Activates the PI3K/AKT/PTEN and Wnt/beta-catenin Signaling Pathways in a Cholangiocarcinogenesis Model | Supak Yothaisong Malinee Thanee Nisana Namwat Puangrat Yongvanit Thidarut Boonmars Anucha Puapairoj Watcharin Loilome |
2014 |
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION 23.0 (15.0), pp. 10463.0-10468.0 |
25 | 0 | 0 | 0 | 0 | 0 | 25 | |
| 53. | PGE(2) signaling and its biosynthesis-related enzymes in cholangiocarcinoma progression | Jurairat Jongthawin Porncheera Chusorn Anchalee Techasen Watcharin Loilome Thidarut Boonmars Raynoo Thanan Anucha Puapairoj Narong Khuntikeo Wichittra Tassaneeyakul Puangrat Yongvanit Nisana Namwat |
2014 |
TUMOR BIOLOGY 8.0 (35.0), pp. 8051.0-8064.0 |
10 | 0 | 0 | 0 | 0 | 0 | 10 | |
| 54. | Risk biomarkers for assessment and chemoprevention of liver fluke-associated cholangiocarcinoma | Puangrat Yongvanit Somchai Pinlaor Watcharin Loilome |
2014 |
JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES 5.0 (21.0), pp. 309.0-315.0 |
33 | 0 | 0 | 0 | 0 | 0 | 33 | |
| 55. | STATs profiling reveals predominantly-activated STAT3 in cholangiocarcinoma genesis and progression | Hasaya Dokduang Anchalee Techasen Nisana Namwat Narong Khuntikeo Chawalit Pairojkul Yoshinori Murakami Watcharin Loilome Puangrat Yongvanit |
2014 |
JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES 10.0 (21.0), pp. 767.0-776.0 |
52 | 0 | 0 | 0 | 0 | 0 | 52 | |
| 56. | Survey of activated kinase proteins reveals PI3K/Akt and Wnt/beta-catenin signaling pathways as potential targets for cholangiocarcinoma treatment | W. Loilome H. Dokduang S. Yothaisong P. Bungkanjana S. Juntana A. Techasen N. Namwat P. Yongvanit N. Khuntikeo A. Puapairoj |
2014 |
EUROPEAN JOURNAL OF CANCER (50.0), pp. S210-S210 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 57. | TPRG1L is a novel microRNA-21 target: a possible linkage between miR-21 and cellular senescence in liver fluke-associated cholangiocarcinoma | P. Chusorn N. Namwat W. Loilome A. Techasen C. Pairojkul N. Khuntikeo B. Tean Teh I. Lee P. Yongvanit |
2014 |
EUROPEAN JOURNAL OF CANCER (50.0), pp. S63-S64 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 58. | Tumor necrosis factor-alpha modulates epithelial mesenchymal transition mediators ZEB2 and S100A4 to promote cholangiocarcinoma progression | Anchalee Techasen Nisana Namwat Watcharin Loilome Kassaporn Duangkumpha Anucha Puapairoj Hideyuki Saya Puangrat Yongvanit |
2014 |
JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES 9.0 (21.0), pp. 703.0-711.0 |
44 | 0 | 0 | 0 | 0 | 0 | 44 | |
| 59. | Advances in the Diagnosis of Human Opisthorchiasis: Development of Opisthorchis viverrini Antigen Detection in Urine | Chanika Worasith Christine Kamamia Anna Yakovleva Kunyarat Duenngai Chompunoot Wangboon Jiraporn Sithithaworn Nattaya Watwiengkam Nisana Namwat Anchalee Techasen Watcharin Loilome Puangrat Yongvanit Alex Loukas Paiboon Sithithaworn Jeffrey M. Bethony |
2015 |
PLoS Neglected Tropical Diseases 10.0 (9.0), pp. |
37 | 0 | 0 | 0 | 0 | 0 | 37 | |
| 60. | Cohort profile: cholangiocarcinoma screening and care program (CASCAP) | Narong Khuntikeo Nittaya Chamadol Puangrat Yongvanit Watcharin Loilome Nisana Namwat Paiboon Sithithaworn Ross H. Andrews Trevor N. Petney Supannee Promthet Kavin Thinkhamrop Chaiwat Tawarungruang Bandit Thinkhamrop |
2015 |
BMC CANCER (15.0), pp. |
69 | 0 | 0 | 0 | 0 | 0 | 69 | |
| 61. | Oxidative stress induced LAT1/CD98 expression via PI3K/AKT signaling pathway in cholangiocarcinoma: a potential therapeutic target | Supak Yothaisong Watcharin Loilome Promsuk Jutabha Hasaya Dokduang Hitoshi Endou Naohiko Anzai |
2015 |
JOURNAL OF PHARMACOLOGICAL SCIENCES 3.0 (128.0), pp. S102-S102 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 62. | A Comprehensive Public Health Conceptual Framework and Strategy to Effectively Combat Cholangiocarcinoma in Thailand | Narong Khuntikeo Watcharin Loilome Bandit Thinkhamrop Nittaya Chamadol Puangrat Yongvanit |
2016 |
PLOS NEGLECTED TROPICAL DISEASES 1.0 (10.0), pp. |
46 | 0 | 0 | 0 | 0 | 0 | 46 | |
| 63. | CD44 variant-dependent redox status regulation in liver fluke-associated cholangiocarcinoma: A target for cholangiocarcinoma treatment | Malinee Thanee Watcharin Loilome Anchalee Techasen Eiji Sugihara Shogo Okazaki Shinya Abe Shiho Ueda Takashi Masuko Nisana Namwat Narong Khuntikeo Attapol Titapun Chawalit Pairojkul Hideyuki Saya Puangrat Yongvanit |
2016 |
CANCER SCIENCE 7.0 (107.0), pp. 991.0-1000.0 |
40 | 0 | 0 | 0 | 0 | 0 | 40 | |
| 64. | Combination of Praziquantel and Aspirin Minimizes Liver Pathology of Hamster Opisthorchis viverrini Infection Associated Cholangiocarcinoma | Pakkayanee Sudsarn Thidarut Boonmars Wipaporn Ruangjirachuporn Nisana Namwat Watcharin Loilome Pranee Sriraj Ratchadawan Aukkanimart Wonkchalee Nadchanan Songsri Jiraporn |
2016 |
PATHOLOGY & ONCOLOGY RESEARCH 1.0 (22.0), pp. 57.0-65.0 |
5 | 0 | 0 | 0 | 0 | 0 | 5 | |
| 65. | Potential of Selenium Compounds as New Anticancer Agents for Cholangiocarcinoma | Xurui Dai Suyanee Thongchot Hasaya Dokduang Watcharin Loilome Narong Khuntikeo Attapol Titapun Piti Ungarreevittaya Puangrat Yongvanit Anchalee Techasen Nisana Namwat |
2016 |
ANTICANCER RESEARCH 11.0 (36.0), pp. 5981.0-5988.0 |
12 | 0 | 0 | 0 | 0 | 0 | 12 | |
| 66. | Xanthohumol inhibits STAT3 activation pathway leading to growth suppression and apoptosis induction in human cholangiocarcinoma cells | Hasaya Dokduang Puangrat Yongvanit Nisana Namwat Chawalit Pairojkul Sakkarn Sangkhamanon Mika Sakurai Yageta Yoshinori Murakami Watcharin Loilome |
2016 |
ONCOLOGY REPORTS 4.0 (35.0), pp. 2065.0-2072.0 |
24 | 0 | 0 | 0 | 0 | 0 | 24 | |
| 67. | Imbalanced adaptive responses associated with microsatellite instability in cholangiocarcinoma | Watcharin Loilome Sasithorn Kadsanit Kanha Muisook Puangrat Yongvanit Nisana Namwat Anchalee Techasen Anucha Puapairoj Narong Khuntikeo Pichai Phonjit |
2017 |
ONCOLOGY LETTERS 2.0 (13.0), pp. 639.0-646.0 |
5 | 0 | 0 | 0 | 0 | 0 | 5 | |
| 68. | Increase in L-type amino acid transporter 1 expression during cholangiocarcinogenesis caused by liver fluke infection and its prognostic significance | Supak Yothaisong Nisana Namwat Puangrat Yongvanit Narong Khuntikeo Anucha Puapairoj Promsuk Jutabha Naohiko Anzai Wichittra Tassaneeyakul Panot Tangsucharit Watcharin Loilome |
2017 |
PARASITOLOGY INTERNATIONAL 4.0 (66.0), pp. 471.0-478.0 |
21 | 0 | 0 | 0 | 0 | 0 | 21 | |
| 69. | Inhibition of L-type amino acid transporter 1 activity as a new therapeutic target for cholangiocarcinoma treatment | Supak Yothaisong Hasaya Dokduang Naohiko Anzai Keitaro Hayashi Nisana Namwat Puangrat Yongvanit Sakkarn Sangkhamanon Promsuk Jutabha Hitoshi Endou Watcharin Loilome |
2017 |
TUMOR BIOLOGY 3.0 (39.0), pp. |
47 | 0 | 0 | 0 | 0 | 0 | 47 | |
| 70. | Nimotuzumab Inhibits Cholangiocarcinoma Cell Metastasis via Suppression of the Epithelial-Mesenchymal Transition Process | Sureerat Padthaisong Malinee Thanee Anchalee Techasen Nisana Namwat Puangrat Yongvanit Aekkaphod Liwatthakun Khittisak Hankla Sakkarn Sangkhamanon Watcharin Loilome |
2017 |
ANTICANCER RESEARCH 7.0 (37.0), pp. 3591.0-3597.0 |
29 | 0 | 0 | 0 | 0 | 0 | 29 | |
| 71. | Opisthorchiasis and cholangiocarcinoma in Southeast Asia: an unresolved problem | Thomas Hughes Thomas O'Connor Anchalee Techasen Nisana Namwat Watcharin Loilome Ross H. Andrews- Narong Khuntikeo Puangrat Yongvanit Paiboon Sithithaworn Simon D. Taylor-Robinson |
2017 |
INTERNATIONAL JOURNAL OF GENERAL MEDICINE (10.0), pp. 227.0-237.0 |
54 | 0 | 0 | 0 | 0 | 0 | 54 | |
| 72. | Protein Kinases as Targets for Opisthorchis viverrini- Associated Cholangiocarcinoma Therapy | Watcharin Loilome Hasaya Dokduang |
2017 |
CURRENT PHARMACEUTICAL DESIGN 29.0 (23.0), pp. 4281.0-4289.0 |
5 | 0 | 0 | 0 | 0 | 0 | 5 | |
| 73. | Teleconsultation ultrasonography: a new weapon to combat cholangiocarcinoma | Nittaya Chamado Vallop Laopaiboon Jiraporn Srinakarin Watcharin Loilome Puangrat Yongvanit Bandit Thinkhamrop Narong Khuntikeo |
2017 |
ESMO OPEN 3.0 (2.0), pp. |
11 | 0 | 0 | 0 | 0 | 0 | 11 | |
| 74. | Upregulation of endothelial nitric oxide synthase (eNOS) and its upstream regulators in Opisthorchis viverrini associated cholangiocarcinoma and its clinical significance | Manida Suksawat Anchalee Techasen Nisana Namwat Puangrat Yongvanit Narong Khuntikeo Attapon Titapun Supinda Koonmee Watcharin Loilome |
2017 |
PARASITOLOGY INTERNATIONAL 4.0 (66.0), pp. 486.0-493.0 |
13 | 0 | 0 | 0 | 0 | 0 | 13 | |
| 75. | Upregulation of TCTP is associated with cholangiocarcinoma progression and metastasis | Nattaporn Phanthaphol Anchalee Techasen Watcharin Loilome Suyanee Thongchot Raynoo Thanan Sakkarn Sungkhamanon Narong Khuntikeo Puangrat Yongvanit Nisana Namwat |
2017 |
ONCOLOGY LETTERS 5.0 (14.0), pp. 5973.0-5979.0 |
15 | 0 | 0 | 0 | 0 | 0 | 15 | |
| 76. | Upregulation of transferrin receptor-I induces cholangiocarcinoma progression via induction of labile iron pool | Wassana Jamnongkan Raynoo Thanan Anchalee Techasen Nisana Namwat Watcharin Loilome Piyapharom Intarawichian Attapol Titapun Puangrat Yongvanit |
2017 |
TUMOR BIOLOGY 7.0 (39.0), pp. |
23 | 0 | 0 | 0 | 0 | 0 | 23 | |
| 77. | Urinary microRNA-192 and microRNA-21 as potential indicators for liver fluke-associated cholangiocarcinoma risk group | Runglawan Silakit Watcharin Loilome Puangrat Yongvanit Suyanee Thongchot Paiboon Sithithaworn Thidarut Boonmars Supinda Koonmee Attapol Titapun Narong Khuntikeo Nittaya Chamadol Anchalee Techasen Nisana Namwat |
2017 |
PARASITOLOGY INTERNATIONAL 4.0 (66.0), pp. 479.0-485.0 |
39 | 0 | 0 | 0 | 0 | 0 | 39 | |
| 78. | Antifibrotic effect of xanthohumol in combination with praziquantel is associated with altered redox status and reduced iron accumulation during liver fluke-associated cholangiocarcinogenesis | Wassana Jamnongkan Malinee Thanee Puangrat Yongvanit Watcharin Loilome Rayno Thanan Phongsaran Kimawaha Tidarat Boonmars Runglawan Silakit Nisana Namwat Anchalee Techasen |
2018 |
PEERJ (6.0), pp. |
12 | 0 | 0 | 0 | 0 | 0 | 12 | |
| 79. | CD44 variant-dependent redox status regulation in cholangiocarcinoma: A target for cholangiocarcinoma treatment | Malinee Thanee Watcharin Loilome Anchalee Techasen Nisana Namwat Attapon Titapun Narong Khuntikeo Shogo Okazaki Eiji Sugihara Hideyuki Saya Puangrat Yongvanit |
2018 |
CANCER SCIENCE (109.0), pp. 37.0-37.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 80. | Cellular senescence and inhibitory effects of PRIMA-1MET in cholangiocarcinoma | Chayanit Piyawajanusorn Watcharin Loilome Yingpinyapat Kittirat Suyanee Thongchot Nisana Namwat |
2018 |
CANCER SCIENCE (109.0), pp. 1382.0-1382.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 81. | Current Perspectives on Opisthorchiasis Control and Cholangiocarcinoma Detection in Southeast Asia | Narong Khuntikeo Attapol Titapun Watcharin Loilome Puangrat Yongvanit Bandit Thinkhamrop Nittaya Chamadol Thidarat Boonmars Teerachai Nethanomsak Ross H. Andrews Trevor N. Petney Paiboon Sithithaworn |
2018 |
FRONTIERS IN MEDICINE (5.0), pp. |
28 | 0 | 0 | 0 | 0 | 0 | 28 | |
| 82. | Diagnostic performance of urinary IgG antibody detection: A novel approach for population screening of strongyloidiasis | Chatanun Eamudomkarn Paiboon Sithithaworn Christine Kamamia Anna Yakovleva Jiraporn Sithithaworn Sasithorn Kaewkes Anchalee Techasen Watcharin Loilome Puangrat Yongvanit Chompunoot Wangboon Prasert Saichua Makoto Itoh Jeffrey M. Bethony |
2018 |
PLOS ONE 7.0 (13.0), pp. |
13 | 0 | 0 | 0 | 0 | 0 | 13 | |
| 83. | Dihydroartemisinin induces apoptosis and autophagy-dependent cell death in cholangiocarcinoma through a DAPK1-BECLIN1 pathway | Suyanee Thongchot Chiara Vidoni Alessandra Ferraresi Watcharin Loilome Puangrat Yongvanit Nisana Namwat Ciro Isidoro |
2018 |
MOLECULAR CARCINOGENESIS 12.0 (57.0), pp. 1735.0-1750.0 |
46 | 0 | 0 | 0 | 0 | 0 | 46 | |
| 84. | Effect of xanthohumol in combination with praziquantel on oxidative stress-induced cholangiocarcinogenesis | Anchalee Techasen Wassana Jamnongkan Malinee Thanee Puangrat Yongvanit Watcharin Loilome Raynoo Thanan Phongsaran Kimawaha Tidarat Boonmars Runglawan Silakit Nisana Namwat |
2018 |
CANCER SCIENCE (109.0), pp. 721.0-721.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 85. | Elevated Levels of Urinary 8-oxodG Correlate with Persistent Periductal Fibrosis after Praziquantel Treatment in Chronic Opisthorchiasis | Chompunoot Wangboon Puangrat Yongvanit Watcharin Loilome Raynoo Thanan Chanika Worasith Chatanun Eamudomkarn Nittaya Chamadol Eimorn Mairiang Jiraporn Sithithaworn Prasert Saichua Banchob Sripa Narong Khuntikeo Jeffrey M. Bethony Paiboon Sithithaworn |
2018 |
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE 6.0 (98.0), pp. 1763.0-1769.0 |
10 | 0 | 0 | 0 | 0 | 0 | 10 | |
| 86. | Increasing of 5-lipoxygenase expression associated with cholangiocarcinoma development | Sasikamon Korphai Anchalee Techasen Nisana Namwat Watcharin Loilome |
2018 |
CANCER SCIENCE (109.0), pp. 194.0-194.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 87. | Inhibition of endothelial nitric oxide synthase in cholangiocarcinoma cell lines - a new strategy for therapy | Manida Suksawat Anchalee Techasen Nisana Namwat Thianrut Boonsong Attapol Titapun Piti Ungarreevittaya Puangrat Yongvanit Watcharin Loilome |
2018 |
FEBS OPEN BIO 4.0 (8.0), pp. 513.0-522.0 |
7 | 0 | 0 | 0 | 0 | 0 | 7 | |
| 88. | Inhibitory effect of EGFR/HER2 inhibitor, varlitinib on cholangiocarcinoma cell growth | Hasaya Dokduang Manida Suksawat Sureerat Padthaisong Wassana Jamnongkarn Malinee Thanee Anchalee Techasen Nisana Namwat Narong Khuntikeao Watcharin Loilome |
2018 |
CANCER SCIENCE (109.0), pp. 746.0-746.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 89. | Inhibitory effect of NVP-BKM120 on cholangiocarcinoma cell growth | Sureerat Padthaisong Hasaya Dokduang Supak Yothaisong Anchalee Techasen Nisana Namwat Puangrat Yongvanit Narong Khuntikeo Attapol Titapun Sakkarn Sangkhamanon Watcharin Loilome |
2018 |
ONCOLOGY LETTERS 2.0 (16.0), pp. 1627.0-1633.0 |
14 | 0 | 0 | 0 | 0 | 0 | 14 | |
| 90. | Oxidative stress down-regulates Early B cell factor 1 resulting in cholangiocarcinoma genesis | Napat Armartmuntree Mariko Murata Anchalee Techasen Watcharin Loilome Nisana Namwat Chawalit Pairojkul Chadamas Sakonsinsiri Somchai Pinlaor Raynoo Thanan |
2018 |
CANCER SCIENCE (109.0), pp. 1286.0-1286.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 91. | Pan-class I PI3K inhibitor inhibits cholangiocarcinoma cell growth | Sureerat Padthaisong Hasaya Dokduang Supak Yothaisong Anchalee Techasen Nisana Namwat Puangrat Yongvanit Narong Khuntikeo Attapon Titapun Sakkarn Sangkhamanon Watcharin Loilome |
2018 |
CANCER SCIENCE (109.0), pp. 745.0-745.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 92. | Potential role of HIF-1-responsive microRNA210/HIF3 axis on gemcitabine resistance in cholangiocarcinoma cells | Runglawan Silakit Yingpinyapat Kitirat Suyanee Thongchot Watcharin Loilome Anchalee Techasen Piti Ungarreevittaya Narong Khuntikeo Puangrat Yongvanit Ji Hye Yang Nam Hee Kim Jong In Yook Nisana Namwat |
2018 |
PLOS ONE 6.0 (13.0), pp. |
18 | 0 | 0 | 0 | 0 | 0 | 18 | |
| 93. | Progranulin modulates cholangiocarcinoma cell proliferation, apoptosis, and motility via the PI3K/pAkt pathway | Minerva Daya Watcharin Loilome Anchalee Techasen Malinee Thanee Prakasit Sa-Ngiamwibool Attapol Titapun Puangrat Yongvanit Nisana Namwat |
2018 |
ONCOTARGETS AND THERAPY (11.0), pp. 395.0-408.0 |
18 | 0 | 0 | 0 | 0 | 0 | 18 | |
| 94. | Prolonged oxidative stress down-regulates Early B cell factor 1 with inhibition of its tumor suppressive function against cholangiocarcinoma genesis | Napat Armartmuntree Mariko Murata Anchalee Techasen Puangrat Yongvanit Watcharin Loilome Nisana Namwat Chawalit Pairojkul Chadamas Sakonsinsiri Somchai Pinlaor Raynoo Thanan |
2018 |
REDOX BIOLOGY (14.0), pp. 637.0-644.0 |
115 | 0 | 0 | 0 | 0 | 0 | 115 | |
| 95. | Resveratrol interrupts the pro-invasive communication between cancer associated fibroblasts and cholangiocarcinoma cells | Suyanee Thongchot Alessandra Ferraresi Chiara Vidoni Watcharin Loilome Puangrat Yongvanit Nisana Namwat Ciro Isidoro |
2018 |
CANCER LETTERS (430.0), pp. 160.0-171.0 |
51 | 0 | 0 | 0 | 0 | 0 | 51 | |
| 96. | Resveratrol interrupts the pro -invasive communication between Cancer associated Fibroblasts and Cholangiocarcinoma cells (vol 430C, pg 160, 2018) | Suyanee Thongchot Alessandra Ferraresi Chiara Vidoni Watcharin Loilome Puangrat Yongvanit Nisana Namwat Ciro Isidoro |
2018 |
CANCER LETTERS (434.0), pp. 206.0-207.0 |
7 | 0 | 0 | 0 | 0 | 0 | 7 | |
| 97. | Suppression of 14-3-3 zeta in cholangiocarcinoma cells inhibits proliferation through attenuated Akt activity, enhancing chemosensitivity to gemcitabine | Yingpinyapat Kittirat Anchalee Techasen Suyanee Thongchot Watcharin Loilome Raynoo Thanan Puangrat Yongvanit Sakkarn Sungkhamanon Attapol Titapun Narong Khuntikeo Nisana Namwat |
2018 |
ONCOLOGY LETTERS 1.0 (15.0), pp. 347.0-353.0 |
9 | 0 | 0 | 0 | 0 | 0 | 9 | |
| 98. | TGF- beta 1: A Potential EMT-Biomarker for prediction of cholangiocarcinoma | Phongsaran Kimawaha Apinya Jusakul Puangrat Yongvanit Watcharin Loilome Nisana Namwat Narong Khuntikeo Anchalee Techasen |
2018 |
CANCER SCIENCE (109.0), pp. 956.0-956.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 99. | The Socioeconomic Burden of Cholangiocarcinoma Associated With Opisthorchis viverrini Sensu Lato Infection in Northeast Thailand: A Preliminary Analysis | Narong Khuntikeo Bandit Thinkhamrop Kanitta Bundhamcharoen Ross H. Andrews Carl Grundy-Warr Puangrat Yongvanit Watcharin Loilome Nittaya Chamadol Weerachai Kosuwan Paiboon Sithithaworn Trevor N. Petney |
2018 |
ASIATIC LIVER FLUKE - FROM BASIC SCIENCE TO PUBLIC HEALTH, PT B (102.0), pp. 141.0-+ |
7 | 0 | 0 | 0 | 0 | 0 | 7 | |
| 100. | Zileuton suppresses cholangiocarcinoma cell proliferation and migration through inhibition of the Akt signaling pathway | Sasikamon Khophai Malinee Thanee Anchalee Techasen Nisana Namwat Poramate Klanrit Attapol Titapun Apiwat Jarearnrat Prakasit Sa-Ngiamwibool Watcharin Loilome |
2018 |
ONCOTARGETS AND THERAPY (11.0), pp. 7019.0-7029.0 |
9 | 0 | 0 | 0 | 0 | 0 | 9 | |
| 101. | Characterisation of the Urinary Metabolic Profile of Liver Fluke-Associated Cholangiocarcinoma | Munirah Alsaleh Paiboon Sithithaworn Narong Khuntikeo Watcharin Loilome Puangrat Yongvanit Nittaya Chamadol Thomas Hughes Thomas O'Connor Ross H. Andrews Elaine Holmes Simon D. Taylor-Robinson |
2019 |
JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY 6.0 (9.0), pp. 657.0-675.0 |
8 | 0 | 0 | 0 | 0 | 0 | 8 | |
| 102. | Cholangiocarcinoma: a guide for the nonspecialist | Munirah Alsaleh Zoe Leftley Thomas A. Barbera Paiboon Sithithaworn Narong Khuntikeo Watcharin Loilome Puangrat Yongvanit I. Jane Cox Nittaya Chamodol Richard R. A. Syms Ross H. Andrews Simon D. Taylor-Robinson |
2019 |
INTERNATIONAL JOURNAL OF GENERAL MEDICINE (12.0), pp. 13.0-23.0 |
36 | 0 | 0 | 0 | 0 | 0 | 36 | |
| 103. | Comparing the performance of urine and copro-antigen detection in evaluating Opisthorchis viverrini infection in communities with different transmission levels in Northeast Thailand | Chanika Worasith Chompunoot Wangboon Kunyarat Duenngai Nadda Kiatsopit Kulthida Kopolrat Anchalee Techasen Jiraporn Sithithaworn Narong Khuntikeo Watcharin Loilome Nisana Namwat Puangrat Yongvanit Elizabeth J. Carlton Paiboon Sithithaworn |
2019 |
PLOS NEGLECTED TROPICAL DISEASES 2.0 (13.0), pp. |
7 | 0 | 0 | 0 | 0 | 0 | 7 | |
| 104. | Discovery and Qualification of Serum Protein Biomarker Candidates for Cholangiocarcinoma Diagnosis | Kassaporn Duangkumpha Thomas Stoll Jutarop Phetcharaburanin Puangrat Yongvanit Raynoo Thanan Anchalee Techasen Nisana Namwat Narong Khuntikeo Nittaya Chamadol Sittiruk Roytrakul Jason Mulvenna Ahmed Mohamed Alok K. Shah Michelle M. Hill Watcharin Loilome |
2019 |
JOURNAL OF PROTEOME RESEARCH 9.0 (18.0), pp. 3305.0-3316.0 |
12 | 0 | 0 | 0 | 0 | 0 | 12 | |
| 105. | Discovery of Serotransferrin Glycoforms: Novel Markers for Diagnosis of Liver Periductal Fibrosis and Prediction of Cholangiocarcinoma | Wassana Jamnongkan Carlito B. Lebrilla Mariana Barboza Anchalee Techasen Watcharin Loilome Paiboon Sithithaworn Narong Khuntikeo Chawalit Pairojkul Nittaya Chamadol Raynoo Thanan Puangrat Yongvanit |
2019 |
BIOMOLECULES 10.0 (9.0), pp. |
9 | 0 | 0 | 0 | 0 | 0 | 9 | |
| 106. | Evaluation of anticancer potential of Thai medicinal herb extracts against cholangiocarcinoma cell lines | Bundit Promraksa Jutarop Phetcharaburanin Nisana Namwat Anchalee Techasen Patcharee Boonsiri Watcharin Loilome |
2019 |
PLOS ONE 5.0 (14.0), pp. |
7 | 0 | 0 | 0 | 0 | 0 | 7 | |
| 107. | Evaluation of a short term effect of praziquantel treatment in opisthorchiasis-induced hepatobiliary inflammation by urinary 8-oxodG | Chompunoot Wangboon Chanika Worasith Raynoo Thanan Chatanun Eamudomkarn Anchalee Techasen Jiraporn Sithithaworn Watcharin Loilome Nittaya Chamadol Somchai Pinlaor Amonrat Jumnainsong Puangrat Yongvanit Narong Khuntikeo Jeffrey M. Bethony Paiboon Sithithaworn |
2019 |
ACTA TROPICA (189.0), pp. 124.0-128.0 |
4 | 0 | 0 | 0 | 0 | 0 | 4 | |
| 108. | In vitro and molecular chemosensitivity in human cholangiocarcinoma tissues | Manida Suksawat Poramate Klanrit Jutarop Phetcharaburanin Nisana Namwat Narong Khuntikeo Attapol Titapun Apiwat Jarearnrat Prakasit Sa-ngiamwibool Anchalee Techasen Watcharin Loilome |
2019 |
PLOS ONE 9.0 (14.0), pp. |
5 | 0 | 0 | 0 | 0 | 0 | 5 | |
| 109. | Mass Spectrometry: A Guide for the Clinician | Munirah Alsaleh Thomas A. Barbera Ross H. Andrews Paiboon Sithithaworn Narong Khuntikeo Watcharin Loilome Puangrat Yongvanit Isobel J. Cox Richard R. A. Syms Elaine Holmes Simon D. Taylor-Robinson |
2019 |
JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY 5.0 (9.0), pp. 597.0-606.0 |
7 | 0 | 0 | 0 | 0 | 0 | 7 | |
| 110. | PRIMA-1(MET) Induces Cellular Senescence and Apoptotic Cell Death in Cholangiocarcinoma Cells | Chayanit Piyawajanusorn Yingpinyapat Kittirat Prakasit Sa-Ngiamwibool Attapol Titapun Watcharin Loilome Nisana Namwat |
2019 |
CANCER GENOMICS & PROTEOMICS 6.0 (16.0), pp. 543.0-552.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 111. | Urine proteomics study reveals potential biomarkers for the differential diagnosis of cholangiocarcinoma and periductal fibrosis | Kassaporn Duangkumpha Thomas Stoll Jutarop Phetcharaburanin Puangrat Yongvanit Raynoo Thanan Anchalee Techasen Nisana Namwat Narong Khuntikeo Nittaya Chamadol Sittiruk Roytrakul Jason Mulvenna Ahmed Mohamed Alok K. Shah Michelle M. Hill Watcharin Loilome |
2019 |
PLOS ONE 8.0 (14.0), pp. |
16 | 0 | 0 | 0 | 0 | 0 | 16 | |
| 112. | A comparison of the proportion of early stage cholangiocarcinoma found in an ultrasound-screening program compared to walk-in patients | Narong Khuntikeo Supinda Koonmee Prakasit Sa-Ngiamwibool Nittaya Chamadol Vallop Laopaiboon Attapol Titapun Puangrat Yongvanit Watcharin Loilome Nisana Namwat Ross H. Andrews Trevor N. Petney Kavin Thinkhamrop Nathaphop Chaichaya Chaiwat Tawarungruang Jaruwan Thuanman Bandit Thinkhamrop |
2020 |
HPB 6.0 (22.0), pp. 874.0-883.0 |
1 | 0 | 0 | 0 | 0 | 0 | 1 | |
| 113. | A panel of protein kinase high expression is associated with postoperative recurrence in cholangiocarcinoma | Sureerat Padthaisong Malinee Thanee Nisana Namwat Jutarop Phetcharaburanin Poramate Klanrit Narong Khuntikeo Attapol Titapun Watcharin Loilome |
2020 |
BMC CANCER 1.0 (20.0), pp. |
4 | 0 | 0 | 0 | 0 | 0 | 4 | |
| 114. | ARID1A alterations and their clinical significance in cholangiocarcinoma | Achira Namjan Anchalee Techasen Watcharin Loilome Prakasit Sa-ngairnwibool Apinya Jusakul |
2020 |
PEERJ (8.0), pp. |
1 | 0 | 0 | 0 | 0 | 0 | 1 | |
| 115. | AuNPs-LISA, an efficient detection assay for Opisthorchis viverrini (Ov) antigen in urine | Wichit Taron Wassana Jamnongkan Anchalee Techasen Jutarop Phetcharaburanin Nisana Namwat Paiboon Sithithaworn Narong Khuntikeo Siriboon Mukdasai Somphou Sayasone Watcharin Loilome Wittaya Ngeontae |
2020 |
TALANTA (209.0), pp. |
5 | 0 | 0 | 0 | 0 | 0 | 5 | |
| 116. | Characterisation of the Serum Metabolic Signature of Cholangiocarcinoma in a United Kingdom Cohort | Munirah Alsaleh Zoe Leftley Thomas A. Barbera Larry K. Koomson Abigail Zabron Mary M. E. Crossey Helen L. Reeves Matthew Cramp Stephen Ryder Shaun Greer Martin Prince Paiboon Sithithaworn Mohamed Shariff Narong Khuntikeo Watcharin Loilome Puangrat Yongvanit Yi-Liang Shen I. Jane Cox Roger Williams Christopher A. Wadsworth Elaine Holmes Kathryn Nash Simon D. Taylor-Robinson |
2020 |
JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY 1.0 (10.0), pp. 17.0-29.0 |
4 | 0 | 0 | 0 | 0 | 0 | 4 | |
| 117. | Circulating TGF-beta 1 as the potential epithelial mesenchymal transition-biomarker for diagnosis of cholangiocarcinoma | Phongsaran Kimawaha Apinya Jusakul Prem Junsawang Watcharin Loilome Narong Khuntikeo Anchalee Techasen |
2020 |
JOURNAL OF GASTROINTESTINAL ONCOLOGY 2.0 (11.0), pp. 304.0-318.0 |
3 | 0 | 0 | 0 | 0 | 0 | 3 | |
| 118. | Curative effect of xanthohumol supplementation during liver fluke-associated cholangiocarcinogenesis: Potential involvement of autophagy | Suyanee Thongchot Malinee Thanee Watcharin Loilome Anchalee Techasen Thidarat Boonmars Prakasit Sa-Ngiamwibool Attapol Titapun Puangrat Yongvanit Ciro Isidoro Nisana Namwat |
2020 |
JOURNAL OF TRADITIONAL AND COMPLEMENTARY MEDICINE 3.0 (10.0), pp. 230.0-235.0 |
3 | 0 | 0 | 0 | 0 | 0 | 3 | |
| 119. | H-1 NMR metabolic phenotyping of Dipterocarpus alatus as a novel tool for age and growth determination | Jutarop Phetcharaburanin Suthicha Deewai Thanaporn Kulthawatsiri Komkid Moolpia Manida Suksawat Bundit Promraksa Poramate Klanrit Nisana Namwat Watcharin Loilome Kitisak Poopasit Somporn Katekaew Penprapa Phetcharaburanin |
2020 |
PLOS ONE 12.0 (15.0), pp. |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 120. | In vitro and in vivo Anti-Tumor Effects of Pan-HER Inhibitor Varlitinib on Cholangiocarcinoma Cell Lines | Hasaya Dokduang Wassana Jamnongkarn Bundit Promraksa Manida Suksawat Sureerat Padthaisong Malinee Thanee Jutarop Phetcharaburanin Nisana Namwat Sakkarn Sangkhamanon Attapol Titapun Narong Khuntikeo Poramate Klanrit Watcharin Loilome |
2020 |
DRUG DESIGN DEVELOPMENT AND THERAPY (14.0), pp. 2319.0-2334.0 |
2 | 0 | 0 | 0 | 0 | 0 | 2 | |
| 121. | LIVER FLUKE-INFECTED CYPRINOID FISH IN NORTHEASTERN THAILAND (2016-2017) | Benjamabhorn Pumhirunroj Ratchadawan Aukkanimart Thidarut Boonmars Pranee Sriraj Parichart Boueroy Atchara Artchayasawat Jiraporn Songsri Panupan Sripan Kanpicha Chomphumee Panaratana Ratanasuwan Porntip Laummaunwai Sukhonthip Khueangchaingkhwang Apiporn Suwanatri Surasit Aunpromma Chatanun Eamudomkarn Narong Khuntikeo Watcharin Loilome Nisana Namwat Puangrat Yongvanit |
2020 |
SOUTHEAST ASIAN JOURNAL OF TROPICAL MEDICINE AND PUBLIC HEALTH 1.0 (51.0), pp. 1.0-7.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 122. | Overexpression of a panel of cancer stem cell markers enhances the predictive capability of the progression and recurrence in the early stage cholangiocarcinoma | Sureerat Padthaisong Malinee Thanee Nisana Namwat Jutarop Phetcharaburanin Poramate Klanrit Narong Khuntikeo Attapol Titapun Sakkarn Sungkhamanon Hideyuki Saya Watcharin Loilome |
2020 |
JOURNAL OF TRANSLATIONAL MEDICINE 1.0 (18.0), pp. |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 123. | Synchrotron FTIR microspectroscopy revealed apoptosis-induced biomolecular changes of cholangiocarcinoma cells treated with ursolic acid | Pornpattra Maphanao Raynoo Thanan Watcharin Loilome Sirinart Chio-Srichan Molin Wongwattanakul Chadamas Sakonsinsiri |
2020 |
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS 12.0 (1864.0), pp. |
1 | 0 | 0 | 0 | 0 | 0 | 1 | |
| 124. | A fluorescence AuNPs-LISA: A new approach for Opisthorchis viverrini (Ov) antigen detection with a simple fluorescent enhancement strategy by surfactant micelle in urine samples | Wichit Taron Wassana Jamnongkan Jutarop Phetcharaburanin Poramate Klanrit Nisana Namwat Anchalee Techasen Paiboon Sithithaworn Narong Khuntikeo Thidarut Boonmars Watcharin Loilome Wittaya Ngeontae |
2021 |
SPECTROCHIMICA ACTA PART A-MOLECULAR AND BIOMOLECULAR SPECTROSCOPY (254.0), pp. |
2 | 0 | 0 | 0 | 0 | 0 | 2 | |
| 125. | Arctigenin inhibits cholangiocarcinoma progression by regulating cell migration and cell viability via the N-cadherin and apoptosis pathway | Sutthiwan Janthamala Apinya Jusakul Sarinya Kongpetch Phongsaran Kimawaha Poramate Klanrit Watcharin Loilome Nisana Namwat Anchalee Techasen |
2021 |
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY 10.0 (394.0), pp. 2049.0-2059.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 126. | Bacterial challenge-associated metabolic phenotypes in Hermetia illucens defining nutritional and functional benefits | Phuc N. Ho Poramate Klanrit Yupa Hanboonsong Umaporn Yordpratum Manida Suksawat Thanaporn Kulthawatsiri Anyarin Jirahiranpat Suthicha Deewai Panya Mackawan Rasana W. Sermswan Nisana Namwat Watcharin Loilome Tueanjit Khampitak Arporn Wangwiwatsin Jutarop Phetcharaburanin |
2021 |
SCIENTIFIC REPORTS 1.0 (11.0), pp. |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 127. | Cancer-Associated Fibroblast-Derived IL-6 Determines Unfavorable Prognosis in Cholangiocarcinoma by Affecting Autophagy-Associated Chemoresponse | Suyanee Thongchot Chiara Vidoni Alessandra Ferraresi Watcharin Loilome Narong Khuntikeo Sakkarn Sangkhamanon Attapol Titapun Ciro Isidoro Nisana Namwat |
2021 |
CANCERS 9.0 (13.0), pp. |
4 | 0 | 0 | 0 | 0 | 0 | 4 | |
| 128. | CD44 modulates metabolic pathways and altered ROS-mediated Akt signal promoting cholangiocarcinoma progression | Malinee Thanee Hasaya Dokduang Yingpinyapat Kittirat Jutarop Phetcharaburanin Poramate Klanrit Attapol Titapun Nisana Namwat Narong Khuntikeo Arporn Wangwiwatsin Hideyuki Saya Watcharin Loilome |
2021 |
PLOS ONE 3.0 (16.0), pp. |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 129. | Diagnostic and Prognostic Value of Circulating Cell-Free DNA for Cholangiocarcinoma | Preawwalee Wintachai Jing Quan Lim Anchalee Techasen Worachart Lert-Itthiporn Sarinya Kongpetch Watcharin Loilome Jarin Chindaprasirt Attapol Titapun Nisana Namwat Narong Khuntikeo Apinya Jusakul |
2021 |
DIAGNOSTICS 6.0 (11.0), pp. |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 130. | High Levels of Serum IgG for Opisthorchis viverrini and CD44 Expression Predict Worse Prognosis for Cholangiocarcinoma Patients after Curative Resection | Attapol Titapun Vor Luvira Tharatip Srisuk Apiwat Jareanrat Vasin Thanasukarn Malinee Thanee Prakasit Sa-Ngiamwibool Sureerat Padthaisong Kassaporn Duangkumpha Manida Suksawat Watcharin Loilome Paiboon Sithithaworn Anchalee Techasen Bandit Thinkhamrop Alexa Dzienny Ayse Caglayan David Park Simran Mahmud Narong Khuntikeo |
2021 |
INTERNATIONAL JOURNAL OF GENERAL MEDICINE (14.0), pp. 2191.0-2204.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 131. | Integration of global metabolomics and lipidomics approaches reveals the molecular mechanisms and the potential biomarkers for postoperative recurrence in early-stage cholangiocarcinoma | Sureerat Padthaisong Jutarop Phetcharaburanin Poramate Klanrit Jia Li Nisana Namwat Narong Khuntikeo Attapol Titapun Apiwat Jarearnrat Arporn Wangwiwatsin Panupong Mahalapbutr Watcharin Loilome |
2021 |
CANCER & METABOLISM 1.0 (9.0), pp. |
1 | 0 | 0 | 0 | 0 | 0 | 1 | |
| 132. | Lipidomic Analyses Uncover Apoptotic and Inhibitory Effects of Pyrvinium Pamoate on Cholangiocarcinoma Cells via Mitochondrial Membrane Potential Dysfunction | Yingpinyapat Kittirat Jutarop Phetcharaburanin Bundit Promraksa Thanaporn Kulthawatsiri Arporn Wangwiwatsin Poramate Klanrit Sakkarn Sangkhamanon Apiwat Jarearnrat Suyanee Thongchot Panupong Mahalapbutr Watcharin Loilome Hideyuki Saya Nisana Namwat |
2021 |
FRONTIERS IN PUBLIC HEALTH (9.0), pp. |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 133. | Mapping of population disparities in the cholangiocarcinoma urinary metabolome | Munirah Alsaleh Zoe Leftley Thomas O'Connor Thomas Hughes Thomas A. Barbera Larry K. Koomson Abigail Zabron Helen Reeves Matthew Cramp Stephen D. Ryder Shaun Greer Martin Prince Paiboon Sithithaworn Narong Khuntikeo Watcharin Loilome Puangrat Yongvanit I. Jane Cox Roger Williams Christopher A. Wadsworth Elaine Holmes Kathryn Nash Ross Andrews Simon D. Taylor-Robinson |
2021 |
SCIENTIFIC REPORTS 1.0 (11.0), pp. |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 134. | Metabolic Changes of Cholangiocarcinoma Cells in Response to Coniferyl Alcohol Treatment | Bundit Promraksa Praewpan Katrun Jutarop Phetcharaburanin Yingpinyapat Kittirat Nisana Namwat Anchalee Techasen Jia V. Li Watcharin Loilome |
2021 |
BIOMOLECULES 3.0 (11.0), pp. |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 135. | Metabolic Profiling of Praziquantel-mediated Prevention of Opisthorchis viverrini-induced Cholangiocyte Transformation in the Hamster Model of Cholangiocarcinoma | Pattama Prommajun Jutarop Phetcharaburanin Nisana Namwat Poramate Klanrit Prakasit Sa-Ngiamwibool Malinee Thanee Hasaya Dokduang Yingpinyapat Kittirat Jia Li Watcharin Loilome |
2021 |
CANCER GENOMICS & PROTEOMICS 1.0 (18.0), pp. 29.0-42.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 136. | Promoter hypermethylation of early B cell factor 1 (EBF1) is associated with cholangiocarcinoma progression | Napat Armartmuntree Apinya Jusakul Chadamas Sakonsinsiri Watcharin Loilome Somchai Pinlaor Piti Ungarreevittaya Chern Han Yong Anchalee Techasen Kanokwan Imtawil Ratthaphol Kraiklang Nattawan Suwannakul Waleeporn Kaewlert Timpika Chaiprasert Raynoo Thanan Mariko Murata |
2021 |
JOURNAL OF CANCER 9.0 (12.0), pp. 2673.0-2686.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 137. | Smartphone-based fluorescent ELISA with simple fluorescent enhancement strategy for Opisthorchis viverrini (Ov) antigen detection in urine samples | Wichit Taron Kittirat Phooplub Sasina Sanchimplee Kanitpong Piyanamvanich Wassana Jamnongkan Anchalee Techasen Jutarop Phetcharaburanin Poramate Klanrit Nisana Namwat Narong Khuntikeo Thidarut Boonmars Paiboon Sithithaworn Sirirat Ouiganon Proespichaya Kanatharana Panote Thavarungkul Chittanon Buranachai Watcharin Loilome Wittaya Ngeontae |
2021 |
SENSORS AND ACTUATORS B-CHEMICAL (348.0), pp. |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 138. | Sulfasalazine modifies metabolic profiles and enhances cisplatin chemosensitivity on cholangiocarcinoma cells in in vitro and in vivo models | Malinee Thanee Sureerat Padthaisong Manida Suksawat Hasaya Dokduang Jutarop Phetcharaburanin Poramate Klanrit Attapol Titapun Nisana Namwat Arporn Wangwiwatsin Prakasit Sa-ngiamwibool Narong Khuntikeo Hideyuki Saya Watcharin Loilome |
2021 |
CANCER & METABOLISM 1.0 (9.0), pp. |
2 | 0 | 0 | 0 | 0 | 0 | 2 | |
| 139. | Targeting Fatty Acid Synthase Modulates Metabolic Pathways and Inhibits Cholangiocarcinoma Cell Progression | Jittima Tomacha Hasaya Dokduang Sureerat Padthaisong Nisana Namwat Poramate Klanrit Jutarop Phetcharaburanin Arporn Wangwiwatsin Tueanjit Khampitak Supinda Koonmee Attapol Titapun Apiwat Jarearnrat Narong Khuntikeo Watcharin Loilome |
2021 |
FRONTIERS IN PHARMACOLOGY (12.0), pp. |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| 140. | Therapeutic challenges at the preclinical level for targeted drug development for Opisthorchis viverrini-associated cholangiocarcinoma | Watcharin Loilome Hasaya Dokduang Manida Suksawat Sureerat Padthaisong |
2021 |
EXPERT OPINION ON INVESTIGATIONAL DRUGS 9.0 (30.0), pp. 985.0-1006.0 |
0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Title | Authors | Year | Journal title | ||
|---|---|---|---|---|---|
| 1. | Expression and Function of Candidate Genes Involved in Cholangiocarcinama | Watcharin Loilome Puangrat Yongvanit |
2005 |
Srinagarind Medical Journal (20 No 3), pp. 159-163 |
|
| 2. | Comparison of Italic cytoxicity of generic paclitaxel and irinotecan formulations with their reference formulations on seven human intrahepatic cholangiocarcinoma cell lines | Nisana Namwat Banchob Sripa Watcharin Loilome Vajarabhongsa Bhudisawadi Wichittra Tassaneeyakul |
2007 |
Srinagarind Medical Journal (22 No 3), pp. 230-234 |
|
| 3. | Determination of Growth Inhibitory Effect of Gemcitabine on Human Intrahepatic Cholangiocarcinoma Cell lines and Comparison of its Inhibition Between the Generic and Reference Formulation | Hasaya Dokduang Nisana Namwat Apinya Jusakul Vajarabhongsa Bhudisawadi Watcharin Loilome Puangrat Yongvanit Banchob Sripa Wichittra Tassaneeyakul |
2010 |
Srinagarind Medical Journal (25 No 1), pp. 2-5 |
|
| 4. | Adverse Effects Caused by Adaptive Imbalance to Genotoxic Stress after Infection and Inflammation | Sasithorn Kadsanit Chadamas Pinitsoontorn Watcharin Loilome Puangrat Yongvanit |
2011 |
Srinagarind Medical Journal (26 No 2), pp. 127-135 |
|
| 5. | PI3K/Akt Signaling Pathway in Normal and Malignant Cells | Supak Yothaisong Watcharin Loilome |
2012 |
Srinagarind Medical Journal (27 No 1), pp. 66-76 |
|
| 6. | Tumor Microenvironment and its Functions | Malinee Thanee Puangrat Yongvanit Watcharin Loilome |
2012 |
Srinagarind Medical Journal (27 No 4), pp. 424-432 |
|
| 7. | Molecular Carcinogenesis of Cholangiocarcinoma II: Associated Genes in the Genesis of Cholangiocarcinoma | Nisana Namwat Watcharin Loilome Puangrat Yongvanit Thailand Khon Kaen University |
2012 |
Srinagarind Medical Journal (27), pp. 364-370 |
|
| 8. | Inhibitory Effects of Xanthohumol on STAT3 Activation and Cancer Development in Cholangiocarcinoma Xenograft Model | Hasaya Dokduang Watcharin Loilome Nisana Namwat Anchalee Techasen Chawalit Pairojkul Narong Khuntikeo Yoshinori Murakami Puangrat Yongvanit |
2013 |
Srinagarind Medical Journal (28 No 4), pp. 195 |
|
| 9. | Expression of 14-3-3 Sigma Protein in Cholangiocarcinoma Progression | Yingpinyapat Kittirat Suyanee Thongchot Watcharin Loilome Anchalee Techasen Puangrat Yongvanit Nisana Namwat |
2014 |
Srinagarind Medical Journal (29 No 4), pp. 133-135 |
|
| 10. | Expression Patterns of Selenoprotein P in Human Cholangiocarcinoma | Xurui Dai Suyanee Thongchot Watcharin Loilome Anchalee Techasen Puangrat Yongvanit Nisana Namwat |
2014 |
Srinagarind Medical Journal (29 No 4), pp. 138-140 |
|
| 11. | Gene Silencing of Translationally Controlled Tumor Protein (TCTP) | Nattaporn Phanthaphol Watcharin Loilome Anchalee Techasen Puangrat Yongvanit Nisana Namwat |
2014 |
Srinagarind Medical Journal (29 No 4), pp. 136-137 |
| ชื่อโครงการ | Authors | ประเภทโครงการ | ปีงบประมาณ | ทุนวิจับ | ||
|---|---|---|---|---|---|---|
| 1. | ตัวตรวจชีวภาพในการคัดกรองกลุ่มเสี่ยงต่อโรคมะเร็งท่อน้ำดีที่สัมพันธ์กับการติดเชื้อพยาธิใบไม้ตับ |
รศ.ดร. นิษณา นามวาท ศ.ดร.สพญ. ธิดารัตน์ บุญมาศ ศ.ดร. พวงรัตน์ ยงวณิชย์ ศ.ดร. สมชาย ปิ่นละออ รศ.ดร. วัชรินทร์ ลอยลม |
ชุดโครงการวิจัย | 2557 | ทุนงบประมาณแผ่นดินประจำปี 2557 | |
| 2. | แบบแผนเปบทีโดมิกส์ในปัสสาวะของผู้ที่มีภาวะ advanced periductal fibrosis ในแหล่งระบาดของโรคพยาธิใบไม้ตับเพื่อใช้เป็นตัวตรวจชีวภาพในคัดกรองกลุ่มเสี่ยง |
รศ.ดร. วัชรินทร์ ลอยลม อ.ดร. อัญชลี เตชะเสน ดร. สิทธิรักษ์ รอยตระกูล รศ.ดร.นพ. ณรงค์ ขันตีแก้ว รศ.ดร. นิษณา นามวาท ศ.ดร. ไพบูลย์ สิทธิถาวร ศ.ดร. พวงรัตน์ ยงวณิชย์ |
โครงการย่อย ภายใต้ชุดโครงการวิจัย | 2557 | ทุนงบประมาณแผ่นดินประจำปี 2557 | |
| 3. | แบบแผนโปรทิโอมิกส์ในซีรัมของผู้ที่มีภาวะ advanced periductal fibrosis ในแหล่งระบาดของโรคพยาธิใบไม้ตับเพื่อใช้เป็นตัวตรวจชีวภาพในคัดกรองกลุ่มเสี่ยง |
ศ.ดร. พวงรัตน์ ยงวณิชย์ อ.ดร. อัญชลี เตชะเสน ดร. สิทธิรักษ์ รอยตระกูล รศ.ดร.นพ. ณรงค์ ขันตีแก้ว รศ.ดร. นิษณา นามวาท ศ.ดร. ไพบูลย์ สิทธิถาวร รศ.ดร. วัชรินทร์ ลอยลม |
โครงการย่อย ภายใต้ชุดโครงการวิจัย | 2557 | ทุนงบประมาณแผ่นดินประจำปี 2557 | |
| 4. | แบบแผนไมโครอาร์เอ็นเอในซีรัมและปัสสาวะของผู้ที่มีภาวะ advanced periductal fibrosis ในแหล่งระบาดของโรคพยาธิใบไม้ตับเพื่อใช้เป็นตัวตรวจชีวภาพในคัดกรองกลุ่มเสี่ยงของโรคมะเร็งท่อน้ำดี |
รศ.ดร. นิษณา นามวาท ศ.ดร. ไพบูลย์ สิทธิถาวร นายชวลิต ไพโรจน์กุล ศ.ดร. พวงรัตน์ ยงวณิชย์ รศ.ดร. วัชรินทร์ ลอยลม อ.ดร. อัญชลี เตชะเสน |
โครงการย่อย ภายใต้ชุดโครงการวิจัย | 2557 | ทุนงบประมาณแผ่นดินประจำปี 2557 | |
| 5. | อิทธิพลของความหลากหลายทางพันธุกรรมของยีน GST ต่อการทำลายดีเอ็นเอในกลุ่มสี่ยงโรคมะเร็งท่อน้ำดีที่เกิดจากพยาธิใบไม้ตับ |
ศ.ดร. ไพบูลย์ สิทธิถาวร ศ.ดร. พวงรัตน์ ยงวณิชย์ ศ.ดร. สมชาย ปิ่นละออ รศ.ดร. วัชรินทร์ ลอยลม |
โครงการย่อย ภายใต้ชุดโครงการวิจัย | 2557 | ทุนงบประมาณแผ่นดินประจำปี 2557 | |
| 6. | กลไกการเปลี่ยนแปลงรูปร่างของเซลล์จากเยื่อบุผิวเป็นมีเซนไคม์ในกระบวนการก่อมะเร็งท่อน้ำดีที่สัมพันธ์กับพยาธิใบไม้ตับ: เป้าหมายใหม่เพื่อการป้องกันและรักษา |
อ.ดร. อัญชลี เตชะเสน ศ.ดร. พวงรัตน์ ยงวณิชย์ รศ.ดร. วัชรินทร์ ลอยลม รศ.ดร. นิษณา นามวาท ศ.ดร.สพญ. ธิดารัตน์ บุญมาศ ผศ.ดร. เรณู ทานันท์ |
โครงการย่อย ภายใต้ชุดโครงการวิจัย | 2559 | ทุนงบประมาณแผ่นดินประจำปี 2559 (เป้าหมาย2) | |
| 7. | การควบคุมวิถีออโตฟาจีในกระบวนการก่อมะเร็งท่อน้ำดีที่สัมพันธ์กับพยาธิใบไม้ตับ: เป้าหมายใหม่เพื่อการป้องกันและรักษา |
รศ.ดร. นิษณา นามวาท รศ.ดร. วัชรินทร์ ลอยลม ศ.ดร.สพญ. ธิดารัตน์ บุญมาศ ศ.ดร. พวงรัตน์ ยงวณิชย์ ผศ.ดร. เรณู ทานันท์ อ.ดร. อัญชลี เตชะเสน |
โครงการย่อย ภายใต้ชุดโครงการวิจัย | 2559 | ทุนงบประมาณแผ่นดินประจำปี 2559 (เป้าหมาย2) | |
| 8. | ตัวชี้วัดทางชีวภาพแบบใหม่จากปัสสาวะเพื่อประเมินการกำจัดพยาธิใบไม้ตับด้วยยาขับพยาธิและเพื่อการตรวจกรองกลุ่มเสี่ยงต่อมะเร็งท่อน้ำดี |
ศ.ดร. ไพบูลย์ สิทธิถาวร รศ.ดร. วัชรินทร์ ลอยลม จิราพร สิทธิถาวร |
โครงการย่อย ภายใต้ชุดโครงการวิจัย | 2559 | ทุนงบประมาณแผ่นดินประจำปี 2559 (เป้าหมาย2) | |
| 9. | บทบาทของยีนก่อมะเร็งท่อน้ำดีในสภาวะความเครียดออกซิเดชันที่สัมพันธ์กับกระบวนการเหนือพันธุกรรมเพื่อการป้องกันและรักษาโรค |
ผศ.ดร. เรณู ทานันท์ ศ.ดร. พวงรัตน์ ยงวณิชย์ รศ.ดร. วัชรินทร์ ลอยลม ศ.ดร. สมชาย ปิ่นละออ อ.ดร. อัญชลี เตชะเสน รศ.ดร. นิษณา นามวาท นายชวลิต ไพโรจน์กุล |
โครงการย่อย ภายใต้ชุดโครงการวิจัย | 2559 | ทุนงบประมาณแผ่นดินประจำปี 2559 (เป้าหมาย2) | |
| 10. | ยีนก่อมะเร็งท่อน้ำดีที่สัมพันธ์กับโรคพยาธิใบไม้ตับ: เป้าหมายใหม่สำหรับการป้องกันและรักษา |
รศ.ดร. นิษณา นามวาท ผศ.ดร. เรณู ทานันท์ รศ.ดร. วัชรินทร์ ลอยลม อ.ดร. อัญชลี เตชะเสน ศ.ดร. สมชาย ปิ่นละออ |
ชุดโครงการวิจัย | 2559 | ทุนงบประมาณแผ่นดินประจำปี 2559 (เป้าหมาย2) | |
| 11. | ฤทธิ์ของสารยั้บยั้งวิถีการส่งสัญญาณของโปรตีนไคเนสเพื่อใช้ในการป้องกันและรักษาโรคมะเร็งท่อน้ำดี |
รศ.ดร. วัชรินทร์ ลอยลม ศ.ดร.สพญ. ธิดารัตน์ บุญมาศ ศ.ดร. พวงรัตน์ ยงวณิชย์ รศ.ดร. นิษณา นามวาท อ.ดร. อัญชลี เตชะเสน ผศ.ดร. เรณู ทานันท์ |
โครงการย่อย ภายใต้ชุดโครงการวิจัย | 2559 | ทุนงบประมาณแผ่นดินประจำปี 2559 (เป้าหมาย2) | |
| 12. | การประยุกต์ใช้เทคนิค histoculture drug response assays ในการพยากรณ์การตอบสนองต่อการรักษาด้วยยาเคมีบำบัดในผู้ป่วยมะเร็งท่อน้ำดี |
รศ.ดร. วัชรินทร์ ลอยลม รศ.ดร. นิษณา นามวาท อ.ดร. อัญชลี เตชะเสน อ.ดร. อภิญญา จุ๊สกุล นพ. อรรถพล ติตะปัญ ม.ล. มานิดา ศุขสวัสดิ |
โครงการย่อย ภายใต้ชุดโครงการวิจัย | 2562 | ทุนงบประมาณแผ่นดินประจำปี 2562 (งบบูรณาการวิจัยและนวัตกรรม) | |
| 13. | การพัฒนาชุดตรวจทางชีวภาพเพื่อใช้ในการพยากรณ์การตอบสนองต่อการรักษาด้วยยาเคมีบำบัดในผู้ป่วยมะเร็งท่อน้ำดี |
รศ.ดร. วัชรินทร์ ลอยลม อ.ดร. อภิญญา จุ๊สกุล รศ.ดร. นิษณา นามวาท อ.ดร. อัญชลี เตชะเสน |
ชุดโครงการวิจัย | 2562 | ทุนงบประมาณแผ่นดินประจำปี 2562 (งบบูรณาการวิจัยและนวัตกรรม) |